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Introduction
Causal inference deals with cause-effect relationships between interventions (expo-
sures) and outcomes (responses) in many fields of study. It aims to infer causal effects
of intervention (exposure) from empirical data on outcomes of interest through design
and analysis. For example in the medical sciences, one might be interested to estimate
the causal effect of a specific drug or other medical intervention on a primary health
or risk outcome. In nutritional studies, one may investigate the effects of nutrition
habits on cancer or chronic illness. In bioassay experiments, one wishes to assess the
effects of herbicides on the dry weight of plants grown in the same pot. In social epi-
demiology, one may attempt to understand the relationship of socio-economic status
with health, and ponder to find the effect on all-cause mortality. For this purpose,
large amounts of data are required to sample through experimental or observational
studies and statistical techniques are used to analyze these data to infer the causal
effects of interest.
For doing so, investigators might be confronted with the difficulty of determining valid
measurements of exposure. Specifically, in some situations exposure is hard to mea-
sure and researchers may not succeed to observe the true exposure for each subject
in practice. For instance, in the context of noncompliance adjustment in randomized
controlled trials, simple measures of compliance with drug therapy, such as pill counts
are notorious for overestimating the amount of drug actually taken. In nutritional
studies for example, it is rational to believe that exposures are not precisely measured
if they are obtained through self-report or questionnaires or even by technical sophis-
ticated tools. In environmental problems individual levels of pollution and radiation
are difficult to measure. In herbicide studies the amount of the herbicide actually ab-
sorbed by the plant is a quantity which cannot be accurately measured. Systematic
measurement errors on exposure thus occur frequently and are inevitable in practice.
Measurement error in exposure forms a common source of bias in exposure effect
estimates on outcome. When no adjustments are made for measurement errors, the
bias of effect estimates can grow unexpectedly large and lead to a loss of efficiency,
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in particular when the exposure effect is confounded by measured or unmeasured
covariates. Briefly, confounding of the exposure effect occurs when the outcome is
influenced by prognostic factors of the exposure other than the exposure itself. These
factors are called confounders.
New concerns over the impact of measurement error have arisen in the context of
recently developed causal models for the noncompliance adjustment (Dunn, 1999;
Goetghebeur and Vansteelandt, 2005). Investigating the impact of systematic mea-
surement error in exposure or error of exposure misclassification in causal models and
correcting for it, forms the topic of this thesis. To the best of our knowledge, this
phenomenon has not been addressed yet in the causal inference literature.
Over the past decades much attention has been paid to the impact of measurement
error and of misclassification error in many of the well known regression models (e.g.,
Fuller, 1987; Gustafson, 2003; Carroll et al., 2006). In particular, estimation strategies
have been proposed that successfully correct estimated exposure effects for error-prone
exposure measurements. In chapter 1, we give an introduction to regression modeling
in settings where some explanatory variables are measured with error. We explain
the impact of measurement error in continuous and categorical explanatory variables.
Specifically, we illustrate for instance that, in simple linear regression of outcome on
explanatory variable, an error-prone explanatory variable leads not only to less precise
estimates of regression coefficients but it also biases them towards zero. Moreover,
we introduce various methods of adjustment for measurement error that can be used
if its magnitude may be estimated from supplementary information.
In chapter 2, we will give an introduction to the statistical framework of counterfac-
tual outcomes for causal inference as it has been developed over the past decades. We
define causal effects and causal models formally in this setting, and state the assump-
tions which allow to identify causal effects. We explain the problem of confounding
and discuss methods to control for measured as well as unmeasured confounding. We
introduce the special clan of problems of noncompliance in randomized controlled tri-
als and expand on methods to adjust for it. We describe the instrumental variables
(IVs) approach to allow for inference on the causal effect of exposure on outcome in
the presence of noncompliance in randomized controlled trials, and for unmeasured
confounder adjustment in observational studies. We continue to investigate the prob-
lem of measurement error in exposure and important practical implications under
linear structural mean models (Robins, 1994; Goetghebeur and Lapp, 1997).
In chapter 3, we elaborate on instrumental variable (IV) estimators for the causal
effect of an exposure when the outcome is dichotomous. Specifically, we give an ex-
pository review of exact as well as approximate IV-estimators for the causal odds
ratio, that have been proposed in the biostatistical, epidemiological and econometric
literature. Methods comparisons are made, both theoretically and via extensive simu-
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lation, and new insights are developed into the assumptions underlying their validity.
The different estimators are used to assess the risk of gastrointestinal (GI) complica-
tions attributable to different non-steroidal anti-inflammatory drugs (instead of Cox-2
inhibitors).
In chapter 4, we will calculate biases and develop analytic methods to correct estima-
tors for systematic measurement error in a continuous exposure under linear structural
mean models for unconstrained outcomes. We focus on the impact of systematic error
in compliance measurements on compliance adjusted analyses. Specifically, we build
on ideas from linear regression models with error in the covariates to show how an
IV for the measurement error can help correct IV-based causal effect estimators for
systematic error under linear structural mean models.
In chapter 5, we explore the consequences of misclassification error on a dichotomous
exposure under causal models, including alternatives to ordinary regression adjust-
ment for confounder control. We focus on inverse probability of treatment weighted
(IPTW) estimators for the parameters indexing marginal structural mean models
and on G-estimators and propensity score adjusted estimators under semiparamet-
ric causal models when the exposure is subject to misclassification. We quantify
the asymptotic bias of causal effect estimators in terms of misclassification proba-
bilities depending on covariates. Furthermore, we formulate misclassification of a
time-varying exposures at each time t in longitudinal repeated measures data. In
chapter 6, we will review the main results of this thesis, give a final discussion and
plans for future work.
Chapters 3, 4 and 5 were originally written as stand-alone articles. Chapter 3 has
been submitted to Statistical Science (Babanezhad, Vansteelandt and Goetghebeur,
2009). Chapter 4 has been accepted for publication in Statistica Sinica (Vansteelandt,
Babanezhad and Goetghebeur, 2008). Chapter 5 has been submitted to the Journal
of Statistical Planning and Inference (Babanezhad, Vansteelandt and Goetghebeur,
2008). The results have been presented at international conferences. The notations
are introduced per chapter and may therefore differ throughout the complete thesis.
While the statistical discussion and development throughout this thesis is general,
our examples are drawn from biostatistics and epidemiology.
Chapter 1
Covariate Measurement Error
in Regression Models
Summary
This chapter gives an introduction to regression modeling in settings where some
explanatory variables are measured with error. The purpose is to provide a summary
of measurement error problems in explanatory variables and of analysis strategies
for correcting this, focusing on traditional regression models. We start by illustrating
how measurement error or misclassification in explanatory variables occurs in real sit-
uations. We then proceed with basic definitions of error structure in continuous and
categorical explanatory variables and with measurement error assumptions. Specif-
ically, we investigate the impact of measurement error and, in particular, misclassi-
fication on parameter estimates in linear regression analysis. We introduce various
methods of adjustment for measurement error that can be used if its magnitude may
be estimated from supplementary information.
1 Introduction and problem setting
Regression analysis is a statistical methodology that utilizes the relationship be-
tween two or more variables so that an outcome (response) variable can be predicted
from the explanatory variables (predictors). The so-called ‘measurement error prob-
lem’ or ‘errors-in-variables problem’ considered in this chapter arises in situations
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where the explanatory variable X is difficult to measure or cannot be accurately
measured for all study subjects. In particular, random or systematic errors occur
in measurements of explanatory variables in a variety of research fields. Systematic
measurement error is referred as a persistent error having zero or nonzero mean that
can be attributed to inaccuracy inherent in the systems of measurement. This error
may occur at various stages of the data collection. It may occur due to imperfect
methods of measuring, or the result of misreporting by subjects, or miscoding by the
collectors of the data, or incorrect transformation from initial reports into a form
ready for analysis, and so on. One should distinguish the systematic error in the
measurements of explanatory variable X from the random error term in regression
models, which is commonly added to the assumed relationship between outcome Y
and explanatory variable X to capture the influence of everything else on Y other
than X. In particular, the effect of the random model errors will reduce with in-
creasing sample size. In contrast, the implications of systematic measurement error
in the explanatory variables does not reduce with increasing sample size (Fuller, 1987;
Fosgate, 2006).
Throughout this chapter, we refer to error in a continuous explanatory variable X as
plain measurement error. When X is discrete (categorical), which is often the case in
medical, epidemiological and biostatistical applications, then misclassification is the
term to use. This is generally studied separately from measurement error in contin-
uous explanatory variables, although there is clearly much overlap. In both cases,
X is also called the ‘error-prone’ or ‘mismeasured variable’. The following examples
illustrate how measurement error or misclassification in explanatory variables occurs
in real-life situations.
Example 1. The effect of nutrition habits on cancer, such as breast and colon cancer
has been well investigated in the literature (e.g., Kipnis et al., 2003; Carroll et al.,
2006). Because it is both difficult and expensive to measure long-term diet in a large
cohort, instead of observing long-term diet, researchers typically measure a 24-hours
recall. That is, each subject’s diet in the previous 24-hours was recalled and nutrition
variables were computed on the basis of this. Measurement error in nutrient instru-
ments can be very large, for example because of the daily and seasonal variability of
an individual’s diet.
Example 2. Alzheimer’s disease is the most common form of dementia. It is thought
that the level of aluminium deposits, which may build up in the brain over time, have
an effect on an evaluation score for diagnosing an individual developing Alzheimer’s
(Campbell, 2002; Thompson and Carter, 2007). If investigators wanted to estimate
the association between the risk of Alzheimer’s disease and the level of aluminium
deposits in the brain, problems would arise because a perfectly accurate measure of
aluminium levels is simply not attainable.
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Example 3. Bashir et al. (1997) discuss a study examining the relationship between
the incidence of minor Ischaemic Stroke and levels of haemostatic factors which retard
the flow of blood in blood vessels. The study follows a case-control design, comparing
a group of subjects who had a minor stroke to a group that did not. Initial blood
samples were assayed twice, giving two measurements of each of the explanatory vari-
ables. Also, one-year follow-up blood samples were obtained for some of the control
subjects, and these were also assayed twice. As is typical for biochemical variables,
mismeasurement is at play in two ways. First, there is pure laboratory error which
leads to two different numerical measurements for the same blood sample. Second,
levels of the haemostatic factors vary somewhat from day-to-day within a given sub-
ject. Operationally, it makes sense to define the explanatory variable as the subject’s
average level, but measurement error arises because of the day-to-day fluctuations
(Gustafson, 2003). Even in the absence of pure laboratory error then, two blood
samples taken on different days are not likely to give identical measurements.
Example 4. The Framingham Heart study is a large cohort study, which follows
individuals for the development of coronary heart disease. The explanatory variables
are systolic blood pressure (SBP) and serum cholesterol, both of which are subject to
measurement error (e.g., MacMahon et al., 1990; Carroll et al., 2006). In particular,
it is impossible to measure long-term systolic blood pressure because blood pressure
measurements are well known to have major daily as well as seasonal variation.
It follows from the above examples that, researchers may not succeed to observe
the true explanatory variable Xi for each subject study i in practice. They instead
observe a variable Wi which approximates, but may differ from Xi for each subject
study i. The observed explanatory variable Wi is related to Xi in terms of an error
model, as described in the next section. The goal of measurement error modeling is to
obtain nearly unbiased estimates of explanatory variable effects and valid inferences
on the outcome of interest. Attainment of this goal requires careful analysis. While it
is tempting to simply plug-in Wi instead of Xi, making no further adjustment in the
usual fitting methods typically leads to biased estimates and misleading statistical
inferences (Schneeweiss and Mittag 1986; Fuller, 1987; Carroll and Stefanski, 1990;
Stefanski and Buzas 1995; Gustafson, 2003; Dunn, 2005; Buzas et al., 2005; Carroll
et al., 2006). In view of this, in this chapter, we shed further light on the known stan-
dard approach for correcting the impact of measurement error in regression models.
Although outcome variables may themselves be subject to measurement error, our
attention is limited to measurement error in explanatory variables as the impact of
the latter type of error is typically more severe.
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2 Models for measurement error
Determining the structure of measurement error or misclassification in explana-
tory variables under regression models initially requires specifying models for the
error process. Such models quantify the relationship between the true explanatory
variable X and the observed explanatory variable W . In particular, they describe
the structure of systematic error in measurements of continuous or discrete (categor-
ical) explanatory variables. In the literature on the measurement error problem, two
general types of measurement error model are commonly considered for continuous
X, where the error in the explanatory variable assessment is the difference between
the observed explanatory variable and the true explanatory variable. For discrete X,
the measurement error model can be defined in terms of conditional misclassification
probabilities.
2.1 Classical error model
In cases where explicit attention is paid to measurement error, the standard error
model is typically the ‘Classical measurement error model’ or ‘Classical additive mea-
surement error model’. This is well suited to describe the situation where the true
explanatory variable X is imperfectly recorded by W ,
W = X + U
where U , the measurement error, is assumed to be independent of X; that is, U ⊥⊥ X.
The classical measurement error model in its simplest form is appropriate when an
attempt is made to determine X directly. Errors of the classical type arise when a
quantity is measured by some device and repeated measurements vary around the true
value. For example, consider the measurement of systolic blood pressure in example
4, which is known to have daily and seasonal variations. In trying to measure long-
term systolic blood pressure, the true long-term blood pressure can be considered
fixed for an individual; the measured value is then perturbed by error. In cases like
this one, it makes sense to use the classical error model (Carroll et al., 2006). In
practice, it is common to assume that the measurement error U has mean 0 so that
E(U |X) = E(U) = 0. This implies that E(W |X) = X, suggesting that W is an
unbiased measure of X. In fact, virtually all developments on measurement error
assume the error to be normally distributed with mean zero and of the classical type
(i.e., independent of the explanatory variable X). Moreover, the error structure of
U could be homoscedastic (constant variance) or heteroscedastic. Note that not all
measurement methods assume unbiased measurements. For instance, a slightly more
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general error model that allows for systematic error is (Freedman et al., 2008),
W = γ0 + γ1X + U,
where U is independent ofX: with E(U) = E(U |X) = 0. This implies that E(W |X) =
γ0 + γ1X, unlike the classical error model, suggesting that W is a possibly biased
measure of X. This model is motivated by dietary self-report data that appear to
conform to this model after a suitable transformation (Kipnis et al., 2003). This
error model is referred to as the ‘Non-classical measurement error model’ or ‘Error
calibration model’ to distinguish it from the classical measurement error model where
γ0 = 0 and γ1 = 1. The term calibration means that W has to be calibrated to make
it unbiased for X, for instance, by using (W − γ0)/γ1.
2.2 Berkson error model
The ‘Berkson error model’ or the ‘Controlled variable model’ is an alternative to
the classical measurement error model, where X varies around W . It is based on the
assumption that the measurement error is independent of the observed explanatory
variable W , in the sense that
X =W + U
where U is independent of W ; that is, U ⊥⊥ W . The Berkson error model has
been found to be useful in agricultural and medical studies. As an example, consider
the herbicide study (Rudemo et al., 1989; Koul and Song 2008) in which a nominal
measured amount W of herbicide was applied to a plant but the actual amount
absorbed by the plant X is unobservable. Here, the actual amount absorbed by the
plant varies around the nominal measured amount W due to error. Other examples
have been studied where the relations between the yield of a crop or the efficacy of
a drug, Y , and the amount of a fertilizer or drug used, X, (Wang, 2004; Carroll et
al., 2006). Suppose the fertilizer or the drug is applied at predetermined doses W .
The actual absorption of the fertilizer in the crop or the drug in the patient’s blood
may vary randomly around the set doses, because of the local earth conditions or
the individual biological conditions. In these cases, if the amount of W is properly
calibrated, then the actual absorption X will vary randomly around W .
In practice, it is common to assume that the measurement error U has mean 0 so
that E(X|W ) =W , suggesting that X is unbiased for W . Deviation from this can be
allowed, for instance by using the error calibration model
X = γ0 + γ1W + U,
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where E(U) = E(U |W ) = 0. This model encompasses the Berkson error model, which
corresponds to γ0 = 0 and γ1 = 1.
Many statistical methods in the literature on measurement error modeling typically
suppose that the error follows the classical measurement error model. However, de-
termining an appropriate error model to use in the data analysis depends upon the
circumstance and the available data.
2.3 Error of misclassification
Many explanatory variables encountered in statistical practice are discrete (cat-
egorical), rather than continuous (e.g., Spiegelman et al., 1995; Gustafson, 2003;
Lederer and Ku¨chenhoff, 2006). In many epidemiologic applications, such categorical
exposures (e.g., level of smoking, dietary in take, quintiles of fat, etc.), for instance
those obtained through self-report or questionnaires, may be error-prone. Misclassifi-
cation may also arise by transforming a continuous variable into a discrete explanatory
variable. Misclassification error basically differs from measurement error as discussed
in previous section because the observed explanatory variable W cannot be expressed
as a sum of the true explanatory variable X with an error variable. Rather, one must
characterize the measurement error in terms of misclassification probabilities.
Example 5. Consider an example where X and Y denote the presence of a par-
ticular mental disorder (MD) such as major depression in parents and in offspring,
respectively in prospective study (Ho¨fler, 2005). The magnitude of the association
between X and Y here would represent the degree of familial aggregation of the dis-
order under consideration. Suppose that W is obtained using an error-prone method
of deriving a diagnosis for MD in the parents. Then there are two misclassification
probabilities in each variable: P (W = 1|X = 0) denotes the conditional probability
that MD is observed in the parents when in fact there is no MD (false positive rate);
and likewise, P (W = 0|X = 1) is the probability that there is apparently no MD,
while the diagnostic criteria are actually met (false negative rate).
The likely extent of misclassification of categorical variables is usually specified in
terms of conditional probabilities of misclassification. These conditional probabilities
are often expressed as the probability of the observed explanatory variable W given
the true explanatory variable X; that is, P (W |X). For dichotomous variables, it is
conventional to express these through the sensitivity, π1|1 = P (W = 1|X = 1), and
the specificity, π0|0 = P (W = 0|X = 0), of the classification. In case-control studies,
the sensitivity refers to the probability of correctly classifying a truly exposed subject
as exposed and the specificity to the probability of correctly classifying an unexposed
subject as unexposed. Thus if sensitivity, for instance, is 0.8 and specificity is 0.7, the
probability of misclassifying an exposed subject as unexposed is 1 − 0.8 = 0.2, and
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the probability of misclassifying an unexposed subject as exposed is 1 − 0.7 = 0.3.
For categorical variables of more than two levels, many different sorts of misclassifi-
cation can occur, which can be specified in a matrix of misclassification probabilities
(Morrissey and Spiegelman 1999; Ku¨chenhoff et al., 2006).
3 Regression models and the impact of measure-
ment error
Measurement error analysis generally involves three parts. Part 1 consists of a
measurement error model describing the relationship between the observed explana-
tory variable W and the unobservable true explanatory variable X. Part 2 consists
of the regression model of interest for the association of outcome Y with X, possibly
adjusted for covariates Z which are measured without error. Part 3 is linking Y and
W , possibly adjusted for covariates Z, under measurement error assumptions such as
nondifferential measurement error (explained in the next section). However, to cor-
rect for bias due to measurement error or misclassification, some further assumptions
are typically required regarding the distribution of the unobservable true explanatory
variable X and the error term U . Most methods for measurement error analysis have
been worked out for ordinary linear regression (Fuller, 1987) and common nonlinear
regression models, such as the logistic regression model (Gustafson, 2003; Carroll et
al., 2006). In this section, we develop a general regression model formulation, but
focus eventually on the simple regression model as an illustrative example. In par-
ticular, let us consider the following general regression model for the association of
outcome Yi with a mismeasured explanatory variable Xi,
E(Yi|Xi, Zi) = h(Xi, Zi;β∗), (1.1)
where covariate Zi is measured without error, h(Xi, Zi;β) is a known function smooth
in β, and β∗ is an unknown finite-dimensional parameter. Given explanatory variable
Xi, h could be the identity function when the outcome Yi is continuous or the logistic
function when Yi is dichotomous.
3.1 Structural and functional models
In the measurement error analysis, it is typically necessary to make assumptions
about the distribution of X. Specifically, one may consider the X’s to be unknown,
nonrandom constants or random variables with a distribution given by a density
function fX(x; γ
∗), where γ∗ may be a vector of nuisance parameters describing the
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distribution of X. In so-called structural models, the explanatory variable Xi is
regarded as a random variable; thus Xi is assumed to be independent random draws
from a distribution for each i = 1, ..., n. In contrast, in so-called functional models, Xi
is regarded as unknown fixed constant for each i = 1, ..., n. Throughout, we mainly
devote attention to the structural model, but it is nonetheless important to say that
functional modeling is attractive because it avoids assumptions.
3.2 Differential and nondifferential measurement error
Measurement error can be either differential or nondifferential. Nondifferential
measurement error in the presence of an error-free covariate Z occurs when Y is
independent of W , given X and Z; that is, Y ⊥⊥W |X,Z so that fY |W,X,Z = fY |X,Z .
The observed measurementW is then said to be a surrogate for X. If this assumption
fails, then the error is said to be differential. The assumption of nondifferential
measurement error thus states that W contains no information for predicting Y in
addition to the information already contained inX and Z. Intuitively, it thus suggests
that the measurement error arises in a manner which is blind to the outcome variable,
so in some sense the problem is limited to one of a difficulty in making measurements.
This assumption is useful (Buzas et al., 2005; Greenland and Gustafson 2006; Carroll
et al., 2006), because it greatly simplifies the link between the association of Y and
W and the association of Y and X (see Section 4). Many statistical methods in
the literature on measurement error modeling are therefore based on the assumption
of nondifferential measurement error. However, it is important to understand this
concept and to recognize when it is an appropriate assumption and when it is not.
Nondifferential error is plausible in many cases. In example 4 of Section 1, X refers to
long-term systolic blood pressure, whereasW denotes the blood pressure measurement
on a single day. It is reasonable to believe that a single day’s blood pressure contains
no more information than long-term blood pressure (Carroll et al., 2006), and hence
that measurement error is nondifferential. Throughout, we focus on nondifferential
measurement error unless stated otherwise.
4 Continuous explanatory variables
We begin with an illustration of the effects of measurement error for the case of
homoscedastic ordinary linear regression where the explanatory variable X is contin-
uous. Consider the multiple linear regression model,
E(Yi|Xi, Zi) = β∗0 + β∗1Xi + β∗2Zi, (1.2)
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where Zi is an error-free covariate and Xi is an error-prone explanatory variable with
mean µx and variance σ
2
x. Here, β
∗ = (β∗0 , β
∗
1 , β
∗) is an unknown finite-dimensional
parameter, with β∗1 encoding the conditional association between Xi and Yi (given
Zi). Under the classical additive measurement error model, Wi = Xi+Ui, we observe
a variableWi instead ofXi, where the measurement error Ui is independent of (Xi, Zi)
with mean zero µu = 0. In this section, we will additionally assume Ui to be normally
distributed with constant variance σ2u which is assumed known or can be estimated
from supplementary data (next section). Suppose that the primary interest of the
study lies in the conditional association β∗1 of X and Y . When the investigator is
unaware of the measurement error or chooses to ignore it, he/she may simply regress
Y on (W,Z), and would then not obtain a consistent estimate of β∗, but instead
obtain an estimate of θ∗ = (θ∗0 , θ
∗
1 , θ
∗
2) indexing the following regression model,
E(Yi|Wi, Zi) = θ∗0 + θ∗1Wi + θ∗2Zi. (1.3)
Throughout, model (1.3) is called the naive model and parameter θ∗ is called the
naive parameter. The latter is implied by model (1.2) by the fact that the rela-
tionship between Y and (W,Z) is greatly simplified when the measurement error is
nondifferential:
E(Y |W,Z) = E{E(Y |W,Z,X)|W,Z}
= E{E(Y |X,Z)|W,Z} = β∗0 + β∗1E(X|W,Z) + β∗2Z. (1.4)
The latter implies that the regression of Y on (W,Z) is equal to the regression of
Y on {E(X|W,Z), Z}. In statistics, a great deal of current research in parametric
and semiparametric statistical inference is organized around estimating equations. In
regression models, one often solves the estimating equation corresponds to that re-
gression model to obtain regression coefficient estimates. The estimating equation is
then called unbiased if it has expectation zero when evaluated at the true parameter
values. If it is unbiased, its solution is a consistent and asymptotically normal estima-
tor for the considered parameters. In the absence of measurement error a consistent
and asymptotically normal estimator for β∗ under model (1.2) can be obtained by
solving,
0 =
n∑
i=1
Ui(Yi,Xi, Zi;β
∗) =
n∑
i=1

 1Xi
Zi

 (Yi − β∗0 − β∗1Xi − β∗2Zi) .
Here, Ui(Yi,Xi, Zi;β
∗) is an unbiased estimating equation, because E{Ui(Yi,Xi, Zi;β∗)} =
0. By replacing W instead of X, U(Yi,Wi, Zi;β
∗) may not generally be unbiased.
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Throughout, we will use estimating equations to find the bias formula for the true
coefficients due to measurement error. Under the naive model (1.3), the limiting
parameter θ∗ is obtained by solving the following expected estimating equation
0 = E{Ui(θ∗)} = E



 1Wi
Zi

 (Yi − θ∗0 − θ∗1Wi − θ∗2Zi)

 . (1.5)
Comparing this with the true model (1.2) then yields a bias formula. Note that,
throughout we use U(θ∗) to denote an estimating function, and U for random mea-
surement error.
4.1 Bias with the Classical error model
For simplicity, we first start with models that no error-free covariate. Consider
linear model (1.2) with no error-free covariate Z and assume the classical error model
holds. As stated, with the classical additive error model, measurement error U is
independent of X with mean 0 and variance σ2u. It follows then from the classical
additive error model that; E(W |X) = X, V ar(W |X) = σ2u, E(W ) = µx, V ar(W ) =
σ2x + σ
2
u, and Cov(W,X) = Cov(X + U,X) = σ
2
x. Under regression model (1.3) with
no covariate Z, the naive coefficient estimators can be obtained by solving,
0 = E{U(θ∗)}
= E
{(
1
W
)
(Y − θ∗0 − θ∗1W )
}
= E
[
E
{(
1
W
)
(Y − θ∗0 − θ∗1W ) |X,W
}]
.
This yields to the following equations under the nondifferential measurement error
assumption,

E{E(Y |X)− θ∗0 − θ∗1W} = E(β∗0 − θ∗0 + β∗1X − θ∗1W ) = 0
E[W{E(Y |X)− θ∗0 − θ∗1W}] = E{(β∗0 − θ∗0)W + β∗1XW − θ∗1W 2} = 0.
It follows from solving the above equations that;
θ∗1 =
Cov(W,X)
V ar(W )
β∗1 =
σ2x
σ2x + σ
2
u
β∗1 .
That is
θ∗1 = λβ
∗
1 (1.6)
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where
λ =
σ2x
σ2x + σ
2
u
(1.7)
and θ∗0 = β
∗
0+(1−λ)β∗1µw. As a result, ordinary least squares regression yields biased
estimators of the regression slopes of error-prone explanatory variables. In particular,
because λ < 1, the least squares regression coefficient θ∗1 is biased towards zero.
This bias does not vanish with increasing sample size. In the measurement error
literature, the attenuation factor λ is called the ‘reliability ratio’ (variance of true
explanatory variable divided by variance of measured explanatory variable, possibly
given the error-free covariate); it expresses the degree of attenuation. It suggests
that measurement error bias increases with decreasing explanatory variable variance.
This usage of the term reliability is standard in technical discussions of measurement
error, although it is used more generally among epidemiologists as a synonym for
reproducibility or precision. If there is information on the magnitude of the error
variance and the distribution of the explanatory variable X, then the above results
allow in principle to correct for measurement error in estimating regression slopes, at
least for reasonably simple forms of measurement error. An asymptotically unbiased
estimator of β∗1 is then given as follows,
βˆ1 =
θˆ1
λ
(1.8)
where θˆ1 is the ordinary least squares estimate of θ
∗
1 . The resulting estimator (1.8) is
sometimes called the regression coefficient corrected for attenuation. Further, E(βˆ1) =
β∗1 and V ar(βˆ1) = V ar(θˆ1)/λ
2. Because λ < 1, it is clear that V ar(βˆ1) > V ar(θˆ1).
This implies correcting for bias entails that the corrected estimator will be more vari-
able than the biased estimator and then have wider confidence intervals. This gen-
erally means that the price for reduced bias is increased variance. This phenomenon
is not restricted to the linear model; it occurs almost universally in the analysis of
measurement error. Figure 1 displays the attenuation factor λ as function of τ where
τ2 = σ2u/σ
2
x. The first impression from this curve is that a moderate amount of mea-
surement error does not cause a substantial attenuation (Gustafson, 2003; Carroll et
al., 2006). For instance τ = 0.1, interpreted as 10% measurement error yield λ = 0.99.
Moreover, one would expect that because W is not the true explanatory variable, it
has a weaker relationship with the outcome than does X. This can be seen by the
attenuation factor and also by the residual variance of regression of Y on W . Indeed,
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Figure 1: Attenuation factor λ as function of τ where τ2 = σ2u/σ
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x for linear regression.
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it follows from the normality assumption and the classical error model that
V ar(Y |W ) = V ar(β∗0 + β∗1X + ǫ|W )
= β∗21 V ar(X|W ) + σ2ǫ
= β∗21 (1− ρ2xw)σ2x + σ2ǫ
= β∗21 (1−
σ2x
σ2w
)σ2x + σ
2
ǫ
= β∗21
σ2uσ
2
x
σ2x + σ
2
u
+ σ2ǫ ,
where σ2ǫ is the variance of random error term in linear regression of Y given X.
We assume the normality assumption, (X,U, ǫ) ∼ N{(µx, 0, 0)′,

 σ2x 0 00 σ2u 0
0 0 σ2ǫ

},
that is, random vector (X,U, ǫ) is normally and independently distributed, where ǫ
is the random error term in model (1.2). Consider now model (1.2) (with error-free
covariate Z) with the classical error model. Under the nondifferential measurement
error assumption
0 = E{U(θ∗)} = E[E{U(θ∗)|X,W,Z}]
= E



 1W
Z

E(Y |X,Z)− θ∗0 − θ∗1W − θ∗2Z

 .
As stated, with the classical error model measurement error U is independent of
(X,Z) with mean 0 and variance σ2u. It then follows from the classical additive error
model that E(W |Z) = E(X|Z),
E(XW |Z) = E{X(X + U)|Z} = E(X2|Z)
and
Cov(W,X|Z) = Cov(X + U,X|Z) = σ2x|z.
Here we suppose that X and Z are linearly related
E(X|Z) = η∗0 + η∗1Z.
In the Appendix, we show that by solving the latter expected estimating equation
that,
θ∗1 = λzβ
∗
1 , (1.9)
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where
λz =
σ2x|z
σ2x|z + σ
2
u
, (1.10)
and σ2x|z = V ar(X|Z). This implies that the bias induced in the regression coefficient
for X subject to measurement error is worsened by the presence of an additional
precisely measured covariate Z, provided X and Z are correlated. The attenuation
factor λz is equal to λ when Z is independent of X. A similar derivation shows that
the coefficient of Z is also biased, unless Z is independent of X. We obtain
θ∗2 = β
∗
2 + (1− λz)β∗1η∗1 . (1.11)
The bias of this regression slope is thus (1−λz)β∗1η∗1 . As a result, measurement error
in X can also induce bias in the regression coefficients of error-free covariates Z. This
has important implications for analysis of covariance models in which the continuous
explanatory variable is measured with error (Carroll, 1989; Buzas et al., 2005; Carroll
et al., 2006). Note that hypothesis tests for the regression slope β∗1 are valid in the
presence of random, nondifferential measurement error (in the sense of preserving the
nominal Type I error rate) because, there is no bias (see expression 1.9) under the
null hypothesis that β∗1 = 0. Tests may however, be less powerful than in the absence
of measurement error. Note also that under the nondifferential measurement error
assumption,
E(Y |W,Z) = β∗0 + β∗1E(X|W,Z) + β∗2Z.
It follows that, when E(X|W,Z) = α∗0 + α∗1W + α∗2Z,
E(Y |W,Z) = β∗0 + β∗1α∗0 + β∗1α∗1W + (β∗2 + β∗1α∗2)Z. (1.12)
This implies that the naive model test that none of the predictors are useful for
explaining variation in Y is valid in the sense of having the desired Type I error rate.
Specifically, examination of (1.3) and (1.12) shows that θ∗2 = 0 is equivalent to β
∗
2 = 0,
only if β∗1α
∗
2 = 0. It follows that the naive test of H0 : β
∗
2 = 0 is valid only if X is
unrelated to Y conditional on Z (β∗1 = 0) or if Z is unrelated to X (α
∗
2 = 0). The
naive tests that are valid, that is, those that maintain the Type I error rate, will still
suffer reduced power relative to the test based on the true data.
4.2 Bias with the Berkson error model
The Berkson models the condition E(X|W ) = W . It follows from the fact that
W ⊥⊥ U , µw = µx, σ2x = σ2w + σ2u and
Cov(W,X) = Cov(W,W + U) = σ2w.
4 Continuous explanatory variables 19
This implies, using (1.7), that λ = 1. That is, when the error in X follows the
unbiased Berkson error model, the naive estimator of slope is an unbiased estimator
of β∗ in linear regression model. However, there is no bias in the naive regression
parameter estimators, but there is an increase in the residual variance because under
model (1.2) and the Berkson error model,
V ar(Y |W ) = V ar(β∗0 + β∗1X + ǫ|W )
= β∗21 V ar(W + U |W ) + σ2ǫ
= β∗21 σ
2
u + σ
2
ǫ .
4.3 Nonlinear regression models
Regression coefficients in generalized linear models, including models of particular
interest in epidemiology such as logistic regression (or probit regression) and poisson
regression, are affected by measurement error in much the same manner as are linear
model regression coefficients. In particular, relative risks and odds ratios are affected
by measurement error much the same as linear model regression coefficients (Rosner
et al. 1989, 1990; Stefanski 1985; Carroll et al., 2006). Suppose that the outcome
variable Y is dichotomous. We now consider model (1.1) with logistic link without
covariates Z,
logitP (Y = 1|X) = β∗0 + β∗1X. (1.13)
Assume that the error in X is nondifferential and follows the classical measurement
error model. Then the observed data model implied by these restrictions, satisfies
P (Y = 1|W ) =
∫
x
P (Y = 1|W,X)fX|W (x|w)dx =
∫
x
P (Y = 1|X)fX|W (x|w)dx.
This integral is not easy to handle, and to the best of our knowledge there is no closed
form solution for the bias expressions. Now consider the above model with the probit
link,
Φ−1{P (Y = 1|X)} = β∗0 + β∗1X.
Under the assumption of normality, we can evaluate the latter integral by the probit
link. Because, as stated, X ∼ N(µx, σ2x) and U ∼ N(0, σ2u) then
E(X|W ) = µx + ρxw σx
σw
(W − µw)
V ar(X|W ) = (1− ρ2xw)σ2x =
(
1
σ2x
+
1
σ2u
)−1
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because ρxw =
σx
σw
in the classical error model. Then the latter integral can be written
as
P (Yi = 1|Wi) =
∫ ∞
−∞
Φ(β∗0 + β
∗
1xi)f(xi;µ
∗
i , σ
∗2)dxi
= Φ
{
β∗0 + β
∗
1µ
∗
i√
1 + β∗21 σ∗2
}
where σ∗2 = ( 1σ2x +
1
σ2u
)−1 and µ∗i = E(Xi|Wi) for i = 1, ..., n (Reeves et al., 1998;
Heid et al., 2002). A direct comparison of the latter with the naive model
P (Yi = 1|Wi) = Φ(θ∗0 + θ∗1Wi)
yields
θ∗1 =
λβ∗1√
1 + σ2uλβ
∗2
1
and
θ∗0 =
β∗0 + (1− λ)µwβ∗1√
1 + σ2uλβ
∗2
1
.
The close relationship between the logit and probit form, namelyG(t) = (1+exp(−t))−1 ≈
Φ(t/h) with h = 1.70, allows us to obtain an approximate asymptotic bias formula
for the logistic regression coefficients in model (1.13).
5 Discrete explanatory variables
As explained in Section (2.3), the situation in which a discrete variable is measured
with error, is referred to as misclassification. The degree of misclassification error
in X can be expressed in terms of misclassification probabilities. In the case of a
dichotomous explanatory variable X, the probability π1|1,z = P (W = 1|X = 1, Z),
for instance expresses how likely it is for someone who is truly exposed with covariate
level Z to be classified as exposed. Likewise, π0|0,z = P (W = 0|X = 0, Z) expresses
how likely it is for someone who is truly unexposed with covariate level Z, to be
classified as unexposed. In view of this, for a dichotomous explanatory variable X
taking the values 0 and 1, the probabilities π1|1,z and π0|0,z are called sensitivity and
specificity respectively. The extent to which π1|1,z and π0|0,z are less than 1 reflects
the severity of the degree of misclassification, with 1 indicating no misclassification
error. An alternative is to use reclassification probabilities, that is P (X = x|W =
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w,Z). Spiegelman et al. (2000) use these to develop inference for logistic regression
with covariate misclassification, and Christopher and Kupper (1995) refer to these
as predictive classification probabilities. We adopt misclassification probabilities here
and reclassification probabilities in chapter 5. In epidemiology, most discussions on
the effects of misclassification of explanatory variables have focused on the impact on
the relative risk or the odds ratio in studies of a dichotomous explanatory variable
(e.g., Morrissey and Spiegelman, 1999; Gustafson, 2003; Ho¨fler, 2005; Jurek et al.,
2005). For instance, let Y = 1 indicate the presence of a particular disease and X = 1
indicate exposure to a putative risk. Typically, the inferential interest focuses on the
odds ratio,
ψ =
P (X = 1|Y = 1)/P (X = 0|Y = 1)
P (X = 1|Y = 0)/P (X = 0|Y = 0) ,
which describes the association between exposure and disease. Here, P (X = 1|Y = 1)
and P (X = 1|Y = 0) are the prevalences of exposure amongst diseased and disease-
free subjects respectively. For instance, Jurek et al. (2005) show how often an ob-
served relative risk is an overestimate of the true relative risk when the bias is towards
the null. In addition to cause bias in effect estimates of the odds ratio, misclassifica-
tion error may lead to an exaggerated precision in confidence intervals. The reason
is that misclassification errors may add further noise to the data (Reade-Christopher
and Kupper, 1991; Neuhaus, 1999). Consider now a linear regression model (1.2)
for a continuous outcome Y given a dichotomous explanatory variable X which is
subject to misclassification. For simplicity, we first start with no error-free covariate
Z. Assuming nondifferential error
E(Y |W ) = E{E(Y |X)|W}
= β∗0 + β
∗
1P (X = 1|W )
= β∗0 + β
∗
1 {WP (X = 1|W = 1) + (1−W )P (X = 1|W = 0)}
= β∗0 + β
∗
1
π0|1µx
1− µw + β
∗
1
{
π1|1µx
µw
+
π0|0(1− µx)
1− µw − 1
}
W
where πw|x = P (W = w|X = x) for w = 0, 1 and x = 0, 1. A direct comparison of
the latter with the naive model, E(Y |W ) = θ∗0 + θ∗1W , shows that
θ∗1 =
µx(1− µx)
µw(1− µw) (π1|1 + π0|0 − 1)β
∗
1 (1.14)
and
θ∗0 = β
∗
0 +
(1− π1|1)µx
1− µw β
∗
1 .
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Let κ = µx(1−µx)µw(1−µw) (π1|1 + π0|0 − 1). Note that µw = P (W = 1) is the function of
(π1|1, π0|0, µx) because
P (W = 1) =
1∑
x=0
P (W = 1|X = x)P (X = x) = 1− π0|0 + (π1|1 + π0|0 − 1)µx.
Substituting the latter into (1.14) yields
κ =
µx(1− µx)
{1− π0|0 + (π1|1 + π0|0 − 1)µx}{π0|0 − (π1|1 + π0|0 − 1)µx}
(π1|1 + π0|0 − 1).
As in the continuous case, κ is often referred to as attenuation factor. When there is
no misclassification, that is; π1|1 = π0|0 = 1, then evidently θ∗1 = β
∗
1 . To interpret κ,
we take its derivative, for instance, with respect to π1|1 for fixed π0|0 and µx:
∂κ/∂π1|1 = µx(1− µx)
a(1− a)− (2a− 1)(π0|0 − a)
{a(1− a)}2 ≥ 0
where a = π0|0 − (π1|1 + π0|0 − 1)µx. This implies that κ is increasing in π1|1 for
fixed π0|0 and µw. Likewise κ is increasing in π0|0 for fixed π1|1 and µx. Thus the
effect of misclassification is an attenuation bias. As expected, the bias also worsens
with the severity of the misclassification. It is usually expected that nondifferential
misclassification of a dichotomous explanatory variable will yield bias towards the null,
although this rule can break down when the variable is polytomous (Gustafson, 2003;
Jurek et al., 2005; Chu et al., 2006). Further, When µx = 0.5, the bias is symmetric
in π1|1 and π0|0, as can be seen by direct inspection of (1.14). For instance, when
µx = 0.5 and π1|1 = π0|0 = 0.9 (which can be interpreted as 10% misclassification),
then θ∗1 = 0.80β
∗
1 , because µw = 0.45 and κ = 0.80. This can be interpreted as 20%
attenuation. Note that, as for continuous explanatory variables, tests whether the
error-prone explanatory variable is associated with the outcome, remain valid in the
presence of measurement error because the bias expression (1.14) is zero under the
null hypothesis H0 : β
∗
1 = 0. They may however be less powerful than in the absence
of measurement error. Further, when κ is known then E(βˆ1) = κ
−1E(θˆ1) = β∗1 and
V ar(βˆ1) = κ
−2V ar(θˆ1). More generally when there is an error-free covariate Z in
model (1.2) with a dichotomous explanatory variable X, misclassification error may
be expressed in terms of
P (W = 1|X,Z = z) = 1− π0|0,z + (π1|1,z + π0|0,z − 1)X,
where πw|x,z is related with the error-free covariate Z for w = 0, 1 and x = 0, 1. In
chapter 5, we investigate the asymptotic bias of the ordinary least squares estimate
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of the regression coefficient in terms of reclassification probabilities when they are
related to the error-free covariate Z. We now investigate the bias of the ordinary
least squares estimate of the regression coefficients β∗ when
πw|x,z = πw|x
for w = 0, 1 and x = 0, 1. We show by solving the following expected estimating
equation under the nondifferential measurement error,
0 = E{U(θ∗)} = E



 1W
Z

 (Y − θ∗0 − θ∗1W − θ∗2Z)


= E



 1W
Z

 (E(Y |X,Z)− θ∗0 − θ∗1W − θ∗2Z)


that θ∗0 = β
∗
0 + µxβ
∗
1 − µwθ∗1 + µz(θ∗2 − β∗2).
This can obviously be obtained by solving the first row of the above equation. In the
Appendix, we further show that
θ∗1 = (π1|1 + π0|0 − 1)
{
µx(1− µx)(1− ρ2)
µw(1− µw)− µx(1− µx)(π1|1 + π0|0 − 1)2ρ2
}
β∗1 (1.15)
and
θ∗2 = β
∗
2 + β
∗
1ρ
√
µx(1− µx)
σz
{
1− (π1|1 + π0|0 − 1)
θ∗1
β∗1
}
where ρ = ρxz and σz =
√
V ar(Z). The coefficient
κ1 = (π1|1 + π0|0 − 1)
{
µx(1− µx)(1− ρ2)
µw(1− µw)− µx(1− µx)(π1|1 + π0|0 − 1)2ρ2
}
is again referred to as the attenuation factor. By taking partial derivatives of κ1,
it is straightforward to show that it is increasing in π1|1 for fixed (π0|0, µx, ρ) and
increasing in π0|0 for the fixed (π1|1, µx, ρ). For the fixed value of (π1|1, π0|0, µx), κ1 is
decreasing in |ρ| (Gustafson, 2003). The latter implies that the attenuation worsens
as the correlation between X and Z increases.
6 Methods for measurement error correction
As stated before, an important problem in most measurement error analysis is
the inability to correct for bias due to measurement error given only the informa-
tion contained in the sample of observed (Y,W,Z) variables. That is, one would not
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be able to correct for bias due to measurement error only based on the information
contained in (Y,W,Z). Over the past decades, a number of statistical techniques
have been proposed for correcting the impact of measurement error and misclassifi-
cation error in an explanatory variable X. The choice of methods depends on the
information distribution of the variables, the magnitude of the error variance, and
the type of error model. They indeed differ according to the assumptions about the
distribution of the unobserved explanatory variable X, the availability of additional
data about the unobserved explanatory variable X and the theoretical background of
the approach, which may be parametric or nonparametric. Fuller (1987) developed
extensive methods for measurement error correction in linear regression models. A
review of measurement error correction techniques in case-control studies is given in
Thu¨rigen el al. (2000). Gustafson (2003) has presented correction methods with a
focus on Bayesian adjustments. Carroll et al. (2006) have provided a comprehensive
account of current statistical methodologies for measurement error correction in non-
linear regression models.
Because under nondifferential measurement error, the observed data likelihood equals
f(Y,W,Z) =
∫
f(Y |X,Z)f(W |X,Z)f(X,Z)dX
or =
∫
f(Y |X,Z)f(X|W,Z)f(W,Z)dX
measurement error correction requires information about either the distribution of
W given X (when the error in X follows the classical measurement error or misclas-
sification probabilities) or of X given W (when the error in X follows the Berkson
error model or reclassification probabilities) possibly conditional on Z. Because X is
unobserved, one usually needs to observe additional data sources, beyond the main
study sample. Additional data can be available in different forms. For instance, a
subsample of observations from X can be recorded for a small group of subjects of the
main study sample. It yields an internal validation data set, from which so-called gold
standard measures of X are available. It follows naturally that missing data methods
can be applied for measurement error correction in this setting (Robins, Rotnitzky
and Zhao, 1994; Carroll et al., 2006). A common alternative is to collect replication
data; that is, replicates {Wij ; j = 1, ..., ki} of the observations for Wi. The simple
case is where ki = 2. In this case, one may choose Wi = (Wi1 +Wi2)/2 as an ob-
served explanatory variable, because the average of the Wij is a better estimate of Xi
than Wi alone. For example, the average ancestry proportion computed on a set of
full siblings would be a more accurate measure of their ancestry proportion than the
value observed on a single individual (Divers et al., 2007). “The individual admixture
proportion estimates obtained by using ancestry informative markers are measure-
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ments of the underlying individual ancestry proportion”. Such measurements may
also help to estimate the measurement error variance σ2u. Suppose that the classical
error model holds and that ki replicate measurements of Xi are available. Then the
usual component of variance analysis (Carroll and Stefanski, 1990; Wang et al., 1995;
Carroll et al., 2006) yields the following estimate of the measurement error variance
on Wij
σˆ2u =
n∑
i=1
ki∑
j=1
(Wij − W¯i0)(Wij − W¯i0)t
n∑
i=1
(ki − 1)
(1.16)
where W¯i0 =
ki∑
j=1
Wij/ki. We will illustrate how to estimate σ
2
u on Framingham
Heart study in the next sections. In the absence of validation data or replicates,
sometimes an (unbiased) instrument data Ti may be available for a subset of the
study participants. Instrument data are another measurements of X in addition to
W . Instrument data or instrumental variable is associated with X, independent of
measurement error U , and has no information about the outcome Y other than what
is available in X (see Section 6.3). Thus, there are generally three kinds of additional
data to that guarantee the parameter identifiability in the present of measurement
error
• Validation data in which X is observed directly;
• Replication data, in which replicates of W are available;
• Instrument data, in which another variable T is observable in addition to W .
In the next subsections, we illustrate methods for correcting for bias due to measure-
ment error or misclassification error in regression models.
6.1 Regression calibration
Regression calibration is a straightforward approach to correct for bias due to
measurement error and has been successfully applied to a broad range of regression
models, in particular linear and logistic regression (Rosner et al., 1996; Thu¨rigen
et al., 2000; Buzas et al., 2005; Spiegelman et al., 2005; Carroll et al., 2006). The
idea underlying this method is the estimation of the regression of X on W , possibly
adjusted for error-free covariates Z. That is, first one obtains an estimate of the
expected explanatory variable X in function of W and Z by fitting an appropriate
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regression (often linear) model, for instance, to an validation data. Then, one fits a
regression of Y on Xˆ and Z, rather than on X and Z, to obtain parameter estimates,
where Xˆ ≡ E(X|W,Z; αˆ), and αˆ is the estimated regression parameter of X on W
and Z. This methodology can be seen in (1.3) and (1.4). Note that for dichotomous
outcome, (1.4) can be approximately written
logitP (Y = 1|W,Z) ≈ β∗0 + β∗1E(X|W,Z) + β∗2Z
where logit(p) = log {p/(1− p)}. This suggests the following two-stage approach:
1. Using validation data, replicate data or instrument data to fit a regression of X
on W and Z to obtain Xˆ;
2. Replace the unobserved X by Xˆ in the regression of Y on X and Z.
Standard errors of the parameters estimates obtained in step 2 must account for the
fact that Xˆ is estimated in step 1 and can be obtained using either the bootstrap or
a sandwich method (e.g., Carroll et al., 2006).
The best linear approximation to X given (W,Z) is
E(X|W,Z) ≈ µx + σwzσxz − σwxσ
2
z
σ2wz − σ2wσ2z
(W − µw) + σ
2
wσxz − σwx
σ2wσ
2
z − σ2wz
(Z − µz) .
The coefficients are calculated from the linear regression X on (W,Z). This approxi-
mation is exact whenX,W and Z are jointly normally distributed. When the classical
error model holds, the latter approximation is equal to
E(X|W,Z) ≈ µw +
(
σ2x
σxz
)′ [
σ2x + σ
2
u σxz
σxz σ
2
z
]−1(
W − µw
Z − µz
)
(1.17)
because µx = µw, σwx = σ
2
x, and σwz = σxz. Note from (1.17) that, when there
is no validation data, the relationship between X and (W,Z) may be inferred from
replicate data or an (unbiased) instrument T . For replicates data, for instance with
ki = 2 and Wi = (Wi1 +Wi2)/2, this follows with
σˆ2u =
n∑
i=1
(Wi1 −Wi)2 +
n∑
i=1
(Wi2 −Wi)2
n
and
σˆ2w = (n− 1)−1
n∑
i=1
(Wi − µˆw)2.
For instrument data, this is because, by definition of unbiased instrument E(T |W,Z) =
E(X|W,Z) (Rosner et al., 1990; Carroll et al., 2006).
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Application: analysis of the Framingham study
The Framingham study on coronary heart disease and blood pressure is a large
cohort study consisting of n = 1615 men aged 31-65 years. The outcome, Y , indicates
1 for the occurrence of coronary heart disease (CHD) within an eight-year period
following exam 3 and 0 otherwise. There are a series of exams taken two years apart
which exam 3 uses as the baseline. Predictors employed in this example are the
patient’s age at exam 2, smoking status at exam 1, serum cholesterol at exam 2
and 3, and systolic blood pressure (SBP) at exam 2 and 3, rather as the average of
two measurements taken by different examiners during the same visit. In this data
set, we consider age, smoking status, and serum cholesterol at exam 3 (cho3) as the
error-free covariates Z. The interest lies in fitting a logistic regression model of CHD
on systolic blood pressure (SBP) which are measured with error conditional on the
error-free covariate Z. The observed explanatory variable W is a modified version of
a transformation of SBP, that is, W = log(SBP − 50) as suggested in Spiegelman
et al. (1984) and Carroll et al. (2006) to make the normality assumption for the
measurement error more plausible. The unobserved explanatory variable X is defined
to be the long-term average ofW . Specifically, SBPmj indicates the jth measurement
of SBP from the mth exam, j = 1, 2, m = 2, 3. The transformed SBP are
Wi1 = log{(SBPi31 + SBPi32)/2− 50}
and
Wi2 = log{(SBPi21 + SBPi22)/2− 50}
for each subject i = 1, ..., 1615. The overall surrogate is W¯i0 = (Wi1 +Wi2)/2, the
sample mean for each subject i. The error model is W = X +U , where U is assumed
to be independent of X with mean zero and variance σ2u.
Example 6. We now perform a measurement error analysis for the Framingham data
by the regression calibration approach. Validation data are unavailable in this study;
instead, two replicates of X are available. We will therefore rely on replicate data.
Let Wi = W¯i0 = (Wi1 +Wi2)/2. Then µˆw =
n∑
i=1
W¯i0/n = 4.364 and σˆ
2
w = 0.045. It
follows from (1.16) for ki = 2 that
σˆ2u =
n∑
i=1
(Wi1 − W¯i0)2 +
n∑
i=1
(Wi2 − W¯i0)2
n
= 0.013.
Note that, the measurement error variance onWi is only half of this, namely 0.006.
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It follows from (1.17) that:
Eˆ(Xi|Wi, Zi) ≈ 4.364 +
(
0.039∑ˆ
xz
)t [
0.045
∑ˆ
xz∑ˆt
xz
∑ˆ
zz
]−1(
Wi − 4.364
Zi − µˆz
)
where σˆ2x = σˆ
2
w − σˆ2u = 0.045 − 0.006 = 0.039, Z = (age, smoke, cho3) and µˆz =
(45.86, 0.77, 228.40). For ki = 2;
∑ˆ
xz
= (n− 1)−1
n∑
i=1
(Wi − µˆw)(Zi − µˆz)t
∑ˆ
zz
= (n− 1)−1
n∑
i=1
(Zi − µˆz)(Zi − µˆz)t
where
∑ˆ
xz is the sample covariance of (X,Z) and
∑ˆ
zz is the sample covariance
of Z. Remember that, when measurement error follows the classical error model,
Cov(W,Z) = Cov(X,Z). We then fit a logistic regression of Y on Xˆ = E(X|W,Z; αˆ)
and Z. The naive estimates are
logitP (Y = 1|W,Z) = −14.949 + 1.706 W + 0.055 age + 0.593 smoke + 0.008cho3
and the regression calibration estimates are
logitP (Y = 1|Xˆ, Z) = −16.180 + 2.013 Xˆ + 0.053 age + 0.601 smoke + 0.008cho3
When we perform the regression calibration approach with Wi =Wi1, so that ki = 1.
Then σˆ2u = 0.013, because this is variance measurement error either on Wi1 or on
Wi1. In this case, µˆw = 4.355 and σˆ
2
w = 0.052. Now the naive estimates are
logitP (Y = 1|W,Z) = −14.182 + 1.524 W + 0.057 age + 0.573 smoke + 0.008cho3
and the regression calibration estimates are
logitP (Y = 1|Xˆ, Z) = −16.474 + 2.099 Xˆ + 0.053 age + 0.582 smoke + 0.007cho3
Table 1.1 summarizes the naive and corrected slope estimate by regression calibration
along with the standard errors when the error-free covariates are age, smoking, choles-
terol level. Standard errors for the regression calibration estimators are obtained by
bootstrap. As Table 1.1 shows, the corrected estimator has bigger standard error
than the naive estimator. This is the price to pay for reduced bias. The results also
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show when W is considered to be the average systolic blood pressure at Exams 2, 3,
the regression calibration estimator is is more efficient (SE = 0.471) than when it is
considered only at Exam 3 (SE = 0.523). This is because by selecting the average of
SBP3 and SBP2, the measurement error variance is twice smaller than by selecting
only SBP3.
Table 1.1: Regression calibration method to correct measurement error on Framingham
study. The Naive and the regression calibration estimator and their standard error
are presented. Standard errors for regression calibration estimator are obtained based
on 10 000 bootstrap resamples.
Estimate W βˆ1 SE σˆ
2
u
SBP3 1.524 0.389 -
Naive
(SBP2+SBP3)/2 1.706 0.417 -
SBP3 2.070 0.523 0.013
R.C.
(SBP2+SBP3)/2 2.011 0.471 0.006
6.2 Simulation-extrapolation
Simulation-extrapolation (SIMEX) is a useful tool for correcting measurement
error in a very broad range of settings. This is the only method that provides a visual
display of the impact of measurement error on regression parameter estimations (Cook
and Stefanski, 1994; Stefanski and Cook, 1995 ; Carroll et al., 1996; Ku¨chenhoff et
al., 2006; Carroll et al., 2006). This method was originally proposed by Cook and
Stefanski (1994) for parametric measurement error models in which the measurement
error variance is known or at least well estimated. This method is helpful for complex
models with a simple measurement error model (Ku¨chenhoff et al., 2006). The basic
idea underlying SIMEX is the fact that the impact of measurement error on regression
coefficients can be determined through simulation. The effect of measurement error
can next be eliminated by extrapolation. In fact, through SIMEX, new samples
with larger error variances are generated by adding simulated errors to the original
observed regressor variables. In this section, we briefly describe the SIMEX approach
and illustrate it on the Framingham study.
The SIMEX procedure is generally performed in two steps:
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1. Simulation: add additional measurement error in known increments to the data
and compute estimates from the contaminated data. Next, establish a trend
between the estimates and the variance of the added errors;
2. Extrapolation: Extrapolate this trend back to the case of no measurement error.
Consider for simplicity the linear regression model E(Y |X) = β∗0+β∗1X with a classical
error model. Suppose that in addition to the (Y,X,W ) data used to estimate the naive
coefficient θ∗1 in model E(Y |W ) = θ∗0 + θ∗1W , there are M − 1 additional data sets
available, each with large error variance of (1+λm)σ
2
u, where 0 = λ1 < λ2 < ... < λM
and m = 1, ...,M . That is, assuming that the variance of the measurement error σ2u
is known, one simulates
Wib(λ) =Wi +
√
λUib i = 1, ..., n, b = 1, ..., B
where Uib are independent standard normally distributed with mean 0 and variance
σ2u. The least squares estimate of the slope from the mth data set, θˆ1m, consis-
tently estimates
σ2x
σ2x+(1+λm)σ
2
u
β∗1 (Cook and Stefanski, 1994; Carroll et al., 2006). The
dependent variables {θˆ1m;m = 1, ...,M} thus relate nonlinearly to the independent
variables {λm;m = 1, ...,M} with mean function
Γ(λ) =
σ2x
σ2x + (1 + λ)σ
2
u
β∗1 λ ≥ 0.
The parameter of interest, β∗1 can thus be obtained from Γ(λ) by extrapolation to
λ = −1; the naive estimate occurs at λ = 0. Specifically, let θˆs(λm) denote the vector
of regression parameter estimators obtained by regression of Y on Wb(λm) for m =
1, ...,M and θˆ(λm) = B
−1 B∑
s=1
θˆs(λm). Here taking the average over the B simulated
data sets is needed to eliminate simulation error. Empirical evidence suggests that
B = 100 is sufficient. For each value of λ, the parameters Θ(λ) = (β0(λ), β1(λ))
corresponded to the (β∗0 , β
∗
1) and their corresponding standard errors are estimated B
times using a chosen estimation method (ordinary least squares, quadratic, nonlinear,
etc.). In the second step, each component of the vector θˆ(λ) is then modeled as
a function of λ and the SIMEX estimator is the extrapolation to λ = −1, which
corresponds the ideal case of no measurement error. When the measurement error
variance σ2u is unknown, it must be estimated with extra data and then substituted σ
2
u
in the SIMEX approach. The unbiasedness of SIMEX estimator depends crucially on
knowing σ2u to being able to determine the functional form of θˆ(λ), and on normality
of the error. For variance estimation, three methods are available: the Delta method
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(Carroll et al., 1996), Jackknife type estimators (Stefanski and Cook, 1995), and the
Bootstrap.
Table 1.2: Simulation-extrapolation approach to correct for measurement error in
the Framingham study. The first row is when W is considered to be systolic blood
pressure at Exam 3. The second row considers W to be the average systolic blood
pressure at Exams 2, 3. The Naive and corrected estimators with their standard error
are presented. The standard errors are obtained via Jackknife variance estimator.
Estimate W βˆ1 SE σˆ
2
u
SBP3 1.524 0.389 -
Naive
(SBP2+SBP3)/2 1.706 0.417 -
SBP3 1.865 0.473 0.013
SIMEX
(SBP2+SBP3)/2 1.931 0.462 0.006
We will perform the SIMEX approach on Framingham study in next example.
In this example, we use the R-package simex which is written by Wolfgang Lederer
(Lederer and Ku¨chenhoff, 2006).
Example 7. We use the replicate SBP measurement from exam 2 and exam 3 for all
study participants. The error model is the classical error model. Like in example 6,
we perform this approach for two cases.
• With Wi = W¯i0 = (Wi1 +Wi2)/2. The naive model is
logitP (Y = 1|W,Z) = −14.949+1.706W+0.055 age+0.593 smoke+0.007 cho3
The SIMEX procedure is repeated B = 1000 times for λ = (0.5, 1, 1.5, 2). The
resulting naive estimator and SIMEX corrected estimator are obtained. Table
2 shows the results for the naive and SIMEX corrected estimator with their
standard error. Figure 2 contains plots of the logistic regression coefficients by
SIMEX (solid circles). The points plotted at λ = 0 are the naive estimates.
• We now choose Wi =Wi1, then the naive model is
logitP (Y = 1|W,Z) = −14.182+1.524W+0.057 age+0.573 smoke+0.008 cho3
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Figure 2: Coefficient extrapolation for the Framingham logistic regression modeling.
The simulated estimates are plotted (solid circles) and extrapolated to λ = 0 (dashed
line) resulting in the SIMEX estimate. Open circles indicates SIMEX estimates ob-
tained with the quadratic extrapolant.
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As we calculated in example 6, σˆ2u = 0.013, for ki = 1. The SIMEX procedure
is repeated B = 1000 times for λ = (0.5, 1, 1.5, 2). Table 1.2 summarizes the
results for the naive and SIMEX corrected estimator with their standard error.
The standard error is obtained via Jackknife variance estimator through the
simex package.
The standard error for the corrected estimators is bigger than for the naive estimator.
This is the price to pay for having smaller bias.
6.3 Instrumental variable methods
In many situations in measurement error analysis, particularly in epidemiological
contexts, neither validation measurements nor replication data can be obtained. One
interesting strategy for measurement error analysis is then to select an instrumental
variable (IV). This is a variable that is
• associated with X;
• independent of W −X where W = X + U , that is, T ⊥⊥ U ;
• conditionally independent of outcome Y given X and Z, that is, T ⊥⊥ Y |X,Z.
Instrumental variables (IV’s) in the context of measurement error are often secondary
measurements of the true explanatory variable X other than W which need not be
unbiased for X. They are obtained by an independent methods (Carroll et al., 2006).
For instance in agronomic experiment,W could be the observed nitrogen in the leaves
of the plant and Y is the dry weight of the plant. We would then expect the true
nitrogen in the leaves, X, to be correlated with nitrogen fertilizer, T , applied to
the experimental plot (Fuller, 1987). Further, as agronomists believe the nitrogen
fertilizer does not provide any more information about the dry weight of the plant
than the nitrogen in the leaves and is independent of the measurement error on the
nitrogen in the leaves. Then nitrogen fertilizer can be considered as an instrumental
variable for the nitrogen in the leaves. Note that a replicate measurement of X can be
considered as an IV, because replicate measurements of X are associated with X, and
are independent of measurement error on X, and have no more information about Y
than X. Note also that an IV is not necessarily a replicate because T is independently
measured for X (Buzas et al., 2005; Carroll et al., 2006). In the Framingham study,
we can use systolic blood pressure at Exam 2, W2, as an instrumental variable for
correcting measurement error.
Roughly, IV is a variable which is highly correlated with the error-prone explanatory
variable X, but is not associated with the outcome Y other than through X or Z,
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and is independent of measurement error U . Assumption (1) is important because
IV-estimators are generally effective only when X and T are strongly correlated.
Assumption (2) says that T does not dependent on the measurement error in X.
Assumption (3) specifies that T does not provide any more information about Y
than X. T is therefore often called a surrogate. If an instrument or an instrumental
variable (IV) is available, consistent estimates may still be obtained in the presence
of measurement error (Fuller, 1987; Amemiya 1990; Stefanski and Carroll, 1991 ;
Stefanski and Buzas, 1995; Buzas et al., 2005; Carroll et al., 2006; Lewbel, 2007).
In fact, estimation method for IVs are widely recognized as an important method
of analysis of linear measurement error models and the best-known method is two-
stage least squares estimation. We first review linear model instrumental variable
estimation in its simplest form. Suppose that Y is linearly related to the error-prone
explanatory variable X, E(Y |X) = β∗0 + β∗1X, and that the classical error model
holds. The interest is to estimate β∗1 . Suppose that the relation between X and T is
also linearly expressed as
E(X|T ) = α∗0 + α∗1T.
Then with the classical error model
E(W |T ) = E(X + U |T ) = α∗0 + α∗1T + E(U |T ).
It follows from assumption (2) that E(X|T ) = E(W |T ). It also follows from the
assumption (3) that
E(Y |T ) = E{E(Y |T,X)|T}
= β∗0 + β
∗
1E(X|T )
= β∗0 + β
∗
1α
∗
0 + β
∗
1α
∗
1T.
That is the slope coefficient of regression Y on T is equal to the product of the slope
coefficient of a regression Y on X and the slope coefficient of a regression W on T .
Note that under the assumption (1), α∗1 is nonzero. The IV-estimator can then be
obtained by a two-stage least squares algorithm as follows:
1. Fit the linear regression of W on T , E(W |T ;α∗), to find an estimate of αˆ of α∗;
2. Fit the linear regression of Y on the predicted values E(W |T ; αˆ).
Equivalently, an IV-estimator for β∗1 can be obtained as
βˆ1 =
n∑
i=1
(Yi − Y¯ )(Ti − T¯ )
n∑
i=1
(Wi − W¯ )(Ti − T¯ )
.
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Fuller (1987) shows that this is a consistent estimator for β∗1 . A consistent estimator
for V ar(βˆ1) can be obtained by the sample moments
ˆV ar(βˆ1) = (n− 1)−1M−2wt MttS
where Mtt = n
−1 n∑
i=1
(Ti − T¯ )(Ti − T¯ )t, Mwt = n−1
n∑
i=1
(Wi − W¯ )(Ti − T¯ )t, and
S = (n− 2)−1
n∑
i=1
{Yi − Y¯ )− βˆ1(Wi − W¯ )}2.
The most common solution to the measurement error analysis for the linear regres-
sion model is the use of instrumental variable estimation. This methodology cannot
be easily applied in the nonlinear regression framework (Stefanski and Buzas, 1995;
Carroll et al., 2006). However, the IV approach is the most widely used technique
for dealing with error in explanatory variables in linear multiple regression prob-
lems. To date the methods proposed for the nonlinear model depend on very strong
restrictions on the distribution of the measurement errors of the variables which cor-
respond to the unknown regression coefficients (Hausman et al., 1995). Hausman et
al. (1995) discuss consistent estimators for nonlinear (polynomial) regression spec-
ifications in which estimators depend on the existence of instrumental variables or
a single repeated observation. Stefanski and Buzas (1995) describe two approaches
to instrumental variable estimation in binary regression measurement error models.
Their methods entail constructing approximated mean models for the binary out-
come as a function of the measured predictor, the instrument and any covariates in
the model. Instrumental variable estimation for generalized linear measurement error
models, that includes linear and logistic regression as special cases, are considered
by Buzas and Stefanski (1996). Carroll et al. (2006) describe the IV methods in a
class of nonlinear measurement error in a way that is closely related to the regression
calibration method. We now review the case where the outcome Y is dichotomous.
Suppose that
logitP (Y = 1|X) = β∗0 + β∗1X.
It also follows from the assumptions of IV that
P (Y = 1|T ) = E{P (Y = 1|T,X)|T}
= E{expit(β∗0 + β∗1X)|T}
≈ expit{β∗0 + β∗1E(X|T )}.
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The last step is implied by E(X|T ) = E(W |T ) and the Taylor series expansion
E {expit(β∗0 + β∗1X)|T} ≈ E [expit{β∗0 + β∗1E(X|T )}
+expit′{β∗0 + β∗1E(X|T )}{X − E(X|T )}+ ...|T
]
= expit{β∗0 + β∗1E(W |T )}
where expit(a) = exp(a)/ {1 + exp(a)}. This estimator can be obtained by a two-
stage algorithm as follows
1. Fit the linear regression of W on T , E(W |T ;α∗), to find an estimate of αˆ of α∗;
2. Fit the logistic regression of Y on the predicted values E(W |T ; αˆ).
The resulting IV-estimator is consistent and an estimate of variance may be obtained
by bootstrap or sandwich method. We now perform the IV methods for the Fram-
ingham study in the next example.
Table 1.3: Results of the instrumental variable method to correct for measurement
error on Framingham study. The instrumental variable is systolic blood pressure at
exam 2. The naive and the instrumental variable estimator with their standard errors
are presented. The IV-estimator’s standard error is obtained based on 10 000 bootstrap
resamples.
Estimate IV βˆ1 SE
Naive estimator - 1.524 0.389
IV-estimator SBP3 2.002 0.520
Example 8. Consider again the Framingham heart study, wherein two systolic
blood pressure measurements from each of two exams were measured. We consider
Wi =Wi1 and Ti =Wi2. First we fit a linear regression of T on W and Z:
E(W |T,Z) = 0.935 + 0.754 T + 0.001 age + 0.012 smoke + 0.0002 cho3 .
Then we fit a logistic regression of Y on Tˆ = E(W |T,Z; αˆ) where αˆ was obtained in
the first step:
logitP (Y = 1|Tˆ , Z) = −16.061 + 2.002 Tˆ + 0.054 age + 0.577 smoke + 0.007 cho3 .
6 Methods for measurement error correction 37
The resulting IV-estimator is equal to 2.002 with standard error 0.501 obtained by
the bootstrap. Table 1.3 summarizes the results of Framingham study data with the
IV method.
6.4 Correcting for misclassification error
Various suggestions have been made on how to correct for bias due to misclassifi-
cation error (Hui and Walter, 1980; Mahajan, 2006; Lederer and Ku¨chenhoff, 2006).
All the above methods for continuous explanatory variables can roughly be adapted
to the case of categorical explanatory variable subject to misclassification. In line
with Section 5, correction is straightforward if one has knowledge of the sensitivity
and specificity. This is for instance the case where internal or external validation
data are available, or these quantities might be considered to be known through good
guesses. Among many other methods, the simulation extrapolation method (SIMEX)
(see Cook and Stefanski, 1994; Carroll et al., 1996) is also a tool for correcting mis-
classification error. The adaptation to the misclassification situation is called the
MisClassification SIMEX (MC-SIMEX) approach. The R-package mc-simex can take
into account misclassification of a categorical response or of a categorical regressor or
of both. Lederer and Ku¨chenhoff (2006) have used MC-SIMEX methods to correct for
bias of the effect of smoking on chronic bronchitis when the sensitivity and specificity
degree were guessed. Lewbel (2007) uses instruments to correct for misclassification in
treatment effect models. Two closely related studies on misclassification in a dichoto-
mous variable are Hui and Walter (1980) and Mahajan (2006), which use a secondary
measurement or an instrument to fit a nonlinear model that includes a mismeasured
binary regressor. Gustafson (2003) elaborates on how to correct misclassification error
with Bayesian adjustments. In the next example, we reanalyze the effect of smoking
on chronic bronchitis of some worker by the MC-SIMEX method, using the same
basic idea for continuous explanatory variables (Lederer and Ku¨chenhoff, 2006).
Example 9. We use data from a study on the Chronic Bronchitis and Dust con-
centration of the Deutsche Forschungsgemeinschaft. The data were recorded during
the years 1960 and 1977 in a Munich plant (1246 workers). This contains Chronic
Bronchitis reaction (1=yes, 0=no) as outcome, Smoking by self report (1=yes, 0=no)
as a discrete explanatory variable, Dust concentration at work (in mg/m3) and Du-
ration of exposure in year. We reanalyze the data set for the effect of self-reported
smoking which is subject to misclassification, W , on Chronic Bronchitis reaction by
the SIMEX method when Dust concentration at work and Duration of exposure are
supposed to be error-free covariates Z. Specifically the aim is to estimate β∗1 , the slope
coefficient of a logistic regression of Chronic Bronchitis reaction on smoking adjusted
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for Z. We first obtain naive estimates by fitting the logistic regression model
logitP (Y = 1|W,Z) = −3.05 + 0.68 smoke + 0.09 dust + 0.04 expo.
Research from other studies shows that about 8% of smokers self-report them as non-
smokers, that is, π01 = P (W = 0|X = 1) = 0.08. It is reasonable to believe that
about 100% of non-smokers self-report them as non-smokers, that is, π00 = P (W =
0|X = 0) = 1. The misclassification matrix for this is then defined (Lederer and
Ku¨chenhoff, 2006); π =
[
π00 1− π11
1− π00 π11
]
=
[
1 0.08
0 0.92
]
Then, we use the mc-simex function in R. The naive and MC-SIMEX corrected es-
timators and their standard error are summarized in Table 1.4. Standard error for
MC-SIMEX corrected estimator is obtained by the Jackknife variance. (The data is
available at www.stat.uni-muenchen.de).
Table 1.4: MC-SIMEX approach to correct misclassification error of smoking on
Chronic Bronchitis. The naive and MC-SIMEX corrected estimators and their stan-
dard error are presented.
Estimate βˆ1 SE
Naive estimator 0.68 0.173
Corrected estimator 0.88 0.224
Appendix 1.A: Derivation of
Asymptotic Bias Expressions
We derive the asymptotic bias expressions under the assumption of normality and
nondifferential measurement error.
Bias expressions when X is continuous
Suppose that E(Y |X) = β∗0 + β∗1X, and that the data are analyzed using the
working model E(Y |W ) = θ∗0 + θ∗1W . By setting the expected estimating equation
functions corresponding to the working model to zero:
0 = E{U(θ∗)} = E
{(
1
W
)
(Y − θ∗0 − θ∗1W )
}
= E
{(
1
W
)
(E(Y |X,W )− θ∗0 − θ∗1W )
}
,
we obtain the limiting values θ∗0 and θ
∗
1 of the ordinary least squares estimators of
the intercept and slope parameters. It follows from the nondifferential measurement
error assumption that
0 = E
{(
1
W
)
(β∗0 + β
∗
1X − θ∗0 − θ∗1W )
}
.
The latter yields
E(β∗0 + β
∗
1X − θ∗0 − θ∗1W ) = 0
E {W (β∗0 + β∗1X − θ∗0 − θ∗1W )} = 0.
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We calculate the asymptotic bias expressions by solving the latter resulting set of
equations.
1. Under the classical additive error model, W = X + U with U ⊥⊥ X. It follows
from the first equation that β∗0 − θ∗0 = θ∗1E(W ) − β∗1E(X). Substituting the
latter into the second equation shows that,
θ∗1 =
Cov(X,W )
V ar(W )
β∗1
=
Cov(X,X + U)
V ar(W )
β∗1 =
V ar(X)
V ar(W )
β∗1 .
As a result:
θ∗1 =
σ2x
σ2x+σ
2
u
β∗1
θ∗0 = β
∗
0 +
µwσ
2
u
σ2x+σ
2
u
β∗1 .
2. Under the Berkson error model, X = W + U , U ⊥⊥ W . It follows from
Cov(X,W ) = Cov(W + U,W ) = V ar(W ) that
θ∗1 = β
∗
1
θ∗0 = β
∗
0 .
Suppose now that E(Y |X,Z) = β∗0 + β∗1X + β∗2Z, and that the data are analyzed
using the working model E(Y |W,Z) = θ∗0 + θ∗1X + θ∗2Z. Analogously, by setting the
expected estimating equation functions corresponding to the working model to zero:
0 = E{U(θ∗)} = E



 1W
Z

 (Y − θ∗0 − θ∗1W − θ∗2Z)

 ,
we obtain the limiting values θ∗0 , θ
∗
1 , and θ
∗
2 . It follows from the nondifferential
measurement error assumption that
0 = E



 1W
Z

 (E(Y |X,W,Z)− θ∗0 − θ∗1W − θ∗2Z)


= E



 1W
Z

 (β∗0 + β∗1X + β∗2Z − θ∗0 − θ∗1W − θ∗2Z)

.
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This yields the following three equations:
β∗0 − θ∗0 + β∗1E(X)− θ∗1E(W ) + (β∗2 − θ∗2)E(Z) = 0 (1.18)
(β∗0 − θ∗0)E(W ) + β∗1E(WX)− θ∗1E(W 2) + (β∗2 − θ∗2)E(WZ) = 0
(β∗0 − θ∗0)E(Z) + β∗1E(ZX)− θ∗1E(WZ) + (β∗2 − θ∗2)E(Z2) = 0. (1.19)
It follows from the first equation that θ∗0 = β
∗
0+β
∗
1µx−θ∗1µw+(β∗2−θ∗2)µz. By plugging
into the second equation, we obtain (β∗2−θ∗2)Cov(W,Z) = θ∗1σ2w−β∗1Cov(X,W ). Next
plugging both into the third equation, we obtain
θ∗1 =
σ2zCov(X,W )− Cov(X,Z)Cov(W,Z)
σ2zV ar(W )− Cov2(W,Z)
β∗1 .
Under the following assumptions,
Z ∼ N(µz, σ2)
U ∼ N(0, σ2u)
W |Z ∼ N(η∗0 + η∗1Z, σ2w|z)
X|Z ∼ N(η∗0 + η∗1Z, σ2x|z)
E(W |Z) = E(X|Z)
together with the classical additive error model, W = U +X with U ⊥⊥ (X,Z), we
obtain
E(XW |Z) = E(X2|Z)
V ar(W |Z) = V ar(X + U |Z) = V ar(X|Z) + V ar(U)
Cov(W,U |Z) = E(WU |Z) = E{(X + U)U |Z} = σ2u
Cov(W,Z) = E{ZE(W |Z)} − E(Z)E{E(W |Z)} = η∗1σ2z = Cov(X,Z).
After some algebraic operations, we find
θ∗0 = β
∗
0 +
σ2u
σ2x|z + σ
2
u
β∗1η
∗
0
θ∗1 =
σ2x|z
σ2x|z + σ
2
u
β∗1
θ∗2 = β
∗
2 +
σ2u
σ2x|z + σ
2
u
β∗1η
∗
1 .
42 Appendix 1.A
Bias expressions when X is discrete
We now derive similar asymptotic bias expressions due to misclassification error
on the dichotomous explanatory variable in the linear model E(Y |X,Z) = β∗0 +
β∗1X + β
∗
2Z, under the nondifferential measurement error. As stated, we suppose
the misclassification probabilities are not related to the error-free covariate Z. That
is, P (W = 1|X = 1, Z) = π1|1 and P (W = 0|X = 0, Z) = π0|0. Let P (W = 1|X,Z) =
a+ bX, where b = π1|1+ π0|0− 1 and a = 1− π0|0. Similarly, by setting the expected
estimating equation functions corresponding to the working model to zero:
0 = E {U(θ∗)} = E



 1W
Z

 (Y − θ∗0 − θ∗1W − θ∗2Z)

 ,
we obtain
θ∗1 = b
[
µx(1− µx)(1− ρ2xz)
µw(1− µw)− µx(1− µx)b2ρ2xz
]
β∗1
θ∗2 = β
∗
2 + β
∗
1ρxz
√
µx(1− µx)
σz
[
1− b θ
∗
1
β∗1
]
upon noting that, V ar(X) = µx(1− µx), V ar(W ) = µw(1− µw), and
µw = P (W = 1) = a+ bµx
E(XW ) = E{XE(W |X,Z)} = (a+ b)µx
Cov(X,W ) = bµx(1− µx)
E(ZW ) = E{ZE(W |X,Z)} = aµz + bE(ZX)
Cov(W,Z) = bCov(X,Z) = bρσxσz
where ρxz is the correlation between X and Z.
Chapter 2
Introduction to Causal
Inference
Summary
This chapter gives an introduction to the statistical framework of counterfactual
outcomes for causal inference as it has been developed over the past decades. We
define causal effects and causal models formally in this setting, and state the assump-
tions which allow to identify causal effects. We explain the problem of confounding
and discuss methods to control for measured as well as unmeasured confounding. We
introduce the special clan of problems of noncompliance in randomized controlled tri-
als and expand on methods to adjust for it. We describe the instrumental variables
approach to allow for inference on the causal effect of exposure on outcome in the
presence of noncompliance in randomized controlled trials, and for unmeasured con-
founder adjustment in observational studies. We continue to investigate the problem
of measurement error in exposure and important practical implications under linear
structural mean models. For detailed exposition and technical aspects of the devel-
oped methods, we refer to the original literature. Basic definitions and notions are
described here, others will be introduced over the next chapters, as necessary.
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1 Introduction
Causal inference deals with cause-effect relationships between interventions (ex-
posures) and outcomes (responses) in many fields of study including biostatistics,
epidemiology and econometrics. The goal of causal inference is typically to estimate
the causal effects of interventions or exposures on outcomes of interest from empirical
data through design and analysis. For instance in biostatistics, one might be inter-
ested to estimate the causal effect of a specific drug or other medical intervention
on a primary health or risk outcome. In epidemiology, for instance, researchers are
concerned with the evaluation of the effect of AZT on HIV viral load or CD4 in a
specific population which is HIV infected. In econometrics, one may wish to evaluate
the effect of educational training on income. In settings as this, statisticians have
known that the detection of any causal effect of an intervention or exposure on an
outcome must rely on knowledge about how experiments were performed or how more
generally the data were generated. In the ideal experiment each subject receives all
interventions or exposures under investigation during a given time interval or at one
specific time point, and the different results under each exposure can be compared.
In practice, this is unfortunately typically impossible and other approaches must be
developed.
Detection and quantification of causal effects forms an ideal evidence basis for policy
decisions and interventions. In several major case studies however, standard statisti-
cal methods have failed. A new formal statistical development of causal inference was
therefore more than welcome when it was first introduced in the 1970’s (Rubin, 1974,
1978; Robins, 1986; Holland, 1988; Pearl, 1988). Results of this era of innovative
theory are now disseminating to applied fields, frequently resulting in important ad-
vances. There are at least two explicit sets of mathematical language for approaching
causal inference. One evolves around the counterfactual outcome model of Neyman-
Rubin, as well as Robins’s extensions (Neyman, 1923; Rubin, 1974; Robins, 1987).
More recently, a second set involves a combination of structural equations together
with a graphical representation, which takes the form of a causal directed acyclic
graph (DAG) to communicate causal relationships (Pearl, 1995, 2000). The counter-
factual outcome model is more explicit for obtaining estimators and estimands. It is
an effective mathematical formalism allowing for parameterization and to clearly state
assumptions which might be needed to identify causal effects. The causal directed
acyclic graphs are also effective tools to check assumptions on the observed relation
between exposure and outcome, and to recognize the likely factors that may bias the
estimated causal effect of exposure on outcome. These are particularly useful to un-
derstand relations in the complex setting of time-varying exposures and outcomes in
longidudinal studies.
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2 Causal effect and counterfactual outcomes
At the individual level, a causal effect could be defined as a contrast between the
possible results from two or more alternative exposures or interventions with only
one of the results actually observed. One thus considers whether and how much
the outcome would have been different had the exposure been different, all other
conditions being the same. For example, suppose that a child who lives near a chemical
factory contracts a rare cancer. Suppose that, we seek to establish whether or not
a chemical spill adjacent to the child’s property was the cause of his/her particular
cancer (Spirtes et al., 2000). By saying that the chemical spill caused the disease on
this individual level, we mean that the cancer would not have occurred had, contrary
to fact, the spill not happened.
In order to avoid unnecessary complications and without loss of generality, we will
conduct our first discussion in a very simple setting, for example considering i =
1, ..., n, subjects which are exposed to a hypothetical dichotomous exposure Xi with
two possible levels (Xi = 1 if exposed, 0 if unexposed). Suppose that half of these
subjects have been exposed to 1, an experimental treatment, and the other half have
been exposed to 0, no experimental treatment which may be placebo or a standard
treatment. Suppose that the experimental treatment Xi is a single dose of vitamin
A versus the control treatment (placebo), and the subject i is a particular child. Let
x ∈ {0, 1} be an index indicating the possible counterfactual receipt of exposure Xi,
we then define Yix as the outcome that child i would have had if he/she received
treatment Xi = x for x = 0, 1. Once the child received the vitamin A, we assume
that Yi1 for that child equals his/her observed outcome Yi, and Yi0 is unobserved for
this child. The variables Yi1 and Yi0 are called counterfactual or potential outcomes
because one of them (namely Yi0 in this case) describes the subject i’s outcome value
that would have been observed under a potential exposure value which (i.e., Xi 6= 0)
did not actually occur (Rubin, 1974, 1978; Holland, 1988; Robins, 1986; Vansteelandt
and Goetghebeur, 2003). Note that, Yi0 is often simply called treatment-free outcome
(identical to Yi in those receiving no treatment, mainly those in the control group,
but a counterfactual in the treated).
Throughout this chapter, we shall write Yi for the measured outcome, Xi for the
observed exposure or treatment, and Yix for the counterfactual or potential outcome
where Xi is set to a possible exposure level x. We use Zi to encode for the baseline
covariates for each subject i. In the general case, however, outcome and exposure are
not limited to be dichotomous as considered in the above hypothetical example. If
the outcome is continuous, for instance the amount of blood pressure reduction under
a possible dose of drug, then there is a correspond set of continuous counterfactual
outcomes indexed by the drug dosage. We are now ready to state our definitions more
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formally.
Individual causal effect. The individual causal effect for a given subject i, for
instance, exposed to treatment Xi = 1 versus placebo Xi = 0 (unexposed), all other
things being equal, can be defined as the difference between counterfactual outcomes,
corresponding to the different possible treatment levels,
Yi1 − Yi0.
If the outcome variable is non zero, we may instead define the causal effect as the
ratio
Yi1/Yi0,
or when it is strictly positive as an outcome difference on the log scale
log Yi1 − log Yi0.
In words, an individual causal effect is a contrast between counterfactual outcomes
of a single subject i under different possible treatment levels. It is generally assumed
that Yi1−Yi0 need not remain the same from one subject to another and, in particular,
one might be interested in investigating how this contrast might be associated with
treatment actually received. In general, there is not enough information to identify an
individual causal effect because counterfactual outcomes of an individual cannot be
observed under both the treatment and the control conditions simultaneously. That
is, we cannot observe both counterfactual outcomes Yi1 and Yi0 for the subject i, but
we do observe Yi = (1−Xi)Yi0 +XiYi1. This assumption is commonly referred to as
the consistency assumption, which states that the observed outcome coincides with
the corresponding counterfactual outcome.
Since one of the counterfactual outcomes is always missing we cannot estimate the
individual causal effect of exposure, Yi1−Yi0, structurally for any of subject i. As this
definition reveals, causal inference can be seen as a problem of missing data. There-
fore, one aims to estimate the causal effect for a population instead, by comparing the
distribution of Yi for subjects with different levels of exposure Xi which may require
weaker assumptions.
Population causal effect. At the population level, a causal effect is defined by
comparison of features of the distribution of counterfactuals such as the mean, spe-
cific probabilities, median, etc.. In particular, for a dichotomous exposure we will
see that a population causal effect is for instance defined by a difference of expected
counterfactual outcomes
E(Yi1 − Yi0),
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or for the positive outcome variable by
log E(Yi1)− log E(Yi0).
The estimand is typically the average causal effect (ACE) of exposure when the out-
come is continuous, or could be the causal risk ratio (CRR), or the causal odds ratio
(COR) when the outcome is dichotomous. These quantities are explained in the next
section. Note that the above definitions do not involve the joint distribution under
the potential exposures, but merely the marginal distribution under each possible
exposure or treatment level.
While one is often investigated in the average difference between treated and un-
treated outcomes across all subjects in a population, one may alternatively wish to
estimate a conditional average causal effect (CACE), for instance conditional on ob-
served treatment
E(Yi1 − Yi0|Xi). (2.1)
In some situations, one may also be interested in the average causal effect within a
subset of the population determined by observed covariates Zi, e.g.
E(Yi1 − Yi0|Xi, Zi).
For example, one might want to know the average causal effect of male alcohol con-
sumption on oesophageal cancer risk. Thus, the causal effect can easily be adapted
by conditioning on covariates provided these are prior to exposure (pre-treatment).
2.1 Causal parameters and causal assumptions
When the distributions of two counterfactual or potential outcomes differ under
the possible levels of different observed exposure X, we say that the exposure X has
a causal, causative or preventive effect on the population. The corresponding causal
effects of interest are generally described by parameters under a statistical (causal)
model for the counterfactual outcomes. For instance, when Y is a continuous outcome,
ACE is a natural choice of causal parameter when the effect of exposure is suspected
to be linear on outcome. Suppose that, one wishes to estimate the effect of college
graduation, which is represented by the dichotomous variable Xi, on some outcome Yi
of interest, say earnings (Rubin, 1997; Abadie, 2003). In this example, Yi1 represents
the potential earnings as a college graduate while Yi0 represents the potential earnings
as a non-graduate. One may consider the following model to infer the average causal
effect on the treated
E(Yi1 − Yi0|Xi = 1) = ψ∗ (2.2)
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where ψ∗ is the causal parameter which is unknown and can be estimated. We only
observe Yi = XiYi1 + (1−Xi)Yi0 under the consistency assumption and comparisons
of earnings for the graduated and non-graduated do not usually yield an unbiased
causal effect of college. Indeed, under the consistency assumption we have
E(Yi|Xi = 1)− E(Yi|Xi = 0) = E(Yi1|Xi = 1)− E(Yi0|Xi = 0)
= E(Yi1 − Yi0|Xi = 1) + E(Yi0|Xi = 1)
−E(Yi0|Xi = 0)
= ψ∗ + E(Yi0|Xi = 1)− E(Yi0|Xi = 0).
The term E(Yi0|Xi = 1) − E(Yi0|Xi = 0) represents the bias caused by endogenous
selection in the treatment. That is, in a selective sample common unobservables may
affect both the outcome and the probability of exposure in unknown ways (Abadie,
2003; Lewbel, 2007). In general, this bias is different from zero. If we assume that
Yix ⊥⊥ Xi, that is, observed treatment and counterfactual outcomes are independent
for all x, then
E(Yix) = E(Yix|Xi = x) = E(Yi|Xi = x).
This implies that E(Yi0|Xi = 1)− E(Yi0|Xi = 0) = 0 and then ψ∗ can be estimated.
However, independence between treatment and counterfactual outcomes may not be
satisfied in most applications where selection for treatment is not random. In some
cases, this assumption is plausible once we condition on a vector of observed covariates
Zi. This situation is called selection on observables (Heckman and Robb, 1985). In
model (2.2), when the exposure has no causal effect, we say that the sharp causal null
hypothesis, ψ∗ = 0, is true.
Similarly, when outcome is dichotomous, we define the probability P (Yix = 1) as the
proportion of subjects that would have developed the outcome had all subjects in the
population of interest received exposure value x. It is then more common to infer the
causal risk ratio (CRR) defined as
P (Yi1 = 1)/P (Yi0 = 1),
or the causal odds ratio (COR) given by
P (Yi1 = 1)/P (Yi1 = 0)
P (Yi0 = 1)/P (Yi0 = 0)
.
The risk ratio and odds ratio are effect measures which can be used to quantify the
strength of the causal effect when it exists. They measure the same causal effect on
different scales. An other causal parameter is called the intention-to-treat parameter.
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This parameter represents the average causal effect obtained by assigning everyone in
the study population to treatment, rather than the control regimen in the context of
a randomized controlled trial (explained further in next section).
To be able to estimate the causal effect, we need to involve assumptions that are
sometimes mathematically untestable based on the data. Examples of such assump-
tions include the assumption of no unmeasured confounders in observational studies
(e.g., Rubin, 1978; Robins et al., 1992) and the assumption that the counterfactual
value Yix for subject i does not depend upon the treatments received by other subjects
j 6= i. This is commonly referred to as the stable unit treatment value assumption
(SUTVA) (e.g., Rubin, 1990; Angrist et al., 1996). We will explain these and other
assumptions throughout the text as necessary.
Causation versus association
We say X and Y are statistically independent if knowing the value of X does not
provide any information about the value of Y , and statistically associated or depen-
dent if knowing the value of X provides some information about the likely value of Y ,
even if this information is very limited and amounts to a modest change in the prob-
ability distribution of Y . Scientific studies show an association between an indepen-
dent variable and dependent variable do not necessarily imply that the independent
variable causes the dependent variable. For example, if dementia is more prevalent
among people with limited education, then knowing someone’s education provides
information, albeit not certainty, on the probability that the person has dementia
(Glymour et al., 2008). Thus we say education and dementia are statistically associ-
ated, which is quite different from saying that (lack of) education causes dementia.
Pearl (2001) says “associations characterize static conditions, while causal analysis
deals with changing conditions”. To show that association is not generally causation,
we will adapt an example from Herna´n (2004) for illustration. In this example, the
treatment X = 1 when a patient receives a heart transplant and 0 otherwise, and the
outcome Y = 1 for death and 0 otherwise. The data are summarized in Table 2.1.
The probability P (Yx = 1) is defined as the proportion of subjects that would have
died had all subjects in the population of interest received exposure value x, hence
the risk of Yx. As Table 2.1 shows, the exposure has no causal effect in the population
because P (Y1 = 1) = P (Y0 = 1) = 0.50, that is, P (Y1 = 1) − P (Y0 = 1) = 0. In
reality however, only one of both potential outcomes is observed. The question is
then how to infer the causal effect of interest, despite the missing data on either Y0
or Y1. When measuring the association between exposure X and outcome Y , we cal-
culate the proportion of subjects that underwent treatment X = 1 (heart transplant)
and compare it with the proportion of subjects that underwent treatment X = 0
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(no heart transplant). Formally, one thus examines whether P (Y = 1|X = 1) equals
P (Y = 1|X = 0). We can easily find that P (Y = 1|X = 1) = 7/13 differs from
P (Y = 1|X = 0) = 3/7. It follows that there is an association between exposure
Table 2.1: Counterfactual outcomes of subjects in a study with dichotomous exposure
X (subtable left); unobserved counterfactual outcomes, dichotomous exposure X and
observed outcome Y (subtable right). Sign ? indicates missingness of the counterfac-
tual outcomes (Herna´n, 2004).
Subject Y0 Y1 X Y Y0 Y1
1 0 1 0 0 0 ?
2 1 0 0 1 1 ?
3 0 0 0 0 0 ?
4 0 0 0 0 0 ?
5 0 0 1 0 ? 0
6 1 0 1 0 ? 0
7 0 0 1 0 ? 0
8 0 1 1 1 ? 1
9 1 1 0 1 1 ?
10 1 0 0 1 1 ?
11 0 1 0 0 0 ?
12 1 1 1 1 ? 1
13 1 1 1 1 ? 1
14 0 1 1 1 ? 1
15 0 1 1 1 ? 1
16 0 1 1 1 ? 1
17 1 1 1 1 ? 1
18 1 0 1 0 ? 0
19 1 0 1 0 ? 0
20 1 0 1 0 ? 0
X and outcome Y . If a risk difference is chosen to report the association, it equals
P (Y = 1|X = 1)−P (Y = 1|X = 0) = 7/13−3/7 = 0.11 which differs from the causal
effect of zero. For this data, P (Y=1|X=1)P (Y=1|X=0) = 1.26 and
P (Y=1|X=1)/P (Y=0|X=1)
P (Y=1|X=0)/P (Y=0|X=0) = 1.56.
These are the association risk ratio (ARR) and the association odds ratio (AOR),
respectively, which may differ from the CRR and COR. Unlike association measures,
causal effect measures cannot be directly computed because of missing data (Table
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2.1, subtable right). We will show (in the next section), under the randomization
assumption Yx ⊥⊥ X, that P (Y = 1|X = x) = P (Yx = 1). Some authors often use
the “do” operator by P (Y |do(X = x)), to distinguish between conditioning on an
exposure in X and the usual conditioning on observing X, P (Y |X = x) (Pearl 1995,
2001; Didelez et al., 2007, 2008); we however use an index for the former.
Experimental studies
A study, where for instance a dichotomous exposure X (X = 1 exposed, X = 0
unexposed) is randomly assigned to n subjects (using some mechanism that assured
each subject was equally likely to be exposed and unexposed) is called a random-
ized experiment or more simply an experimental study. In randomized experiments,
the exposed and unexposed groups are comparable a priori (under the assumption of
perfect compliance which is explained in next section). This implies that if subjects
were randomly assigned to group X = 1 and X = 0, the proportion of subjects with
counterfactual outcome Y1 = 1 among the exposed will be the same in group X = 1
as in group X = 0. Thus, which particular group x got the exposure is irrelevant for
the value of P (Y1 = 1|X = x) for x = 0, 1. Formally, we say that both groups are ex-
changeable. Due to exchangeability in ideal, randomized experiments, association is
causation (Herna´n, 2004; Herna´n and Robins, 2006). In particular, association mea-
sures can be interpreted as effect measures of the assignment of the randomized treat-
ments. Under noncompliance however, the assigned treatment does not necessarily
coincide with treatment actually received. In any case, under randomization Yx ⊥⊥ X;
but only with prefect compliance this translates into P (Yx = 1) = P (Y = 1|X = x).
In Table 2.1, for instance for x = 1, P (Y1 = 1) = P (Y = 1|X = 1) = 7/13. In the
next section, we will elaborate on noncompliance in the randomized experiments.
Observational studies
Investigators often use observational studies when controlled experiments are in-
feasible or unethical. For instance, in the epidemiological setting randomized con-
trolled trials are unlikely to be carried out to evaluate the effect of complex nutritional
regimes or it is unethical to asses the effect of smoking and alcohol consumption by
randomly allocating individuals to these exposures. Instead, in observational studies
which are also called nonrandomized studies or sometimes quasi-experiments, the ex-
posed and unexposed groups are generally not comparable and not exchangeable. One
thus cannot estimate causal effects merely by calculating associations without mak-
ing additional assumptions (Pearl, 2000; Herna´n, 2004; Herna´n and Robins, 2006).
A major challenge in conducting observational studies is to draw inferences that are
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acceptably free from overt biases, as well as to assess the influence of potential hid-
den biases. One basic solution to this problem is to adjust for pertinent confounding
(Robins et al., 2000; Henneman et al., 2002; Greenland, 2000). In the next chapter,
we investigate in more detail the problem of unmeasured confounders in observational
studies. That is, adjusting the effect of variables which might be confounded in the
effect of exposure on the outcome of interest.
In general, determining an appropriate experiment to use to detect causal parameter
depends upon the circumstance of exposures and the outcome of interest. The causal
effect estimate of an exposure might be more robust when the exposure of interest
can be randomly assigned (Glymour et al., 2008). The strength of this design arises
because randomization essentially eliminates common prior causes (confounding) as
an explanation for a statistical association. For example, many observational studies
have found that postmenopausal hormone therapy (HT) reduced the risk for coro-
nary heart disease (CHD). A randomized study of HT reported an increased risk for
recurrent CHD among HT users, the discrepancy was interpreted as evidence that
experimentation trumps observation (Nananda et al., 2003). Consider also, for ex-
ample, the effect of antioxidant vitamin intake on the risks of cancer, cardiovascular
disease, and mortality. Observational studies have shown protective effects against
these outcomes (Khaw et al., 2004), while in contrast, randomized trials have shown
no effect. It has been suggested that the disparity in results is likely due to confound-
ing by behavioral and social factors acting across the life course. For example, factors
related to childhood social class may be important confounders of the association
between antioxidant vitamin intake and disease outcome.
2.2 Causal directed acyclic graphs (DAGs)
Directed acyclic graphs (DAGs) are a useful graphical tool in causal inference
that can help to detect the causal effect of an exposure on an outcome in the presence
of other variables. They in fact graphically encode all conceived causal influences
between all observed variables in an experiment of interest. In particular, the DAG
together with structural equation models allows to check the causal assumptions that
one relies on to identify the causal effect of exposure on outcome. They can also
reveal which measured and unmeasured factors are critical confounders of the actual
exposure effect on outcome. In this section, we briefly pay attention to the causal
directed acyclic graph (DAG) as used by Pearl (1995, 2000, 2001) (Greenland et al.,
1999; Robins et al., 2000).
A DAG is a set of vertices (or nodes) and a set of edges (arrows) that connect pairs
of these vertices. The vertices corresponds to variables and the edges will denote a
certain relationship that holds between pairs of variables. For example, we might
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have a set of three vertices: V1, V2, V3, and a set of two edges among these vertices:
(V 1 → V 2, V 2 → V 3). A DAG represents a picture, or path diagram. For example,
this DAG looks like: V 1→ V 2→ V 3. In a DAG, each edge represents a direct causal
relationship, no spurious association. The DAG in fact encodes the possible existence
of (direct or indirect) causal influence between all relevant variables, and the absence
of a (direct or indirect) causal influences between them. Besides representing causal
relations, causal DAGs also encode the causal determination of statistical associations.
• If exposure X causes outcome Y , then X and Y will generally be associated.
Figure 1 represents a follow-up study of HIV-infected patients where X is the
dose of the treatment, say AZT, and Y indicates for example the presence of
detectable HIV RNA; that is, Y = 1 if HIV RNA is detectable in the blood and
is 0 otherwise.
X=AZT Y=HIV RNA
Figure 1: Causal acyclic graph indicating that AZT causes HIV RNA.
• If exposure X and outcome Y share a common cause, then X and Y will gen-
erally be associated, even if neither is the cause of the other. Figure 2 shows
that Z =(CD4, age, etc.) is a common cause of AZT and HIV RNA.
Z=(CD4, age)
X=AZT Y=HIV RNA
Figure 2: Causal acyclic graph that Z (such as CD4 lymphocyte, age, etc.) is a
common cause of AZT and HIV RNA.
• A direct cause of variable V on the DAG is called a parent of V and V is called
a parent’s child. In Figures 1 and 2, AZT is a parent of HIV RNA and HIV
RNA is a child of AZT.
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Following Pearl (1995, 2001), a causal DAG is a set of nodes V = (V 1, ..., V n),
corresponding to variables, and directed edges amongst nodes such that no variable
Vi can cause itself (acyclic). A path is a sequence of nodes connected by edges
regardless of arrowhead direction; a directed path is a path which follows the edges
in the direction indicated by the graph’s arrows. Further definitions,
• The ancestors of V are those variables ancestors with V as a descendant but
are a direct cause only of its children (where direct is always relative to the
other variables on the DAG). Thus, V is caused by all its ancestors, but only
its parents are direct causes.
• A path collides at a variable V if the path enters and exits V through arrow-
heads, in which case V is called a collider : → V ←.
• There are different types of paths between a variable V1 and a variable V2:
– A directed path from V1 to V2, as in Figure 1
– A backdoor path from V1 to V2: a path whose first edge is an arrow pointing
to V1 and whose last edge is an arrow pointing to V2.
– A blocked path between V1 and V2 : a path that has one or more colliders;
otherwise it is unblocked or open. Thus, a back-door path and a directed
path are open paths.
To explain the above terminologies consider Figure 3. In this Figure, X is not a
parent of Y and Y is not a child of X since there is no arrow from X to Y . However,
there is a directed path from X to Y through E, so X is an ancestor of Y and Y is a
descendant of X. There is a back-door path from X to Y through Z and a blocked
path between X and Y because L is a collider on the path from X to Y going through
E and L. Finally, there are 2 open paths between X and Y ; one through Z (the
back-door path) and one through E (the directed path). In Figure 1, the AZT to HIV
RNA arrow indicates a direct effect of AZT on HIV RNA, and shows no confounders
of the effect of AZT on HIV RNA. Figure 2 shows a mediated effect of CD4 on HIV
RNA in addition to the direct effect of AZT.
Formal definition. Let V¯m−1 = (V1, ..., Vm−1) be the vector of ‘ancestors’ of Vm,
PAm be the vector of ‘parents’ of Vm, and Vm(v¯m−1) is a function of v¯m−1 alone
through the values of the parents. A DAG satisfies the following conditions,
• All one-step counterfactuals Vm(v¯m−1) exist.
– each directed edge represents a stable and autonomous physical relation-
ship. That is, it is conceivable to change such relationship without changing
the others.
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Z
X
E
Y
L
Figure 3: An example of a DAG.
– there is reasonable agreement as to the hypothetical intervention which
sets X equal to x.
• Vm(v¯m−1) = Vm(pam) is a function of v¯m−1 alone through the values of the
parents. Once all parents are manipulated, no further variable can have an
influence. For example, X → Z → Y expresses that Yxz = Yx∗z = Yz. This is
called the restriction assumption that says X has no direct effect on Y except
through Z.
• Observed variables and counterfactuals are obtained recursively from Vm(v¯m−1).
For example, X → Z → Y expresses that Yx = Yxz(x) = Yz(x), and Z = Z(x)
and Y = Yx = Yxz(x) = Yz(x). This is the consistency assumption that links
potential outcomes to the observed data.
• All common causes of any two variables are included as variable on the DAG.
This is called the no omitted confounders assumption.
{Vm+1(v¯m), ..., Vn(v¯n−1)} ⊥⊥ Vm|V¯m−1 = v¯m−1
where v¯m−1 is subvector of v¯k, k ≥ m.
As stated, the central question in the analysis of the causal effect is: can the controlled
(post-intervention or post-treatment), f(Yx), be estimated from the pre-intervention
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distribution fY |X,Z(y|x, z)? “A fundamental theorem in causal analysis states that
such identification would be feasible whenever the causal model is Markovian, that
is, the graph is acyclic (containing no directed cycles) and all error terms are jointly
independent”(Pearl, 2001).
Theorem 1.(The causal Markov conditions)
The probability density P of the observables is Markov relative to the DAG if,
P (V1, ..., Vn) =
n∏
m=1
P (Vm|PAm)
or equivalently, for m = 1, ..., n, P (Vm|V¯m−1) = P (Vm|PAm).
For example for the variables in Figure 2, the joint density can be factorized
fY,X,Z(y, x, z) = fY |X,Z(y|x, z)fX|Z(x|z)fZ(z).
Intervention density
As stated, our initial goal was to identify the intervention density
P (V1(x), ..., Vn(x))
where X ⊂ V .
Corollary. (Truncated factorization)
For any Markovian model, the distribution generated by an intervention x on a set of
X is given by the truncated factorization
P (V1(x), ..., Vn(x)) =
n∏
m|Vi 6=X
P (Vm|PAm)I(X = x).
It follows that the intervention density of V (x) is identified from the observed data
under the causal graph. Under the DAG of Figure 2, we can write the intervention
density of V (x) as,
f(Yx,Xx, Zx) = f(Y |X = x,Z)f(Z)I(X = x)
then
f(Yx) =
∫
f(y|X = x,Z = z)fZ(z)dz.
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In particular, we can identify the average causal effect of X on Y (relative risk or
odds ratio causal effect in case of dichotomous outcome Y )
E(Y1 − Y0) =
∫ ∫
yf(y|X = 1, Z = z)f(z)dydz −
∫ ∫
yf(y|X = 0, Z = z)f(z)dydz
=
∫
{E(Y |X = 1, Z = z)− E(Y |X = 0, Z = z)}f(z)dz.
We are now able to derive any intervention density under a given causal DAG. While
observed outcome is replaced by counterfactual outcome Yx, the direct arrow from
AZT to HIV RNA is removed to make Yx a non descendant of X. Figure 4 shows
this. On the causal DAGs, the independence can be verified by using d-separation.
Z
X=AZT Yx
Figure 4: Causal acyclic graph that Z is measured confounder (CD4 lymphocyte, age,
etc.) and replace observed outcome (HIV RNA), Y , by potential outcome Yx.
D-separation is a relation between three disjoint sets of vertices in a directed graph
G. “To test whether X is independent of Y given Z in any distribution compatible
with G, we need to test whether the nodes corresponding to variables Z block all
path from nodes in X to nodes in Y ” (Pearl, 2000). Blocking is to be interpreted
as stopping the flow of information (or dependency) between the variables that are
connected by such paths. “The intuition behind d-separation is simple and can best
be recognized if we attribute causal meaning to arrows in the graph” (Pearl, 2000).
A set C is said to d-separate A from B if and only if C blocks every path from a
node in A to a node in B. In Figure 4, Yx and X are d-separated by Z, because
all paths connecting X and Yx are blocked by Z. Then, X and Yx are conditionally
independent for all x, given Z; that is, Yx ⊥⊥ X|Z for all x. This is referred to as no
unmeasured confounders. As a result, if Yx and X are not associated within levels
of Z, then the conditional association between X and Y , given Z, reflects the causal
effect of X on Y within levels of Z. Otherwise, the conditional association between
X and Y , given Z, must be spurious.
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3 The problem of confounding in observational stud-
ies
In causal inference, as explained, one searches for the causes of an outcome, based
on associations with various variables that are measured in the study. In addition
to the exposure that the study is investigating, there may be other factors that are
associated with the exposure and independently affect the outcome. For instance,
in a study on the health effects of smoking, smokers groups may be older than non-
smokers, and more of them may be male. That would confound the relationship
between smoking and heart disease, since even non-smoking older males are at high
risk of heart disease. If the prevalence of these factors differs between the smokers and
non-smokers being compared, this will yield a biased estimate of the causal effect of
exposure on the outcome of interest. These factors are called confounding factors or
variables. In most standard literature a confounder is defined as a variable associated
with exposure, and associated with outcome conditional on exposure and not on the
causal pathway between exposure and outcome. In Figure 2, Z =(CD4, age and
etc.) is confounder for the association between AZT and HIV RNA. It is important
to control for confounding by measuring the known confounders and including them
as covariates in the data analysis. However, one major problem is that confounding
variables are not always measured or even imaginable. VanderWeele, Herna´n and
Robins (2008) investigate the sign of the bias that arises when control for confounding
is inadequate. Further, they show that if only one unmeasured confounding variable
is present in the data setting, it is relatively easy to draw a conclusion about the
direction of the bias. If there is more than one unmeasured confounding variable,
this becomes much more complex. In view of this, there are various methods which
have been proposed for adjusting for measured confounders. These different methods
may produce different estimates for the causal effect of an exposure in a specific
study. In this section, we describe two methods for adjusting for confounders under
the assumption of no unmeasured confounders. Others are discussed in chapter 5. In
addition to these methods, we describe a method that is well established to control for
unmeasured confounders in both RCTs and observational studies. This methodology
is called the instrumental variables (IVs) method and we will describe it in a separate
section.
3.1 Stratification
In order to estimate the causal effect of exposureX on outcome, one has to account
for the effect of confounding factors. Confounding adjustment may improve precision,
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or make precision worse, but is primarily designed to avoid bias. One method to deal
with confounding is by stratification. If the no unmeasured confounders assumption
Yx ⊥⊥ X|Z (2.3)
holds, then
f(yx|Z) = f(yx|X = x,Z) = f(y|X = x,Z),
and
E(Yx|Z) = E(Yx|X = x,Z) = E(Y |X = x,Z).
That is, the density and mean of Yx can be obtained by dividing the population within
strata defined by the values of Z and estimating the outcome density and mean in that
stratum for subjects with X = x. This approach is called stratification and it applies
often when confounding factors are categorical. Stratification involves an unknown
data law, f(y|X = x,Z) which can be estimated non-parametrically. The resulting
causal effect estimator may behave erratically in moderate sample size because Z is
usually high dimensional. Suppose that we will postulate the following conditional
model
E(Yx|Z) = g{ω(Z) + ψ∗x} (2.4)
where g(.) is a known link function and ω(.) known up to a finite dimensional nuisance
parameter for each x. This model is called a conditional structural mean model. For
instance, when g is the identity function and ω(Z) linear, model (2.4) is the following
causal model,
E(Yx|Z) = α∗0 + α∗1Z + ψ∗x
where α∗0, α
∗
1, and ψ
∗ are unknown finite dimensional parameters. The causal param-
eter equals ψ∗ = E(Y1 − Y0|Z). If ψ∗ is non-constant in Z, then Z is said to be a
moderator of the effect of X on Y . If there is a linear interaction between exposure
and confounders, the structural model for the conditional mean of Yx given Z is as
follows
E[Yx|Z] = α∗0 + α∗1Z + ψ∗1x+ ψ∗2xZ
where ψ∗2 is an interaction effect of exposure and confounders. The causal parameter
is then equal to ψ∗1 + ψ
∗
2Z = E(Y1 − Y0|Z). An example of interaction is seen in the
case of oral contraceptive use, X, and its effect on cardiovascular disease, Y , adjusted
for smoking, Z. Because smoking Z amplifies thromboembolic-disease risk Y in oral
contraceptive users, interaction is said to exist (Curtis et al., 2006). This is why oral
contraceptives carry a boxed warning advising against their use in smokers. In this
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model, Z is a moderator of the effect of X on Y if ψ∗2 is non zero. In the case where
the outcome Y is dichotomous, model (2.4) is for instance as follows,
logitP (Yx = 1|Z) = α∗0 + α∗1Z + ψ∗x
where logit(p) = log {p/(1− p)}. The causal odds ratio is then
exp(ψ∗) =
P (Y1 = 1|Z)/P (Y1 = 0|Z)
P (Y0 = 1|Z)/P (Y0 = 0|Z) .
Under assumption (2.3), the conditional SMM (2.4) implies the following model for
the observed data
E(Y |X,Z) = g{ω(Z) + ψ∗X}, (2.5)
for instance,
E(Y |X,Z) = α∗0 + α∗1Z + ψ∗X.
Thus consistent estimates for ψ∗ under the conditional SMM (2.5) can be obtained
by fitting an ordinary conditional mean model, or for instance, by fitting a logistic
conditional mean model
logitP (Y = 1|X,Z) = α∗0 + α∗1Z + ψ∗X.
3.2 Propensity score
In model (2.4) the association ω(Z) of confounders with outcome is often problem-
atic to specify. Because estimates for ψ∗ may then be inconsistent, tests of no causal
effect may be invalid. When the assumed model for ω(Z) is incorrect and exposure
X is dichotomous, one solution is to adjust for the propensity score (Robin, 1997;
Rosenbaum and Robin, 1983; Rosenbaum, 2002). This is an approach which indeed
provides a means for adjusting for selection bias in observational studies of causal
effects. Creating strata in which subjects are matched on the propensity score al-
lows one to balance measured variables between treated and untreated subjects. The
propensity score is the conditional probability of receiving a given exposure (treat-
ment) given a vector of measured covariates. It is usually estimated using logistic
regression. Therefore instead of the high dimensional confounder Z, one adjusts for
the propensity score
p(Z) = P (X = 1|Z)
where p(Z) is the propensity score and p encodes for the propensity score. The key
point is that the no unmeasured confounders assumption implies that
Yx ⊥⊥ X|p(Z).
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Because
P (X = 1|Yx, p(Z)) = E{P (X = 1|Yx, Z)|Yx, p(Z)}
= E{P (X = 1|Z)|Yx, p(Z)}
= p(Z).
Therefore, it follows that adjusting for the propensity score is sufficient. For example
when
E(Yx|p(Z)) = α∗0 + α∗1p(Z) + ψ∗x
consistent estimates of ψ∗ can be obtained by fitting the following model for the
observed data
E(Y |p(Z)) = α∗0 + α∗1p(Z) + ψ∗X.
The propensity score adjustments work better in settings where there is little overlap
in the distribution of confounders between exposed and unexposed subjects (Rubin,
1997; Lunceford and Davidian, 2004). When exposure X is continuous, estimates for
the parameter ψ∗ indexing model (2.4) may be obtained via G-estimation (Robins et
al., 1992; Brumback et al., 2003) which is discussed in chapter 5.
Example 1. Birth weight is of concern to physicians because it is a strong predictor
of infant mortality and birth defects. Women‘s behavior during pregnancy (including
diet, smoking habits and receiving prenatal care) can greatly alter the chances of
delivering a baby of normal birth weight. We reanalyze birth weight data (Hosmer
and Lemshow, 2000) of 189 babies. Table 2.2 shows the estimates of causal effect of
Table 2.2: Estimates and 95% confidence intervals and p-value of the smoking effect
with different methods for adjusting for confounders. The subtable left is presented
when the outcome is birth weight measured in gram units and the subtable right is
when the outcome is an indicator of low birth weight.
Continuous outcome Dichotomous outcome
Adjusting ψˆ 95 % CI P.value exp(ψˆ) 95 % CI P.value
No adjusting -0.28 (-0.49, -0.07) 0.0090 2.02 (1.08,3.78) 0.0270
OLS -0.35 (-0.59, - 0.13) 0.0007 2.88 (1.30, 6.22) 0.0070
PS -0.36 (-0.57 , -0.16) 0.0022 2.94 (1.35, 6.38) 0.0060
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maternal smoking during pregnancy on average birth weight following different meth-
ods for controlling confounding. In this example, the confounders are: maternal age,
maternal weight at last menstrual period, race, and maternal history of hypertension.
The percentage of self reported nonsmokers was 61 %. The adjustment for confound-
ing was done twice, once for the case where outcome (birth weight) is continuous
(subtable left) and once where outcome is dichotomous (low birth weight) (subtable
right). Table 2.2 shows, average causal effects of smoking on average birth weight are
relatively similar for the OLS and PS causal effect estimators (see subtable left) and
suggests strong evidence of a harmful smoking effect. Specifically, the PS estimator
suggests a 360 gram (95% confidence interval (160, 570)) decrease in average birth
weight due to smoking.
4 Randomized clinical trials and the problem of
noncompliance
In a typical clinical trial, patients are mainly randomized to one specific dosing
strategy of treatment A or treatment B over a period of time. The primary analy-
sis should compare patients in their randomly assigned treatment groups A and B.
There is almost universal agreement among clinical trialists that such intention-to-
treat (ITT) analysis is the primary analysis of randomized clinical trials (RCTs).
Intention-to-treat (ITT) analysis. ITT analysis is a standard analysis in ran-
domized clinical trials (RCTs). This approach analyzes subjects by comparing their
outcomes according to the intention to treat each subject rather than treatment
received. In fact, ITT estimators measure the effect of assignment rather than
treatment. For instance, in a RCT, the randomization indicator Ri is equal to 1
if subject i is assigned to treatment and 0 if he/she is assigned to placebo; then
ψˆITT = Eˆ(Yi|Ri = 1) − Eˆ(Yi|Ri = 0). This is the most suitable approach for prag-
matic trials that aim to measure the effectiveness (the benefit of treatment policy)
of a treatment and is less suitable to measure the efficacy (the benefit of actually
receiving a treatment) of a treatment (e.g., Sommer and Zeger, 1991; Goetghebeur et
al., 1998; Dunn et al., 2005).
For scientific experiments involving human participants, noncompliance and partial
compliance are very common. Noncompliance might generally be defined as partial
or zero adherence to a subject’s prescribed treatment. The term ‘noncompliance’ or
‘non-adherence’ is commonly applied for these events and the term ‘departure from
randomized treatments’ is also often used. In practice, it is reasonable to believe that
most, if not all, randomized clinical trials are not an ideal experiment where sub-
4 Randomized clinical trials and the problem of noncompliance 63
jects actually receive their randomly allocated treatment exactly as they have been
prescribed in the experiment’s treatment protocol. This is particularly true for com-
plex treatments (Dunn and Bentall, 2007). Because many patients may fail to take
their prescribed medicine, they would not actually receive all of the prescribed dose
they were randomly assigned to (Efron and Feldman, 1991; Goetghebeur et al., 1998;
Nagelkerke et al., 2000; Goetghebeur and Vansteelandt, 2005; Dunn et al., 2005).
Others may take the medicine or receive an alternative treatment that had been allo-
cated to other people in the trial. The reasons for noncompliance may be associated
with the outcome variable and thereby act as measured confounders (prognostic vari-
ables), more importantly, one typically also needs to acknowledge the existence of
unmeasured confounders (Efron and Feldman, 1991; Fischer-Lapp and Goetghebeur,
1999; Nagelkerke et al., 2000). Noncompliance with assigned treatment therefore is
a ubiquitous issue in RCTs. There are no universally accepted guidelines on non-
compliance analysis to date. The following examples show different ITT estimates in
imperfect RCTs.
Example 2. Sommer and Zeger (1991) study the effect of vitamin A supplementa-
tion on mortality in preschool children in a trial carried out in Indonesia. Children
allocated to the vitamin A supplementation did not always receive it and no placebo
treatment was given in the control group due to a local law. In totally 23 682 children
were randomized to receive vitamin A supplementation or no intervention (in a clus-
ter randomized fashion) (Table 2.3). Ignoring the clustering, ITT analysis suggests
Table 2.3: Vitamin A trial data, according to Sommer and Zeger (1991). Dichotomous
outcome (alive/dead).
Treatment compliance Control compliance
No Yes Total No Yes Total
Alive 2385 9663 12048 - - 11514
Dead 34 12 46 - - 74
Total 2419 9675 12094 - - 11588
an effectiveness with relative risk, RR = 0.60 and 95 % CI (0.41, 0.86). That is,
allocation to vitamin A reduced mortality to 60%.
Example 3. Goetghebeur et al. (1998) present further details on this trial of the
effect of vitamin A supplementation on mortality in preschool children on a slightly
modified data base. They consider that children were randomized to receive two doses
of vitamin A, one at the beginning of period 1 (0-4 months) and one at the beginning
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of period 2 (5-8 months) or not, any child surviving 12 months was considered to be
censored. Compliance can be to either the first dose, the second dose, or both or nei-
ther. Specifically, they refine the binary compliance summary, retaining the number
of high dose vitamin A pills children received: 0, 1, or 2. By using Cox regression,
ITT analysis suggests a moderate but potentially important effect (β = −0.43) and
95 % CI (−0.73,−0.23) of vitamin A supplementation on mortality. (Note that in
example 1, the causal parameter is a risk ratio, and in this example it is the effect of
measured as a hazard ratio.)
Example 4. Cole and Chu (2005) present the Herpetic Eye Disease Study which
randomized 703 ocular herpes patients to 365 days of acyclovir or placebo between
1992 and 1996. In this trial, there was over 90 per cent compliance in both arms.
Compliance was assessed by pill counts at study visits planned for 1, 3, 6, 9 and 12
months post-randomization. If a patient did not return pill bottles, then compliance
was estimated from medication cards used by the patient to record when pills were
taken and/or the physician’s judgment. The result was an estimate of the percent
compliance over the intended follow-up, irrespective of endpoint status (i.e., count of
treated days divided by 365). The hazard of recurrence in the acyclovir arm was 0.55
times the hazard in the placebo arm using ITT analysis with 95 % CI (0.41, 0.75)
(Data not presented here).
The limitations of an analysis which ignores noncompliance have received growing
concern in the causal inference literature. It is important to attempt to reduce the
rate of noncompliance in these circumstances but at the same time one wishes to
estimate the causal effect of exposure at the levels that were actually taken. Indeed,
the challenge to the trialists is to draw valid inference from the data actually obtained
from such a trial. An alternative to the ITT analysis is the ‘as-treated analysis’, in
which subjects are classified by the treatment actually received. As argued before,
this analysis is unsatisfactory since confounders associated with switching treatment
threaten the causal interpretation of treatment effects (Nagelkerke et al., 2000). For
example, if the most treatment resistant patients in the less effective treatment group
switch to the more effective treatment, they may decrease the average level of im-
provement for the more effective treatment, also leading to an underestimate of the
true causal difference between the two treatments. An other analysis that most au-
thors also use is the ‘per-protocol analysis’ (pp), which excludes any data collected
from a subject after they have departed from the randomized treatment. In words,
subjects who depart from randomized treatment are included in the analysis only up
until the point of departure (White, 2005).
All of these approaches consider treatment actually received in combination with
treatment assigned, two jointly observed variables. A very different approach moves
beyond this. In the placebo controlled noncompliance context (Angrist et al., 1996;
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Dunn et al., 2005), subjects are often classified into four categories: (a) compliers, are
those who take the treatment whatever treatment is assigned (b) always-takers, are
those who would take the assigned active treatment no matter what their assignment
(c) never-takers, are those who would not take the treatment no matter what their
assignment, and (d) defiers, are those who would take the treatment opposite from
their assignment regardless of the treatment they were assigned to. In the placebo
controlled clinical trials one often assumes that the subjects allocated to the placebo
do not get access to the treatment (no contamination) and there is only one form of
noncompliance to be observed. When there is no noncompliance in the control group
(no contamination), subjects are divided into compliers and never-takers. Treatment
effect is most meaningful for compliers. With no noncompliance in the control group,
efficacy among compliers equals efficacy among the treated. In the next example, we
compare the ITT, as-treated and PP-analysis on vitamin A trial.
Example 5. ITT analysis showed a moderate effectiveness with relative risk (RR =
0.60) and 95 % CI (0.41, 0.86). That is, allocation to vitamin A reduced mortality to
60% in example 2. By performing a per-protocol analysis, we find a RR of 0.19 with
95 % CI (0.11, 0.36), which shows mortality was much higher among children ran-
domized to vitamin A who did not receive it than in the control arm. By performing
an as-treated analysis, we find a RR of 0.16 with 95 % CI (0.09, 0.29), which shows
an even more extreme risk ratio.
Therefore, if investigators were to take a naive look at the association between mea-
sured treatment compliance and outcome in the treated group they would most likely
be misled. In view of this, there have been a number of recent proposals on how to
use compliance and how to adjust for noncompliance in the analysis. Briefly, some
authors used treatment arm (randomization) as an instrumental variable for correct-
ing noncompliance in trials comparing either several levels of a single active treatment
or a single active treatment to placebo (e.g., Robins, 1989; Angrist et al., 1996; Goet-
ghebeur et al., 1998). Others (e.g., Rubin, 1997) proposed maximum likelihood and
Bayesian inferential methods for CACE, which impose additional assumptions and
are then more efficient than standard instrumental variable methods. To reduce the
noncompliance impact, some authors also resist analyzing the data in a double-blind
manner when subjects in the placebo arm lack access to treatment. However, these
approaches generally require various strict assumptions. Efron and Feldman (1991)
show compliance is an uncontrolled covariate. They “modeled the mean effect of
treatment (cholestyramine) in a placebo controlled trial as a linear function of the
percentage of assigned cholestyramine that is actually taken”. Recent methods for
causal inference offer new insights and opportunities by estimating what ITT analysis
would have been, had everyone complied perfectly. Robins (1994), and Goetghebeur
and Lapp (1997) have used semi-parametric structural linear mean models (defined in
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next section) for compliance adjustment in RCTs. These models consider treatment-
free outcome as a reference for observed outcome.
5 Instrumental variables (IVs)
The method of instrumental variables (IV) has originally been applied in the
econometrics literature when the independent variable X is correlated with the error
term ǫ in the linear regression of Y on X. Suppose that the outcome Y is linearly
related to the observed exposure X as follows
Y = β∗0 + β
∗
1X + ǫ. (2.6)
A consistent OLS estimator for β∗ can be obtained when ǫ and X are uncorrelated
(Martens et al., 2006; Herna´n and Robins, 2006). Now suppose that in the data
setting there is an unmeasured confounder U , such that the true model in fact is
Y = β∗0 + β
∗
1X + γ
∗U + δ (2.7)
where δ is the random deviation of Y from the expected value based on the model
and is independent of U and x, but we still proceed with our naive OLS estimator
as for model (2.6). Since X and ǫ are no longer uncorrelated, we will obtain an
inconsistent estimate for β∗. In view of this problem, a much more common approach
in econometrics traditionally and recently in epidemiological applications, is to find
a variable that is strongly correlated with exposure X, has no direct effect on the
outcome Y , and is conditional independent of Y given X. Such a variable is called an
instrumental variable (IV). Suppose that the random variable V is an instrumental
variable, then
X = θ∗0 + θ
∗
1V + τ
where error terms ǫ and τ are uncorrelated and θ∗1 6= 0. An asymptotically unbiased
estimate of the effect of X on Y , β∗1 , can then be obtained as
βˆ∗1 =
n∑
i=1
(Vi − V¯ )(Yi − Y¯ )/n
n∑
i=1
(Vi − V¯ )(Xi − X¯)/n
.
This estimator is in fact consistent, when V is uncorrelated with the error term ǫ
(Herna´n and Robins, 2006). We can say that the numerator measures the effect
of the IV on the outcome Y and the denominator measures the effect of the IV
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on the exposure X. This estimator is indeed obtained by a two-stage least squares
algorithm. First regressing X on V , and then regressing Y on the predicted value
of X obtained from the first regression of X on V (Wooldridge 2002, 2003). In the
case of a dichotomous IV, the numerator and denominator are simply the difference
in mean outcome and mean exposure between V = 1 and V = 0, respectively.
Random variable V is generally an instrumental variable (IV) if:
• it is associated with exposure X;
• it affects the outcome Y only through X;
• the association between V and Y is unconfounded.
Instrumental variable methods were invented more than 70 years ago, and were first
used in economics and econometrics in connection with structural equation models.
They have more recently entered the medical, epidemiological and biostatistical lit-
erature, mainly in connection with noncompliance adjustment in randomized clinical
trials (Goetghebeur et al., 1998; Robins, 1998; Greenland, 2000) and in the context
of Mendelian randomization studies (Didelez and Sheehan, 2007; Lawlor et al., 2008;
Didelez et al., 2008), as well as in observational studies. Although, randomized con-
trolled trials (RCTs) remain the gold standard for research, the analysis based on
these trials is problematic when in the presence of noncompliance there are unmea-
sured confounders (Robins, 1998; Goetghebeur et al., 1996; Greenland, 2000; Dunn,
2005; Herna´n and Robins, 2006). However, the crux of observational studies is also
that treatment status is not controlled by the researcher and can be related to var-
ious background variables (confounders) which might be unknown (Rosenbaum and
Rubin, 1983; Rubin, 1997). Observational studies compare subjects that have cho-
sen (or whose physicians have chosen) to take a treatment of interest to the other
group of subjects. Any difference in outcome between the two groups could be due
to the treatment altering the outcome or it could be that the treatment has no effect
but the reason for choosing to take the treatment is the cause of any difference. In
view of this, the instrumental variable (IV) method is one methodology that has been
used to overcome the effect of unmeasured confounders in both types of studies. An
instrumental variable (IV) must satisfy some strong assumptions to allow for consis-
tent effect estimates. Indeed, its power is derived solely from the assumption that
the instrument only affects the outcome indirectly through the exposure (Martens et
al., 2006; Herna´n and Robins, 2006). Although this assumption is untestable based
on the data only, it is plausible by design. The main problem therefore remains to
find a convincing instrumental variable that has strong correlation with exposure X.
The stronger this association the more precise the instrumental variable estimate of
exposure effect.
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5.1 IVs and imperfect randomized studies
In RCTs, treatment assignment can provide a perfect IV for the effect of received
treatment on outcome and indeed a randomization based exposure adjusted analysis
is an alternative to ITT analysis (Greenland, 2000; Goetghebeur and Vansteelandt,
2005; Dunn, 2005; Herna´n and Robins, 2006). The dichotomous randomization vari-
able R takes the value 1 if a subject is randomly allocated to receive the active treat-
ment or new intervention, and the value 0 if the allocation is to receive the placebo
treatment or control condition. For ease of discussion, we consider the dichotomous
treatment X in which X = 1 for exposed, 0 otherwise. The outcome variable can be
continuous (often normally distributed) or dichotomous. The variable Z is a covari-
ate measured prior to randomization (pre-randomization). The potential randomized
assignment outcome is defined as Xr for r = 0, 1. Then the effect of randomization on
receipt of treatment for subject i is: Xi1−Xi0. We cannot observe this difference for
each subject because that subject is only ever randomized to one of the conditions.
The treatment status can then be expressed as X = (1 − R)X1 + (1 − R)X0. In
practice, we observe X. Following Angrist et al. (1996), there are only three possi-
bilities for the randomization effect on X: X1 −X0 = 1, or 0, and or −1. These are
corresponding to the compliers; always-takers, never-takers; and defiers, respectively
where, X1−X0 = −1 (defiers) is often not realistic and ignored as a possibility in the
analysis. In this setting, Yirx may represent the counterfactual outcome of interest
that would have been observed if (possibly contrary to fact) subject i were randomized
to arm r and treatment x were given; r = 0, 1, x = 0, 1 (Robins, 1998; Vansteelandt
and Goetghebeur, 2003). For instance in the vitamin A trial (Sommer and Zeger,
1991), Yi11 would have been observed if child i were randomized to vitamin A and
vitamins A were received. Consider now a double-blind RCT with noncompliance
where the relationship between received treatment and outcome is influenced by un-
observed confounders. To be able to infer the causal effect of X on Y , the following
assumptions must be satisfied,
1. R is associated with exposure X;
2. R affects the outcome Y only through X (exclusion restriction);
3. no confounding for the effect of R on Y (randomization assumption).
With the above assumptions randomization R is an instrumental variable (IV) for
the effect of received treatment on outcome. Let U indicate confounding factors,
which may be partly observed or entirely unobserved, that affect both the exposure
and the outcome. Figure 5 presents a DAG that satisfies these assumptions. These
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R X Y
U
Figure 5: A double-blind randomized trial with randomization assignment R as an
IV. U is partly observed or entirely unobserved confounders.
assumptions cannot easily be tested from the observable data as they involve the un-
observable U . However, in a double-blind RCT the above assumptions are satisfied by
design (Herna´n and Robins, 2006). Assumption (1) holds because trial subjects are
more likely to receive treatment if they were assigned to treatment. Assumption (2)
holds by effective double-blindness. This assumption indeed says that for essentially
all subjects, assigned treatment has no direct effect on the outcome when received
treatment is held fixed. Thus, under this assumption Yrx = Yx. The assumption (3)
holds by the random assignment. The assumption (3) implies that R ⊥⊥ Y |X,U . In
addition to the above assumptions, the monotonicity assumption P (X1 > X0) = 1
may also be assumed to hold. This rules out the existence of defiers and classifies
a subject of the population into always-takers, compliers, and never-takers. The IV
assumptions are also made explicitly conditional on covariates to allow for the fact
that instruments can be related to these background variables. The usual instrumen-
tal variable estimator in a randomized trial with noncompliance may be viewed as
estimating the differential effect of treatment on compliers. It can be simply written
as
ψˆIV =
Eˆ(Y |R = 1)− Eˆ(Y |R = 0)
Eˆ(X|R = 1)− Eˆ(X|R = 0) .
As stated, the numerator is the standard estimator for the treatment effect of R on
Y (ITT of R on Y ), and the denominator is the standard estimator for the treatment
effect of R on experimental exposure X (ITT of R on X). Because R is randomly
assigned, as in the case of a natural experiment, both estimates are consistent (Green-
land, 2000). It follows from ψˆIV that, the weaker the association between R and X
the more the ITT effect will be inflated because of the shrinking denominator.
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Consider now treatment effects which are linear in received dose
Yx − Y0 = ψ∗x
then
Y = Y (X) = Y0 + ψ
∗X.
Due to randomization R is an IV, it is not associated with outcome in the absence of
treatment, that is, not associated with the potential treatment-free outcome. Because
Y0 is independent of R given Z, by the randomization assumption of the IV
E(Y |R,Z) = E(Y0|R,Z) + ψ∗E(X|R,Z)
= E(Y0|Z) + ψ∗E(X|R,Z).
Assuming for instance models: E(X|R,Z) = α∗0 + α∗1R + α∗2Z, fit this model first to
obtain predictions E(X|R,Z; αˆ). At the second stage another linear model E(Y0|Z) =
β∗0 + β
∗
1Z allows to estimate β
∗. Then an estimate of ψ∗ is obtained by fitting the
model
E(Y |R,Z) = β∗0 + β∗1Z + ψ∗E(X|R,Z; αˆ)
for instance using ordinary least squares. Thus, the IV estimators for ψ∗ is derived
in two-stages:
1. regress compliance on the instrumental variable (and covariates) and obtain
predictors;
2. regress outcome on predicted compliance (and covariates).
Standard errors must acknowledge the fact that predictions are imprecise. Note that,
standard software for Two-stage least squares estimation thus allows to correct for
noncompliance under certain assumptions.
We present a Blood Pressure Reduction trial as an example of a randomized trial and
analyze it in this chapter and in chapter 4.
Blood Pressure Reduction trial
Goetghebeur and Lapp (1997), and Goetghebeur and Vansteelandt (2005) ana-
lyzed a double-blind, three-arm trial on blood pressure reduction which randomized
some 300 hypertensive patients in the U.K. in the years 1989-1990. After a initial
run-in period of 4 weeks on placebo, patients were randomly assigned to one of two
experimental treatments (Nebivolol, Atenolol), or placebo. Each treatment is pre-
scribed at one tablet a day at breakfast. At study entry, baseline characteristics such
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as sex, height, weight, age and diastolic blood pressure (DBP), were recorded. In
all, five clinic visits were scheduled a fortnight apart, starting from the beginning of
the run-in. DBP was measured at each visit. At visit 3, the 4-week active treatment
period started. For a sample of 164 patients, this indicated the start of electronic
compliance monitoring: a device in the pill container measured exact times at which
patients opened and closed the container. Because of technical problems with the
electronic monitors, compliance data of 10 patients were missing. This left samples
of size 54, 49, and 51 available for analysis on treatment arms Nebivolol, Atenolol,
and the placebo arm respectively. The compliance measure used is the percentage of
assigned active dose which was actually taken.
Table 2.4 compares the results of an ITT analysis, As-treated analysis, and IV esti-
mators (with and without adjustment for covariates) in the DBP trial. For instance,
IV estimator I in the left subtable shows that among subjects who chose to take on
average 1 pill (Nebivolol) per day, the blood pressure reduction would on average
have been 9.56 mmHg (95 % CI (5.29, 13.83)) smaller had they not taken any pills
(Nebivolol). The subtable right shows also how with different observed exposures a
significantly different average causal effect on the blood pressure is found.
Table 2.4: Estimates and 95% confidence intervals and p-value of the effect of both
treatments (Nebivolol and Atenolol) versus placebo. The IV estimator I indicates that
baseline covariates are not adjusted and the IV estimator II indicates that all baseline
covariates are adjusted for DBP trial.
Nebivolol versus Placebo Atenolol versus Placebo
Estimators ψˆ∗ 95 % CI P.value ψˆ∗ 95 % CI P.value
ITT -8.11 (-11.66, -4.56) 10−4 -9.55 (-13.77, -5.34) 2×10−4
As treated -5.98 (-11.37, -3.96) 2×10−4 -8.54 (-12.82, -4.25) 10−4
IV estimatorsI -9.56 (-13.83, -5.29 ) 2×10−4 -10.38 (-15.06, -5.69) 3×10−4
IV EstimatorsII -7.63 (-11.77, -3.48 ) 2×10−4 -7.44 (-11.92, -2.96) 10−4
For instance, IV estimator I suggests that the average blood pressure reduction would
have been 9.56 mmHg (95% CI 5.29, 13.83) smaller over the study period among those
who choose to take on average one pill per day, had they not taken the exposure. In
contrast, ITT shows 8.11 mmHg (95% CI 4.56, 11.66). Greenland (2000) obtains the
IV estimation for the causal effect of vitamin A on mortality for the data in Table
2.5, where he applies the IV method to control for confounding when acknowledging
noncompliance in this trial. First, the proportion of subjects who are compliers is
estimated in the treatment arm: Pˆc = 0.80 (c indicates compliers). He then obtains
the IV estimate of the risk difference (RD) produced by treatment comparing x = 1
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to x = 0: mˆ•1−mˆ•0pˆc = −324 per 100 000=-0.324 % with 95 % CI (-0.55 %, -0.10 %),
this is a 324/639=51 % risk reduction. The quantities m•1 is the average outcome if
every one is assigned treatment (R=1): mˆ•1 = 4612095 = 380 per 100 000; and m•0 is
the average outcome if every one is assigned to placebo (R=0): mˆ•0 = 7411588 = 639
per 100 000. Because the original data set is not available, this estimated CI is not
exact for the Sommer and Zeger data set (Greenland, 2000).
Table 2.5: One year mortality data from the randomized trial of vitamin A supple-
mentation in children (Sommer and Zeger, 1991). Risk indicates deaths per 100 000
within one year.
R = 1 R = 0
X = 1 X = 0 Total X = 1 X = 0
Deaths (Y = 1) 12 34 46 0 74
Total 9675 2419 12094 0 11588
Risk 124 1406 380 undefined 639
5.2 IVs in observational studies
The interest in IV methods stems from the fact that, in the presence of unmea-
sured confounders, one can estimate the causal effect of nonrandomized exposure
on an outcome of interest by using an instrumental variable. Specifically, while the
causal effect of exposures are distorted by unmeasured confounders, which is a ma-
jor concern of researchers carrying out epidemiological and Mendelian randomization
studies, the instrumental variable (IV) approach is relatively straightforward once
an IV has been identified and is strong enough to correct for the bias confounding
in observational studies. Finding a valid IV or an IV which is strongly correlated
with the exposure is however quite difficult. We list some convincing examples. In
a study of the risk of gastrointestinal (GI) complications attributable to different
non-steroidal anti-inflammatory drugs (instead of Cox-2 inhibitors), Brookhart et al.
(2007) choose the physician’s prescribing preference as an instrumental variable and
argued it might satisfy the IV assumptions (see chapter 3). Leigh and Schembri (2004)
use the cigarette price per region as an IV to estimate the effect of smoking on health.
The use of genetic variants as instrumental variable (IV) is applied to analyze the
causal relationship between exposure and a disease outcome. Some papers have de-
scribed Mendelian randomization as an IV analysis (Thomas and Conti, 2004; Didelez
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and Sheehan, 2007; Lawlor et al., 2007). In the next chapter, we will elaborate on
the application of IV methods for handling this long-standing inferential problem in
observational studies. Before doing so we point to one final important complication
in this filed: measurement error in exposure.
6 Measurement error and causal models
In addition to confounding, an important but largely overlooked impediment us-
ing compliance measurements to validly estimate the effect of received assigned drug
dosing, is measurement error. Although in recent years, new measuring devices such
as drug concentrations and electronic caps that monitor the opening and closing of a
medication container have been used besides pill counts and questionnaires to mea-
sure compliance, measurement error remains a serious problem. Medication event
monitoring systems (MEMS) record the exact timing of opening of drug containers,
providing more informative data than previously available (Urquhart and De Klerk,
1998). Nonetheless, accurate measures of treatment compliance have proved difficult
to obtain (Dunn, 1999; Goetghebeur and Vansteelandt, 2005). Partly because each
method only indirectly measures drug intake and none of them records whether a
subject swallows tablets or not. Moreover, there are concerns that subjects may take
more than 1 pill out of the MEMS container, or they may not swallow all pills that
they took out. In practice, it is then reasonable to believe that the treatment com-
pliance measurements are measured with error, that is, true treatment compliance
measurements may inherently differ from the observed treatment compliance mea-
surements. More specifically, the true exposure (treatment compliance measurement)
will be equal to the observed exposure plus or minus some error value. It is well known
that (as discussed in chapter 1) not adjusting for systematic measurement error can
downwardly or upwardly bias estimates for the causal effect of exposure. Therefore,
systematic measurement error in exposure is a real concern in many practical settings
and the causal effect estimator in the context of compliance measurements contin-
ues to be asymptotically biased when systematic measurement error in exposure is
ignored. While a large literature has become available on measurement error in ex-
planatory variables for the linear and nonlinear association models (as discussed in
the chapter 1), little attention has been paid so far to insight into the impact of
the measurement error problem in exposure in the context of newly developed causal
models with compliance measurements. “Dunn (1999) is one of the rare authors who
recognizes explicitly the importance of exposure measurement error in the field of
causal inference for compliance data. “He points out that all clinical measures are
fallible, and that compliance measures are particularly hard to obtain”. Goetghebeur
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and Vansteelandt (2005), have investigated this problem and show how this can be
handled when the average size of the error is known. In next the sections, we review,
linear structural mean models (LSMMs) (Robins, 1994; Goetghebeur and Lapp, 1997;
Goetghebeur and Vansteelandt, 2005) for the analysis of randomized trials subject
to noncompliance and consider for their performance under common complications of
measurement error in exposure. We provide a worked example of applying LSMMs
with a correction for measurement error in exposure in the Blood Pressure Reduc-
tion trial (Goetghebeur and Vansteelandt, 2005). In this context, we also consider
log-linear and logistic structural mean models (Robins, 1997; Vansteelandt and Goet-
ghebeur, 2003; Robins and Rotnitzky, 2004; Goetghebeur and Vansteelandt, 2005).
6.1 Structural mean models
The linear, log-linear and logistic structural mean models (SMMs) (Robins, 1994,
1998; Fischer-Lapp and Goetghebeur, 1999; Vansteelandt and Goetghebeur, 2003;
Goetghebeur and Vansteelandt, 2005) are recently developed causal models that al-
low to adjust for noncompliance to the prescribed therapy in randomized clinical
trials when one is interested in the effect of the amount of drug actually taken. The
structural mean models (SMMs) express the expected causal effect of treatment as
a function of the amount of drug actually taken. In the next section, we introduce
LSMMs and apply then to reanalyze the Blood Pressure Reduction trial to estimate
the effect of the percentage of assigned active dose that subjects actually took. We in-
vestigate the impact of measurement error on estimated exposure effects. Specifically,
we examine the impact of measurement error under a plausible range of expected er-
rors on the measurement of both active treatments (namely, Nebivolol and Atenolol)
in this trial by a sensitivity analysis as in by Goetghebeur and Vansteelandt (2005).
6.2 Linear structural mean models (LSMMs)
Consider the Blood Pressure Reduction trial described in the previous section.
Having defined potential or counterfactual outcomes and causal effects in section 2.1,
we now formulate these under the LSMM. We develop this for a single active treat-
ment versus placebo. We let the received experimental treatment be continuous, for
this example, and denote the percentage of active drug actually taken for subject
i by Xi. Let Ci denote the observed compliance pattern under the assigned treat-
ment. Then, on the active treatment arms, Xi = h(Ci) is a meaningful summary
of the pattern of exposure (Goetghebeur and Lapp, 1997). In this trial there is no
contamination expected. The randomization indicator Ri is to equal 1 if randomized
to the treatment arm and 0 to placebo arm. We denote Yi as the observed outcome
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variable. To estimate the causal effect of Xi on the outcome, we would ideally like to
measure how subjects on the active treatment arm would respond if they took placebo
instead of active treatment. As stated, the reference outcome for this possible sce-
nario is called a potential treatment-free outcome and denoted by Yi0r, assignment
treatment following Ri = r(r = 0, 1). With this notation we are making the exclusion
restriction assumption (Angrist et al., 1996) that randomization assignment Ri has
no direct effect on outcome. In a double-blind trial, one expects any effect of random-
ized assignment on outcome to be captured by the effect of assignment on exposure.
Under this assumption, we can use Yi0, (Yi0,0 = Yi0,1 = Yi0), to denote the potential
treatment-free outcome of patient i regardless of treatment arm. Thus, the contrast
Yi − Yi0 is the causal effect of actually received of exposure Xi for subject i relative
to no exposure. LSMMs regress the mean of this contrast at fixed levels of exposure
Xi on the randomized treatment assignment Ri and possibly baseline covariates Zi
for each subject i in a double-blind placebo-controlled trial in the following way,
E(Yi − Yi0|Xi, Ri = 1, Zi) = ψ∗Xi. (2.8)
Causal parameter ψ∗ is an unknown finite-dimensional parameter, which expresses the
expected change in outcome when those exposed to Xi = 1 would have their treat-
ment set to Xi = 0 (placebo). These models make no direct assumption on selected
treatment compliance levels and placebo prognosis but rely on the IV assumption
and a parametric form for the causal effects (Goetghebeur and Lapp, 1997). These
are special cases of structural nested mean models (Robins, 1994; Goetghebeur and
Lapp, 1997). In the DBP trial, exposures are the daily amount of experimental drug
intake or dose as measured by electronic devices. The baseline covariates Z=(age, sex,
height, weight, and diastolic blood pressure) are measured before randomization (pre-
randomization). For each subject i = 1, ..., n, we assume observed data (Yi,Xi, Ri, Zi)
represent n independent and identically distributed random vectors. Primary inter-
est lies in the effect of treatment on expected diastolic blood pressure reduction from
baseline (i.e. the time of active randomization). Note that, the treatment compliance
level Xi is a post-randomization variable and Zi contains pre-randomization variables.
As stated before, because the potential treatment-free outcome Yi0 is not observed
(it is sometimes called latent treatment- free outcome), we would not be able to es-
timate causal parameter ψ∗ without some assumptions. The information necessary
to estimate ψ∗ can be drawn from the combination of the following 3 assumptions
(Robins, 1994; Goetghebeur and Lapp, 1997; Vansteelandt and Goetghebeur 2003,
2004; Goetghebeur and Vansteelandt 2005).
1. To link treatment-free outcome to observed outcome, we assume that Yi = Yi0
(consistency assumption) for subjects with Xi = 0. In fact, this assumption
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states that on both arms, the observed outcome in the actually untreated subset
(Xi = 0) corresponds to Yi0. Under this assumption indeed, E(Yi − Yi0|Xi =
0, Ri, Zi) = 0.
2. Treatment-free outcomes have equal averages in both randomized arms, within
strata of baseline covariates Zi (randomization assumption), E(Yi0|Zi, Ri) =
E(Yi0|Zi). This assumption holds in well-conducted blinded randomized trials
because treatment-free outcomes are not affected by received treatment and can
therefore be envisaged as fixed characteristics of each subject.
3. The expected causal effect (2.8) follows the LSMM (model assumption).
Under assumptions (1)-(3) and further mild regularity conditions, a consistent, asymp-
totically normal estimator for ψ∗ can be obtained for active treatment A versus
placebo. Under model (2.8), we derive
E(Yi − ψ∗XiRi|Xi, Ri, Zi) = E(Yi0|Xi, Ri, Zi).
It follows from the randomization assumption that
E(Yi − ψ∗XiRi|Ri = 1, Zi) = E{E(Yi − ψ∗XiRi|Xi, Ri = 1, Zi)|Ri = 1, Zi}
= E(Yi0|Ri = 1, Zi) = E(Yi0|Zi),
and similarly, E(Yi|Xi, Ri = 0, Zi) = E(Yi0|Ri = 0, Zi) = E(Yi0|Zi), since Xi ≡ 0.
Then
E(Yi − ψ∗XiRi|Ri = 1, Zi) = E(Yi − ψ∗XiRi|Ri = 0, Zi). (2.9)
In words, the latter states that, after subtracting the average causal effect of Xi from
the observed outcome Yi on the treatment arm, both randomized groups have the
same average at fixed levels of baseline covariates Zi. Therefore,
g(Zi)E [{Ri − P (Ri = 1|Zi)}{Yi − ψ∗XiRi − q(Zi)}|Zi] = 0
for any finite-dimensional function g(Zi) and scalar function q(Zi). This implies that
by solving the following unbiased estimating equation,
n∑
i=1
Ui(ψ
∗) =
n∑
i=1
g(Zi) [{Ri − P (Ri = 1|Zi)}{Yi − ψ∗XiRi − q(Zi)}] = 0 (2.10)
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we can find an estimator ψˆ∗ of ψ∗. The estimating equation Ui(ψ∗) is unbiased; that
is, E{Ui(ψ∗)} = 0 because
E{Ui(ψ∗)} = E [E{Ui(ψ∗)|Zi}]
= E[E [E{Ui(ψ∗)|Ri, Zi}|Zi]]
= E [E[g(Zi){Ri − P (Ri = 1|Zi)}
×{E(Yi − ψ∗XiRi|Zi, Ri)− q(Zi)}|Zi]]
= E [g(Zi)E{Ri − P (Ri = 1|Zi)|Zi}E{Yi − ψ∗XiRi − q(Zi)}|Zi}]
= 0.
Therefore, the resulting estimator ψˆ∗ is a consistent and asymptotically normal esti-
mator for ψ∗ under model (2.8) (Robins, 1994; Goetghebeur and Lapp, 1997). For
each choice of g(Zi) and q(Zi) = E(Yi0|Zi), the solution to (2.10) yields a consistent
estimator under assumptions (1)-(3) with known P (Ri = 1|Zi). Note that, an opti-
mal choice of g(Zi) and q(Zi) will yield the semi-parametrically efficient estimate for
ψ∗. Note also that ψˆ∗ can be made more efficient as Zi becomes more predictive of
compliance. “When ψˆ∗ is found, it can be used to calculate expected treatment-free
outcomes Yi0 = Yi − ψˆ∗XiRi on both arms and to check whether their regression on
Xi coincides on both arms as dictated by (2.9)”. Under model (2.8), a closed form
solution ψ∗ can be obtained as a function of g(Zi) and q(Zi):
ψˆ∗ =
n∑
i=1
g(Zi){Ri − P (Ri = 1|Zi)}{Yi − q(Zi)}
n∑
i=1
g(Zi){Ri − P (Ri = 1|Zi)}Xi
.
Following Robins (1994) and Goetghebeur and Lapp (1997), a consistent estimator
for the variance of ψˆ∗ can also be derived from
V ar(ψˆ∗) = Ωˆ/τˆ2
where Ωˆ = 1/n
n∑
i=1
Ui(ψˆ∗)U ti (ψˆ∗) and τˆ = 1/n
n∑
i=1
g(Zi){P (Ri = 1|Zi) − Ri}XiRi.
For instance, in the DBP trial data with q(Zi) = E(Yi − ψ∗RiXi|Zi) and g(Zi) = Zi
where Zi contains all baseline covariates, we obtain ψˆ∗ = −7.51 with 95 % confidence
interval (−11.09,−3.93).
6.3 Error manifest and estimation process
As stated, in spite of recent technically sophisticated tools, for measuring com-
pliance with an assigned drug dosing regimen, errors in exposure measurement are
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inevitable. As discussed in chapter 1, when actual exposure level Xi is imperfectly
measured, we observe Wi instead of Xi which may potentially differ from Xi for each
subject i = 1, ..., n. Therefore identification of the causal effect under model (2.8)
requires additional assumptions that we will investigate in chapter 4. In this section
we illustrate how, for instance, the estimation approach under (2.8) will proceed with
the measurement error problem. As discussed in chapter 1, for our example, suppose
that the error on exposure Xi follows the classical measurement error model (a similar
development can be made for the Berkson error model), that is, Wi = Xi + Ui with
Ui ⊥⊥ (Xi, Zi), where Ui is a measurement error term. In the context of measurement
error, it is often assumed that the error term Ui has mean zero with homoscedastic
variance σ2u which is known or can be estimated from an extra data set. Here, we
assume that E(Wi − Xi|Zi, Ri) = E(Ui|Zi, Ri = 1) = δ∗; that is Ui has conditional
mean δ∗ which is the same quantity as in the classical measurement error model.
This indeed considers average measurement error in groups determined by levels of
covariate Zi to be constant, a restriction that can be relaxed. When δ
∗ = 0 for all Zi,
that is E(Wi|Zi, Ri = 1) = E(Xi|Zi, Ri = 1), we say that the measurement error is
conditionally unbiased. Note that we are using the notation U for unmeasured con-
founders, Ui(.) for estimating equations, and here Ui as a measurement error term.
Now our observed data is (Yi,Wi, Ri, Zi). We can write the conditional mean inde-
pendence (2.9) for the observed data as
E{Yi − ψ∗(Wi − δ∗)Ri|Ri, Zi} = E{Yi − ψ∗(Wi − δ∗)Ri|Zi}.
Note that, this is designed to make the predicted treatment-free outcome, Yi−ψ∗(Wi−
δ∗)Ri mean independent of Ri conditional on Zi. By this, under model (2.8) and an
uncontaminated control group, we show that the following estimating equation is
unbiased with arbitrary index functions g(Zi) and q(Zi)
n∑
i=1
Ui(ψ
∗, δ∗) =
n∑
i=1
g(Zi){Ri − P (Ri = 1|Zi)}{Yi − ψ∗(Wi − δ∗)Ri − q(Zi)} = 0
E{Ui(ψ∗, δ∗)} = E[E [E{Ui(ψ∗, δ∗)|Ri, Zi}|Zi]]
= E[E[g(Zi){Ri − P (Ri = 1|Zi)}
×{E(Yi − ψ∗(Wi − δ∗)Ri|Zi, Ri)− q(Zi)}|Zi]]
= E [g(Zi)E{Ri − P (Ri = 1|Zi)|Zi}
×E{Yi − ψ∗(Wi − δ∗)Ri − q(Zi)}|Zi}]
= 0.
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Following Goetghebeur and Vansteelandt (2005), and Vansteelandt and Goetghebeur
(2003), the most efficient estimation in the class determined by the latter unbiased
estimating equation can be obtained from qopt(Zi) = E(Yi|Zi, Ri = 0) and
gopt(Zi) = {E(Wi|Zi, Ri = 1)− δ∗}Zi
× [{1− P (Ri = 1|Zi)}V ar{Yi − ψ∗(Wi − δ∗)Zi|Zi, Ri = 1}
+P (Ri = 1|Zi)V ar(Yi|Zi, Ri = 0)]−1 .
6.4 The impact of biased measurement error
We examine the potential impact of biased measurement error on estimated treat-
ment effects under model (2.8) in the context of the DBP trial. For doing so, we
reanalyze both active treatments A and B separately versus placebo assuming the
over reporting of dose is for instance 0 %, 10 % or 20 %. Specifically, we reana-
lyze the data, assuming E(W − X|Z,R) = E(U |Z,R) = δ∗ is equal to, 0 %, 10 %
or 20 % with and without adjustment for baseline covariates, where 0 % encodes
the situation where measurement error is ignored. This considers that when not all
Table 2.6: Sensitivity analysis for the DBP trial under LSMM with and without ad-
justment for covariates, when the average measurement error is 0 % , 10 % or
20 %. The first row refers to Z = 1 (no covariates) and the second row is adjusting
for covariates. Treatment A refers to ‘Nebivolol’ and treatment B refers to ‘Atenolol’.
δ = 0.0 δ = 0.10 δ = 0.20
Classical Classical Berkson Classical Berkson
A vs. Plac. 9.56 (2.10) 10.84 (2.39) 8.55 (1.87) 12.51 (2.79) 7.73 (1.68)
B vs. Plac. 10.37 (2.41) 11.64 (2.72) 9.36 (2.17) 13.25 (3.12) 8.52 (1.97)
A vs. Plac. 7.51 (1.83) 8.50 (2.06) 6.73 (1.64) 9.77 (2.38) 6.09 (1.48)
B vs. Plac. 7.50 (2.18) 8.37 (2.45) 6.79 (1.96) 9.47 (2.79) 6.20 (1.78)
openings of the pill container correspond to the actual pill intake, exposure will be
over reported. This sensitivity analysis has been done for active treatment A versus
placebo by Goetghebeur and Vansteelandt (2005). Table 2.6 summarizes the results
when the error in active treatments follows the classical error model or the Berkson
error model. Note that when δ∗ = 0, the estimated average blood pressure reduction
with the Classical error model and the Berkson error model are the same. Table 2.6
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Figure 6: Estimated average blood pressure ψˆ∗ with 95 % confidence interval in
function of δ∗ for both treatments A=‘Nebivolol’ and B=‘Atenolol’ separately ver-
sus placebo for the DBP trial. The first row refers to Z = 1 (no covariates) and the
second row is adjusting for covariates. Dotted lines show the upper and lower bound
of confidence intervals.
6 Measurement error and causal models 81
shows the estimated average blood pressure reduction with standard error as a sen-
sitivity analysis for the DBP trial. The second and third columns of Table 2.6 show
that when the average measurement error δ∗=10 % or 20 %, the analysis under the
LSMM estimates a more substantial blood pressure decrease for a given treatment
dose under the classical error model than under the Berkson error. Standard errors
are however not small. As a result, this analysis shows how ignoring measurement
error will yield biased estimates and misleading inference. In Figure 6, we let the
constant average error vary over the interval (-0.5, 0.5) and display the impact of
biased measurement error on estimated treatment effects in model (2.8). The top row
refers to Z = 1 (no covariates) and the second row is adjusting for covariates.
6.5 Log-linear and logistic structural mean models
When the outcome of interest is strictly positive, one may postulate a log-linear
structural mean model (Robins, 1994, 1997; Vansteelandt and Goetghebeur, 2003)
which is a special case of the multiplicative structural mean model (SMM). This
model in fact assumes that a linear function of dose, possibly adjusted for covariates,
explains the difference in log means of treated and potential treatment-free outcomes.
For instance, the model for a constant by linear treatment effect is:
log{E(Yi|Xi, Zi, Ri = 1)} − log{E(Yi0|Xi, Zi, Ri = 1)} = ψ∗Xi. (2.11)
This model “implies that if some group on the treatment arm received the zero dose,
X = 0, its expected values of the observed and potential treatment-free outcomes
would coincide”. With a dichotomous outcome, model (2.11) indicates that the prob-
ability of success for subjects who received treatment Xi = 1 would become exp(ψ
∗)
smaller if they had not received the treatment . These parameters describe different
aspects of the causal risk ratio
P (Yi = 1|Xi, Zi, Ri = 1)
P (Yi0 = 1|Xi, Zi, Ri = 1) = exp(ψ
∗Xi).
It follows under this model that
E(Yi|Xi, Zi, Ri = 1) exp(−ψ∗Xi) = E(Yi0|Xi, Zi, Ri = 1).
Key to the identification of ψ∗ is the randomization assumption, Yi0 ⊥⊥ Ri|Zi, which
implies
E{Yi exp(−ψ∗Xi)|Zi, Ri} = E{Yi exp(−ψ∗Xi)|Zi}.
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This expression can be obtained by virtue of the randomization assumption
E{Yi exp(−ψ∗Xi)|Zi, Ri = 1} = E [E{Yi exp(−ψ∗Xi)|Xi, Zi, Ri = 1}|Zi, Ri = 1]
= E{E(Yi0|Xi, Zi, Ri = 1)|Zi, Ri = 1}
= E(Yi0|Zi, Ri = 1) = E(Yi0|Zi),
and similarly, E{Yi exp(−ψ∗Xi)|Zi, Ri = 0} = E(Yi0|Zi). The set of unbiased es-
timating equations can be obtained by replacing Yi − ψ∗XiRi by Yi exp(−ψ∗Xi) in
(2.10). Note that, when outcome is dichotomous, there is a closed form solution for
estimating ψ∗.
Researchers were also interested in knowing whether actual exposure would increase
the probability of success Yi = 1. In a classical regression model, we model the causal
effect of exposure level Xi = x on the probability of success via a logistic regression
model:
logitP (Yi = 1|Xi = x) = β∗0 + β∗1x.
This model implies that P (Y=1|X=x)/P (Y=0|X=x)P (Y=1|X=0)/P (Y=0|X=0) = exp(β
∗
1x). We can similarly model
the causal effect of exposure on outcome via the logistic structural mean model. Mod-
els (2.8) and (2.11) are natural models for real and positive outcomes respectively, but
they may fail to yield probabilities of success between 0 and 1 when accommodating
dichotomous data (Vansteelandt and Goetghebeur, 2003). For this reason, one may
consider the logistic structural mean models instead (Vansteelandt and Goetghebeur,
2003; Robins and Rotnitzky, 2004)
logit{P (Yi = 1|Xi, Zi, Ri = 1)} − log{P (Yi0 = 1|Xi, Zi, Ri = 1)} = ψ∗Xi. (2.12)
Here, the unknown causal parameter ψ∗ compares the success odds under observed
compliance on the treatment arm with the success odds for the same group of people
had they received placebo. In fact, their parameters describe different aspects of the
causal odds ratio
P (Yi = 1|Xi, Zi, Ri = 1)/P (Yi = 0|Xi, Zi, Ri = 1)
P (Yi0 = 1|Xi, Zi, Ri = 1)/P (Yi0 = 0|Xi, Zi, Ri = 1) = exp(ψ
∗Xi).
Although the randomization assumption still holds here, the problem of the logistic
SMMs stems from the fact that, it is hard to predict:
E(Yi0|Zi, Ri = 1) =
∫
expit [logit{P (Yi = 1|Xi, Zi, Ri = 1)}
−ψ∗Xi] f(xi|Zi, Ri = 1)dxi
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where expit(a) = exp(a)/{1 + exp(a)}. Therefore, to obtain an estimating equation
the estimation approach outlined for linear and log-linear SMMs, does not work for lo-
gistic SMMs. Robins (1999) showed that ψ∗ in model (2.12) can not be estimated with
G-estimation. Vansteelandt and Goetghebeur (2003) solve this problem by proposing
IVs estimators for ψ∗ under an additional model for the observed relationship between
outcome and exposure in the experimental arm. They postulate for instance a logistic
regression model
logitP (Yi = 1|Xi, Zi, Ri = 1) = m(Xi, Zi, Ri = 1;β∗)
e.g. = β∗0 + β
∗
1Xi + β
∗
1Zi + β
∗
1XiZi
where β∗ can be estimated by logistic regression model. Under the randomization
assumption and some further mild regularity conditions, they find the unbiased esti-
mating equation
n∑
i=1
g(Zi){Ri−P (Ri = 1|Zi)}[Riexpit{m(Xi, Zi, Ri = 1;β∗)−ψ∗X)}+(1−Ri)Yi] = 0,
and by solving this, a consistent estimate for ψ∗ under model (2.12) can be obtained.
Chapter 3
On the Performance of
Instrumental Variable
Estimators of the Causal
Odds Ratio
Summary
Inference for causal effects can benefit greatly from the availability of an instru-
mental variable (IV) which, by definition, is associated with the given exposure, but
not with the outcome of interest except through a causal exposure effect. Estimation
methods for instrumental variables are now well established for continuous outcomes.
The case of dichotomous outcomes turns out much more difficult and has received far
less attention to date. In this article, we give an expository review of exact as well
as approximate IV-estimators for the causal odds ratio, that have been proposed in
the biostatistical, epidemiological and econometric literature. Methods comparisons
are made, both theoretically and via extensive simulation, and new insights are de-
veloped into the assumptions underlying their validity. The different estimators are
used to assess the risk of gastrointestinal (GI) complications attributable to different
non-steroidal anti-inflammatory drugs (instead of Cox-2 inhibitors).
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1 Introduction
It is well known that most causal analyses of observational data rely heavily on the
untestable assumption of no unmeasured confounders. According to this assumption,
one has available all prognostic factors of the exposure that are also associated with
the outcome other than via a possible exposure effect on outcome. Concerns about
the validity of this assumption plague observational data analyses (see e.g. Prentice,
Pettinger and Anderson, 2005) and increase the uncertainty surrounding many study
results (Greenland, 2005; Vansteelandt et al., 2006). This is especially true in settings
where the data analysis is based on registry data or focuses on research questions
different from those conceived at the time of data collection. Substantial progress can
be made in settings where measurements are available on a so-called instrumental
variable (IV). This is a prognostic factor of the exposure, which is not associated
with the outcome, except via a possible exposure effect on outcome (Herna´n and
Robins, 2006).
IVs have a long tradition in econometrics and are becoming increasingly popular
in biostatistics and epidemiology. This is partly because the existence of an IV is
sometimes guaranteed by design. For instance, randomized encouragement designs
whereby, say, smoking pregnant women are randomly assigned to intensified encour-
agement to quit smoking or not, yield - by virtue of randomization - a valid IV
for assessing the effects of smoking on low birth weight (Permutt and Hebel, 1989).
The growing success of IV methods in biostatistics and epidemiology can, however,
be mainly attributed to applications in genetic epidemiology (Smith and Ebrahim,
2004). Here, the random assortment of genes transferred from parents to offspring
resembles the use of randomization in experiments and is therefore often referred to
as ‘Mendelian randomization’. Building on this idea, genetic variants may sometimes
qualify as an IV for estimating the relationship between a genetically affected exposure
and a disease outcome (Didelez and Sheehan, 2007; Lawlor et al., 2008).
Estimation methods for IVs are now well established for continuous outcomes.
The case of dichotomous outcomes turns out much more difficult and has received
far less attention to date. This paper therefore combines different, scattered devel-
opments in the biostatistical, epidemiological and econometric literature and aims to
improve the clarity and comparability of these developments by casting them within
a common causal framework based on counterfactuals. This will yield new insights, in
particular into the assumptions underlying each of the considered methods and into
their successfulness at approximating the causal odds ratio, which we define explicitly
in the next section. In Sections 2.2 and 2.3, we focus on exact IV methods for the
causal odds ratio under logistic structural mean models, as proposed by Vansteelandt
and Goetghebeur (2003, 2005) and later extended in Robins and Rotnitzky (2004). In
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particular, we clarify the connections between both approaches. We then consider a
number of approximate IV estimators that are popular in epidemiology (see Sections
2.3 and 2.4) and in econometrics (see Section 2.5). Both theoretical arguments and
extensive simulation are used to contrast the different estimators, which are eventually
used to assess the risk of gastrointestinal (GI) complications attributable to different
non-steroidal anti-inflammatory drugs (instead of Cox-2 inhibitors). Because many
commonly employed IV analyses do not require covariate adjustment, this will also be
the motivating setting for most of the article. In the discussion section, we elaborate
on covariate-adjusted IV estimators and extensions to longitudinal data.
2 IV-estimators of the causal odds ratio
Our goal in this article is to assess the causal effect of an arbitrary exposure Xi,
measured for subjects i = 1, ..., n, on a dichotomous outcome Yi. For instance, in the
data analysis section 3, we will estimate the effect of Cox-2 treatment Xi = 1 (versus
non-selective NSAIDs Xi = 0) on gastrointestinal bleeding (i.e. Yi = 1; Yi = 0
otherwise). To succeed, we will assume in this paper that we have measured for
each subject i an instrumental variable (IV) Zi for the effect of Xi on Yi which, by
definition, satisfies the following properties: (a) Zi is associated with Xi; (b) Zi affects
the outcome Yi only through Xi (i.e. often referred to as the exclusion restriction);
(c) the association between Zi and Yi is unconfounded (i.e. often referred to as the
randomization assumption) (Herna´n and Robins, 2006). In Section 3, as in Brookhart
and Schneeweiss (2007), we choose the physician’s prescribing preference for Cox-2
(versus non-selective NSAIDs) as an instrumental variable (i.e. Zi) for the effect of
Cox-2 treatment on gastrointestinal bleeding. This qualifies as a possible IV because
it is associated with Cox-2 treatment (i.e. (a)), because it seems reasonable that the
physician’s prescribing preference can only affect a patient’s gastrointestinal bleeding
through his/her prescription (i.e. (b)) and is not otherwise associated with patient’s
gastrointestinal bleeding (i.e. (c)). The latter assumption would fail if for instance
patients with high risk of bleeding are more often seen with physicians who prefer
Cox-2 (Herna´n and Robins, 2006).
2.1 Causal odds ratio and logistic structural mean models
We define causal effects in terms of comparisons of each subject i’s observed out-
come with a counterfactual outcome Yi0, which denotes the outcome value that we
would have observed for that subject if the exposure were controlled at some cho-
sen reference exposure level 0 (e.g. non-selective NSAIDs). In particular, we will
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summarize causal effects in terms of the causal odds ratio
odds (Yi = 1|Xi, Zi)
odds (Yi0 = 1|Xi, Zi) , (3.1)
where for any Y ∗i , odds (Y
∗
i = 1|Xi, Zi) ≡ P (Y ∗i = 1|Xi, Zi) /P (Y ∗i = 0|Xi, Zi). This
expresses how much the odds of ‘success’ would change for subjects with exposure
level Xi and instrumental variable Zi, if their exposure were set to the reference level
0. It thus measures the effect of received treatment, or, the so-called treatment effect
in the treated (Herna´n and Robins, 2006; Robins, VanderWeele and Richardson, 2006;
Didelez, Meng and Sheehan, 2008). Because of identifiability constraints (Vanstee-
landt and Goetghebeur, 2005), we will assume that the causal odds ratio obeys the
simple loglinear model restriction, (3.1) = exp(ψ∗Xi), where ψ∗ is an unknown pa-
rameter. Equivalently, we will conduct inference under the logistic structural mean
model (Vansteelandt and Goetghebeur, 2003)
logitE(Yi|Xi, Zi)− logitE(Yi0|Xi, Zi) = ψ∗Xi, (3.2)
where logit(p) = log {p/(1− p)}. In Section 2.2, we will review exact IV methods for
the causal odds ratio exp(ψ∗Xi) under model (3.2), that have been introduced in the
statistical literature. In Sections 2.3 and 2.4, we will review approximate IV methods
for the causal odds ratio that have been introduced in the epidemiological literature
on Mendelian randomization and propose related novel procedures. In Section 2.5,
we discuss generalized method of moments (GMM) estimators that are frequently
considered in econometrics.
2.2 Exact estimation in logistic structural mean models
Although Yi may well depend on Zi (in the presence of an exposure effect), the
IV-assumptions imply that Yi0 ⊥⊥ Zi. To make use of this, Vansteelandt and Goet-
ghebeur (2003) average over the observed exposure values in model (3.2). Because this
is not possible without making additional parametric modelling assumptions (Robins
and Rotnitzky, 2004), they model the expected observed outcome, conditional on the
exposure and instrumental variable. For instance, one may choose
logitP (Yi = 1|Xi, Zi) = β∗0 + β∗1Xi + β∗2Zi + β∗3XiZi, (3.3)
where β∗0 , β
∗
1 , β
∗
2 , β
∗
3 are unknown scalar parameters. More generally, one may postu-
late that
logitE(Yi|Xi, Zi) = m(Xi, Zi;β∗), (3.4)
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where m(Xi, Zi;β) is a known function, smooth in β, and β
∗ is an unknown finite-
dimensional parameter. An estimate βˆ of β∗ can be obtained using standard methods
(e.g. using maximum likelihood estimation). Combining the causal model (3.2) with
the so-called association model (3.4) yields a prediction for the counterfactual outcome
Yi0 for each subject i which, for given ψ, equals
Hi(ψ, βˆ) = expit{m(Xi, Zi; βˆ)− ψXi},
where expit(a) ≡ exp(a)/{1 + exp(a)}. Because
E(Yi0|Zi) = E(Yi0)
under the IV-assumptions, the value of ψ∗ can now be chosen as the value ψ which
makes the empirical means equal, once Yi0 is replaced by Hi(ψ, βˆ). For a dichotomous
instrument Zi, taking the values 0 and 1, one thus chooses ψ such that∑
iHi(ψ, βˆ)Zi∑
i Zi
=
∑
iHi(ψ, βˆ)(1− Zi)∑
i(1− Zi)
. (3.5)
When also the exposure is dichotomous, model (3.3) is guaranteed to hold and the
following closed-form estimator is obtained:
ψˆ = log

−Q1 ±
√
Q21 − 4Q2(Q2 − Xˆ11 + Xˆ10)Q3
2Q2

 , (3.6)
where Xˆxz is the percentage of subjects with X = x amongst those with Z = z, and
Q1 = (Q2 + Xˆ10) exp(βˆ0 + βˆ1) + (Q2 − Xˆ11) exp(βˆ0 + βˆ1 + βˆ2 + βˆ3)
Q2 = expit(βˆ0)Xˆ00 − expit(βˆ0 + βˆ2)Xˆ01
Q3 = exp(βˆ0 + βˆ1 + βˆ2 + βˆ3) + exp(βˆ0 + βˆ1).
In most cases, (3.6) yields a unique estimator of the causal odds ratio, although
multiple or no solutions are rarely obtained when precision is limited due to small
sample size or outcome mean close to 0 or 1. This is illustrated in Figure 1, which
displays the left- and righthand side of (3.5) in function of ψ for 3 settings. The top
2 panels are based on the same simulated data set. They show that 2 or no solutions
can be obtained for the same data set, depending on whether the association model
(3.4) includes an interaction between exposure and instrument (left panel) or not
(right panel). The bottom panel corresponds to the data analysis of Section 3, where
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Figure 1: Plot of the left- (solid) and righthand side (dotted) of expression (3.5) as a
function of ψ. Top: simulated data set (Right: with β∗4 = 0 in model (3.3)); Bottom:
observed data set.
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a single solution was obtained. Our experience indicates that, when 2 solutions are
obtained, one of them usually corresponds to an effect size which is so large that it
would be deemed unrealistic. When no solutions are obtained, this can sometimes
be resolved by choosing a less parsimonious association model (as in Figure 1, top)
or by adjusting for covariates (see the discussion section). For general instruments, a
consistent point estimator of ψ∗ can be found by solving unbiased estimating equation
0 =
n∑
i=1
[
d(Zi)−
∑n
j=1 d(Zj)
n
]
Hi(ψ, βˆ) (3.7)
for ψ, where d(Zi) is an arbitrary function of Zi, e.g. d(Zi) = Zi (see Vansteelandt
and Goetghebeur (2003) for choices that yield a semiparametric efficient estimator of
ψ∗). This thus leads to the following 2-stage approach:
1. First fit the association model (3.4), for instance using maximum likelihood
estimation, and obtain an estimate βˆ of β∗;
2. Next, solve equation (3.7) to obtain an estimate ψˆ of ψ∗.
The resulting estimator will be referred to as ‘Exact IV-estimator I’ throughout.
In the Appendix, we show that when the association model includes an intercept
and main effect in Zi (as in model (3.3)) and is fitted using maximum likelihood
estimation in standard generalized linear model software, then its solution is robust
to misspecification of the association model (3.4) when ψ∗ = 0. This approach thus
yields a valid test of the causal null hypothesis that ψ∗ = 0, even when both models
(3.2) and (3.4) are misspecified. This ‘local’ robustness property (Vansteelandt and
Goetghebeur, 2003) also guarantees that estimators of the causal odds ratio will have
small bias under model misspecification when the true exposure effect is close to, but
not equal to zero.
A drawback of the parameterization by Vansteelandt and Goetghebeur (2003)
is that the association model may be incongenial with the causal model. Specifi-
cally, there may be no values of the causal parameter ψ for which E{Hi(ψ, β∗)|Zi} =
E{Hi(ψ, β∗)} over the entire support of Zi under the model (where β∗ now corre-
sponds to the limiting value of βˆ). In the Appendix, we show that this may happen
when parametric restrictions are imposed on the main effect of the instrumental vari-
able in the association model (3.4), but not when that main effect is left unrestricted.
In the common situation of a dichotomous instrument, this imposes no limitations on
the applicability of this method so long as a main effect of the IV is included in the
association model. When the instrument is categorical with 3 levels, as is often the
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case in Mendelian randomization studies where a marker coding is used as the instru-
ment, this requires using two dummy regressors for the instrument in the association
model. For general IVs, this would require using a generalized additive association
model which leaves the main effect of the IV unrestricted (apart from smoothness
restrictions).
Robins and Rotnitzky (2004) developed an alternative approach for estimation of
ψ∗ in model (3.2), which guarantees a congenial parameterization by avoiding direct
specification of an association model. They parameterize instead the selection-bias
function
logitE(Yi0|Xi, Zi)− logitE(Yi0|Xi = 0, Zi) = q(Xi, Zi; η∗) (3.8)
where q(Xi, Zi; η) is a known function satisfying q(0, Zi; η) = 0, smooth in η, and
η∗ is an unknown finite-dimensional parameter. That q(Xi, Zi; η∗) encodes the de-
gree of selection bias can be seen because q(Xi, Zi; η
∗) = 0 for all Xi implies that
E(Yi0|Xi, Zi) = E(Yi0|Zi) and thus implies that the association between exposure and
outcome (more precisely, Yi0) is unconfounded (conditional on Zi). The approach of
Robins and Rotnitzky (2004) relies on the following iterative procedure (which is here
simplified because of the absence of covariate adjustment):
1. Compute a maximum likelihood estimator αˆ for the finite-dimensional param-
eter α∗ indexing a model for the conditional exposure density P (Xi|Zi;α∗);
2. For fixed ψ (starting from an initial value ψ0), compute maximum likelihood
estimators ηˆ(ψ) and ωˆ(ψ) for the parameters η∗ and ω∗ indexing the implied
association model
P (Yi = 1|Xi, Zi;ψ, η∗, ω∗) = expit{ψXi + q(Xi, Zi; η∗) + v(Zi; η∗, ω∗)} (3.9)
where v(Zi; η
∗, ω∗) ≡ logit {E(Yi0|Xi = 0, Zi)} must satisfy
ω∗ ≡ logitE(Yi0) (3.10)
=
∫
expit{q(Xi = x,Zi; η∗) + v(Zi; η∗, ω∗)}P (Xi = x|Zi;α∗)dx
3. Solve the following estimating equation for ψ:
0 =
n∑
i=1
[
d(Zi)−
∑n
j=1 d(Zj)
n
]
Hi(ψ, αˆ, ηˆ(ψ), ωˆ(ψ)) (3.11)
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where
Hi(ψ, α, η, ω) =
expit(M2i){1− expit(M2i)}
expit(M1i){1− expit(M1i)}{Yi − expit(M1i)}
+expit(M2i)
M1i = ψXi + q(Xi, Zi; ηˆ(ψ)) + v(Zi; ηˆ(ψ), ωˆ(ψ))
M2i = q(Xi, Zi; ηˆ(ψ)) + v(Zi; ηˆ(ψ), ωˆ(ψ))
and where the choice of d(Zi) is specified next. Note the similarity between
estimating equations (3.7) and (3.11): the first contribution of Hi(ψ, α, η, ω) is
a scaled residual of the implied association model (3.9), which yields an approx-
imately zero contribution to the estimating equation, regardless of the value of
ψ; the second contribution, expit(M2i), corresponds to Hi(ψ, βˆ) in (3.7).
4. Repeat steps 2 and 3, updating ψ in step 2 with the estimate obtained in step
3, until convergence.
The resulting estimator of ψ∗ will be referred to as ‘Exact IV-estimator II’ throughout.
It is consistent and asymptotically normal when, besides the logistic structural mean
model (3.2), model (3.8) for the selection bias function and the model for the exposure
distribution P (Xi|Zi;α∗) are all correctly specified. At the null hypothesis that ψ∗ =
0, the estimator is (locally) robust against misspecification of these models.
When the instrument is dichotomous, d(Zi) = Zi is the only possible function of
Zi, up to linear transformations. When the instrument is continuous or discrete with
more than two levels, a semiparametric efficient estimator of ψ∗ can be obtained by
choosing
d(Zi) = d2(Zi)− E{d2(Zi)}
E{d3(Zi)}d3(Zi)
d2(Zi) = d3(Zi) (E {expit(M2i){1− expit(M2i)}Xi|Zi}
−E{expit(M2i){1− expit(M2i)}Xi})
d3(Zi) =
(
E
[{expit(M2i){1− expit(M2i)}}2
expit(M1i){1− expit(M1i)} |Zi
]
+ var{expit(M2i)|Zi}
)−1
.
In both cases, however, we recommend Exact IV-estimator I for practical data anal-
ysis (a) because it is equally valid for discrete instruments and approximately so for
continuous instruments when smoothing techniques are used to model their associ-
ation with outcome; (b) because it is computationally much simpler as it does not
involve iteratively solving estimating equations, nor solving integral equation (3.11);
and (c) because it does not rely on correct specification of the conditional density of
Xi, given Zi.
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2.3 Exact estimation in probit structural mean models
The previous estimation principles can also be used for fitting the probit structural
mean model
Φ−1 {E(Yi|Xi, Zi)} − Φ−1 {E(Yi0|Xi, Zi)} = φ∗Xi, (3.12)
where Φ−1 is the probit link and φ∗ is unknown. This is possible upon replacing the
logit link with the probit link. A simpler parametric estimator can be obtained under
the additional assumptions:
1. that the exposure is normally distributed conditional on the instrumental vari-
able with mean α∗0+α
∗
1Zi and constant standard deviation σ
∗, where α∗0, α
∗
1, σ
∗
are unknown;
2. that a probit association model holds:
Φ−1 {E(Yi|Xi, Zi)} = θ∗0 + θ∗1Xi + θ∗2Zi, (3.13)
where θ∗0 , θ
∗
1 , θ
∗
2 are unknown.
Indeed, combining the probit structural mean model (3.12) and association model
(3.13) yields
E(Yi0|Xi, Zi) = Φ{θ∗0 + (θ∗1 − φ∗)Xi + θ∗2Zi}.
Averaging over the exposure, conditional on Zi (see the Appendix), then gives
E(Yi0|Zi) = Φ
{
θ∗0 + θ
∗
2Zi + (θ
∗
1 − φ∗)(α∗0 + α∗1Zi)√
1 + (θ∗1 − φ∗)2σ2∗
}
, (3.14)
from which it follows that θ∗2 = (φ
∗ − θ∗1)α∗1. This suggests the following two-stage
approach:
1. First regress the exposure on the instrumental variable using ordinary least
squares and obtain estimates αˆ1 for the regression slope α
∗
1 and σˆ for the residual
standard deviation σ∗;
2. Next regress outcome on exposure and instrumental variable by fitting model
(3.13) to obtain estimates θˆ1 and θˆ2 for the regression slopes θ
∗
1 and θ
∗
2 , respec-
tively.
The resulting estimator
φˆ = θˆ1 +
θˆ2
αˆ1
(3.15)
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for φ∗ will be referred to as ‘Two-stage IV-estimator I’ throughout.
An alternative estimator is obtained by averaging over the exposure in the asso-
ciation model (3.13) and using the previous identity θ∗2 = (φ
∗ − θ∗1)α∗1 to obtain
E(Yi|Zi) = Φ
(
θ∗0 + φ
∗α∗1Zi + θ
∗
1α
∗
0√
1 + θ∗21 σ2∗
)
.
This suggests regressing the outcome on the instrumental variable using the probit
regression model
Φ−1{E(Yi|Zi)} = λ∗0 + λ∗1Zi (3.16)
to obtain an estimate λˆ1 for the unknown regression slope λ
∗
1, and then estimating
φ∗ as
φˆ =
λˆ1
√
1 + θˆ21σˆ
2
αˆ1
. (3.17)
We will refer this estimator as the ‘Two-stage IV-estimator II’ throughout. Both
these estimators have, to the best of our knowledge, not been previously considered.
Thomas and Conti (2004) propose to estimate φ∗ as
φˆ =
λˆ1√
αˆ21 − λˆ21σˆ2
.
This estimator will be referred to as ‘Two-stage IV-estimator III’ throughout. It is
obtained by substituting θˆ1 with φˆ in expression (3.17).
An advantage of Two-stage IV-estimators II and III over Two-stage IV-estimator
I is that they preserve the Type I error rate of tests of the causal null hypothesis (i.e.
φ∗ = 0) when the model is misspecified, because λ∗1 = 0 at the causal null hypothesis.
An additional advantage of Two-stage IV-estimator III is that it does not involve
estimates from the two association models (3.13) and (3.16) and may therefore lend
itself better to use in meta-analyses based on summary statistics. However, we do not
recommend Two-stage IV-estimator III for data analysis because it is not guaranteed
to be be valid when the exposure effect on outcome differs from zero (i.e. φ∗ = 0)
and is confounded (i.e. θ∗2 6= 0). In addition, this estimator is only defined when
−αˆ1/σˆ < λˆ1 < αˆ1/σˆ.
When the outcome mean lies between 10% and 90%, the above Two-stage IV-
estimators yield approximate estimates of the causal odds ratio because of the iden-
tity exp(ψ∗) ≈ exp(φ∗/0.6071) (McCullagh and Nelder, 1983). For dichotomous
exposures, related estimators can be obtained via probit structural equation models
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that replace the linear regression model for Xi in assumption 1 above, with a probit
regression model (see e.g. Rassen et al., 2008).
2.4 Approximate estimation in logistic structural mean mod-
els
Approximate IV-estimators of the causal odds ratio can be obtained by averaging
over the observed exposure values in model (3.2) using the following approximations
E {logit E(Yi|Xi, Zi)|Zi} ≈ logit E(Yi|Zi)
E {logit E(Yi0|Xi, Zi)|Zi} ≈ logit E(Yi0|Zi).
This together with the logistic structural mean model (3.2) implies
logit E(Yi|Zi) ≈ logit E(Yi0|Zi) + ψ∗E(Xi|Zi)
= ω∗ + ψ∗E(Xi|Zi), (3.18)
where ω∗ ≡ logitE(Yi0) = logitE(Yi0|Zi) under the IV-assumptions. An approximate
IV-estimator of the causal odds ratio may thus be obtained using the following two-
stage approach:
1. First obtain an estimate of the expected exposure in function of the IV by fitting
an appropriate regression model. Let the predicted exposure be Xˆi ≡ Eˆ(Xi|Zi).
2. Next, fit the logistic regression model
logit E(Yi|Zi) = ω + ψXˆi. (3.19)
The estimate of the regression slope in that model will be referred to as the
‘Approximate IV-estimator’ of ψ∗ throughout.
When the IV is dichotomous, it follows from (3.18) that
ORY |Z ≡
odds(Yi = 1|Zi = 1)
odds(Yi = 1|Zi = 0) ≈ exp(ψ
∗)∆X|Z
where ∆X|Z ≡ E(Xi|Zi = 1)− E(Xi|Zi = 0), or equivalently,
ψ∗ ≈ log(ORY |Z)
∆X|Z
. (3.20)
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The Approximate IV-estimator is commonly employed in the analysis of Mendelian
randomization studies (Thompson et al., 2003) and comes under a variety of names
(e.g. a Wald-type estimator in Didelez, Meng and Sheehan (2008) and 2-stage logistic
approach in Rassen et al. (2008)). It lends itself particularly well to use in meta-
analyses based on summary statistics because the approximation (3.20) can be used,
even when information on ORY |Z and ∆X|Z is obtained from different studies (Minelli
et al., 2004; Smith et al., 2005). However, because of the made approximations, the
Approximate IV-estimator tends to be biased, even in large samples, and requires
correct specification of the first stage regression model for the expected exposure
(Didelez, Meng and Sheehan, 2008; Rassen et al., 2008; Henneman, van der Laan and
Hubbard, 2002). This is true except at the null hypothesis of no causal effect because
Yi ⊥⊥ Zi at the null hypothesis so that the usual maximum likelihood estimator of ψ
indexing model (3.19) will then converge to 0 in probability.
The bias of the Approximate IV-estimator can sometimes be attenuated by ad-
ditionally including Ri ≡ Xi − Xˆi as a regressor in model (3.19) (Nagelkerke et al.,
2000; Palmer et al., 2008). The resulting estimator of ψ∗ will be referred to as the
‘Adjusted IV-estimator’. This modification often tends to be rewarding because Ri
captures part of the confounders that influence the relationship between Xi and Yi, so
that adjustment for Ri removes some residual confounding bias. Indeed, suppose that
all confounders of the exposure effect can be summarized in a scalar measurement Ui
and that the contributions of the instrument Zi and confounder Ui are additive in
the sense that Xi = h(Zi) + Ui for some function h. Suppose additionally that the
conditional mean E(Xi|Zi) is known so that Xˆi = h(Zi) and thus Ri = Ui. Then
fitting model
logit E(Yi|Xi, Zi, Ui) = β˜∗0 + ψ∗Xi + β˜∗1Ri
= β˜∗0 + ψ
∗E(Xi|Zi) + (ψ∗ + β˜∗1)Ri
will yield a consistent estimator of the conditional causal odds ratio
ψ∗ =
odds (Yi = 1|Xi = 1, Zi, Ui)
odds (Yi0 = 1|Xi = 1, Zi, Ui) =
odds (Yi = 1|Xi = 1, Zi)
odds (Yi0 = 1|Xi = 1, Zi) , (3.21)
where we use that Ui is completely determined by Xi and Zi in the last identity.
When the contributions of the instrument Zi and confounder Ui on the exposure
are not additive, then the Approximate IV-estimator may be biased, even at the
causal null hypothesis. In contrast, when they are additive, then it is still prone to
some bias because the model for E(Xi|Zi) may be misspecified and because, even
when it is correctly specified, E(Xi|Zi) is not known in practice so that Ri is an
imprecise estimate of Ui. It remains to be explored whether methods for measurement
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error correction, such as SIMulation-EXtrapolation (Carroll et al., 2006), can help
attenuate this bias.
2.5 Generalized method of moments
In the econometrics literature, the confounder Ui is commonly assumed to have an
additive effect on the outcome (Amemiya, 1974; Foster, 1997; Johnston et al., 2008)
in the sense that
E(Yi|Xi, Ui) = expit(β∗ + ψ˜∗Xi) + Ui, (3.22)
where β∗, ψ˜∗ are unknown and where E(Ui|Xi) = 0. This model implies that
logitE(Yi|Xi, Ui)− logitE(Yi0|Xi, Ui) = ψ˜∗Xi, (3.23)
which is closely related to the logistic structural mean model (3.2), except that it
additionally conditions on Ui. Because, for each x, Yix ⊥⊥ Xi|Ui when Ui represents
all confounders of the exposure effect, model (3.23) implies the marginal structural
model
E(Yix) = E {E(Yix|Xi = x,Ui)} = expit(β∗ + ψ˜∗x)
considered by Henneman, van der Laan and Hubbard (2002). This demonstrates that
exp(ψ˜∗) can be interpreted as the marginal (i.e. population averaged) causal odds
ratio
exp(ψ˜∗) =
odds (Yi1 = 1)
odds (Yi0 = 1)
.
This may differ from (3.1) because of noncollapsibility of the odds ratio and because
subjects with different observed exposure levels may experience different effects of the
same exposure. Using that Zi ⊥⊥ Ui under the IV-assumptions, estimators βˆ for β∗
and ψˆ for ψ∗ can be obtained by solving the following unbiased estimating equations:
0 =
n∑
i=1
Yi − expit(β + ψXi)
0 =
n∑
i=1
Zi {Yi − expit(β + ψXi)} .
An efficient estimator is obtained (Greene, 2003) by next calculating the 2×2 matrix
W ≡ 1
n
n∑
i=1
(1 Zi)
′
e2i (1 Zi)
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with ei ≡ Yi − expit(βˆ + ψˆXi) and subsequently re-estimating β∗ and ψ∗ as those
values minimizing
n∑
i=1
(1 Zi) e
2
iW
−1 (1 Zi)
′
. (3.24)
The resulting estimator will be referred to as the ‘GMM estimator’ throughout.
It follows from the unbiasedness of the estimating functions (1 Zi)
′{Yi−expit(β∗+
ψ˜∗Xi)} at ψ˜∗ = 0 that the GMM estimator is (locally) robust against model misspec-
ification at the null hypothesis of no causal effect. However, it is not guaranteed to
exist and is inconsistent away from the causal null hypothesis because the dichoto-
mous nature of the outcome implies that the error term Ui retains a dependence on Xi
so that the basic assumption Zi ⊥⊥ Ui underlying this method is violated (Henneman,
van der Laan and Hubbard, 2002).
3 Application
Studies of outcomes associated with exposure to pharmaceutical products in rou-
tine clinical practice are often observational. In this section, we analyse one such
study (Brookhart et al., 2006; Brookhart and Schneeweiss, 2007) where the goal is
to assess short-term effects of Cox-2 treatment (as compared to non-steroidal anti-
inflammatory treatment) on the risk of gastrointestinal (GI) bleeding within 60 days.
As Table 3.1 shows, of the 37 842 new non-selective NSAID users drawn from a large
population based cohort of medicare beneficiaries who were eligible for a state-run
pharmaceutical benefit plan, 26 407 patients were placed on Cox-2 treatment. Let the
received treatment Xi equal 1 if subject i was placed on Cox-2 and 0 for non-selective
NSAIDs. Let the outcome Yi indicate 1 for upper gastrointestinal (GI) bleeding within
60 days of initiating an NSAID for subject i, and 0 otherwise. As in Brookhart and
Schneeweiss (2007), we use the physician’s prescribing preference for Cox-2 (versus
non-selective NSAIDs) Zi as an instrumental variable for the effect of Cox-2 treatment
on gastrointestinal bleeding. To obtain Exact IV-estimator I under model (3.2), we
first fitted the logistic association model
logitEˆ (Yi|Xi, Zi) = −4.89 + 0.11Xi − 0.33Zi
and then obtained ψˆ = −2.508 by solving (3.5). This corresponds with a causal odds
ratio of exp(ψˆ) = 0.081 (95% confidence interval (0.010, 0.826)). The same result
is obtained using Exact IV-estimator II. This result is in stark contrast with the
logistic regression estimate exp(0.11) = 1.12 (95% confidence interval (0.849, 1.495))
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Table 3.1: Observed data with Xi indicating received treatment (Cox-2 (1) versus non-
selective NSAIDs (0)), Zi indicating the physician’s prescribing preference (Cox-2 (1)
versus non-selective NSAIDs (0)), and Yi indicating gastrointestinal (GI) bleeding (1)
within 60 days of initiating an NSAID for subject i.
Zi = 0 Zi = 1
Yi = 0 Yi = 1 Yi = 0 Yi = 1
Xi = 0 5640 39 5722 34
Xi = 1 6740 60 19493 114
as obtained from the above association model. To obtain the Two-stage IV-estimators,
we next fitted a probit model of Yi on Xi and Zi
Φ−1 {E(Yi|Xi, Zi)} = −2.43 + 0.04Xi − 0.12Zi.
Further noting that a linear regression analysis of Xi on Zi yields an estimated slope
of αˆ1 = 0.23 and a residual variance of σˆ
2 = 0.20, we obtain a causal odds ratio of
0.454 (95% confidence interval (0.240, 0.870)) using Two-stage IV-estimator I, 0.452
(95% confidence interval (0.234, 0.908)) using Two-stage IV-estimator II and 0.443
(95% confidence interval (0.197, 0.924)) using Two-stage IV-estimator III. Given the
small risk of gastrointestinal bleeding (0.65%), these Two-stage IV-estimates are likely
biased estimates of the causal odds ratio. Finally, from a logistic regression of Yi on
Zi,
logitE(Yi|Zi) = −4.83− 0.31Zi,
we obtain a causal odds ratio of exp(−0.31/0.23) = 0.258 (95% confidence interval
(0.086, 0.798)) using the Approximate IV-estimator. By additionally adjusting for the
residual in a linear regression analysis of Xi on Zi, a very similar estimate of 0.251
(95% confidence interval (0.085, 0.758)) is obtained using the Adjusted IV-estimator.
Finally, the GMM-estimator (0.401 with 95% confidence interval (0.083, 2.422)) should
not be well trusted because the objective function (3.24) reaches a minimum far from
zero. The results of the data analysis are summarized in Table 3.2. Overall, on the
basis of Exact IV-estimator I, we estimate roughly that for new NSAID users on Cox-
2, the risk of gastrointestinal bleeding would increase with at least 17% (= 1− 0.826)
if they were to use non-selective NSAIDs. Note that because of the low prevalence of
gastrointestinal bleeding, the different estimates have large imprecision, despite the
large sample size. To improve our understanding of the relative performance of the
different estimators, we will conduct simulation experiments in the next section.
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Table 3.2: Estimated causal odds ratios and 95% bootstrap percentile confidence in-
tervals based on 10 000 bootstrap resamples.
IV-Estimators exp(ψˆ) 95%CI
Logist. reg. 1.121 (0.849, 1.495)
Exact I 0.081 (0.010, 0.826)
Approximate 0.258 (0.086, 0.798)
Adjusted 0.251 (0.085, 0.758)
Two-stage I 0.453 (0.240, 0.870)
Two-stage II 0.452 (0.234, 0.908)
Two-stage III 0.443 (0.197, 0.924)
4 Simulation study
4.1 Dichotomous exposure
To compare the performance of the considered IV-estimators in the presence of
unmeasured confounders, we conducted several simulation studies. Each simulation
study was based on 1000 replications of sample size 1000. In each replication, a
dichotomous instrumental variable Zi was generated with P (Zi = 0) = P (Zi = 1) =
0.50. Next, a dichotomous exposure Xi was generated, which takes the value 1 with
probability P (Xi = 1|Zi) = expit(α∗0 + α∗1Zi), for chosen values of α∗0 and α∗1, and 0
otherwise. Finally, a dichotomous outcome was generated under the logistic structural
mean model (3.2) with the additional assumption that q(Xi, Zi; η
∗) = η∗Xi, for chosen
values of ψ∗ and η∗ (additional simulations with q(Xi, Zi; η∗) = η∗0Xi + η
∗
1XiZi gave
qualitatively similar results). This happened by letting Yi equal 1 with probability
P (Yi = 1|Xi, Zi) = expit{(ψ∗ + η∗)Xi + v(Zi; η∗, ω∗)}
and 0 otherwise, where v(Zi; η
∗, ω∗) solves
E(Yi0) =
1∑
x=0
expit{η∗x+ v(Zi; η∗, ω∗)}P (Xi = x|Zi),
and where E(Yi0) was chosen to match settings with either high or low prevalence
E(Yi). In particular, we chose the mean outcome E(Yi) to equal 0.05, 0.25 or 0.50,
causal effect sizes ψ∗ = 0 or 2, and different degrees of confounding η∗ equal to −2
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or 0, where η∗ = 0 encodes no confounding of the effect of X on Y . These different
parameter settings represent studies with instrumental variables of varying strength,
corresponding to mean differences ∆X|Z equal to 0.15 or 0.25, and corresponding
correlation coefficients between X and Z equal to 0.16 and 0.26, respectively. In
the case where the information was weakest (mean outcome 5% and δxy = 0.15) we
additionally considered a sample size of 10 000.
Amongst the exact estimation approaches, the closed-form estimator (3.5) was
evaluated under the nonparametric working association model m(Xi, Zi;β
∗) = β∗0 +
β∗1Xi+β
∗
2Zi+β
∗
3XiZi. When the discriminantQ
2
1−4Q2Q3(Q2−Xˆ11+Xˆ10) in (3.6) was
negative, no estimator was obtained with this approach. In the rare occasions where 2
solutions were obtained, the one closest to the Two-stage IV-estimator I was selected
because of its relatively adequate performance as compared to the other approximate
estimators. Exact IV-estimator II was not displayed because it was identical to Exact
IV-estimator I. Finally, no Two-stage IV-estimator III was obtained when αˆ21 − λˆ21σˆ2
was negative.
Tables 3.3-3.5 present the results of the simulation studies for dichotomous ex-
posure, including the ordinary logistic regression estimator. Because of outlying es-
timates in a number of simulations, we focus on the median bias (mean bias), the
robust MCD-estimate of the standard deviation (sample standard deviation), the me-
dian absolute deviation (i.e. median|ψˆ − ψ∗|) (mean squared error), and finally the
percentage of simulations in which an estimate was obtained (% conv.).
The simulation analyses in Table 3.3 reveals that only the Exact IV-estimator is
guaranteed to be asymptotically unbiased, although there can be a bias when the
outcome prevalence is small. This bias was no longer seen in a simulation study with
sample size 10 000 (not shown), indicating that it is a finite-sample bias due to the
lack of information at low prevalence. All other estimators suffer bias, even when the
association between outcome and exposure is unconfounded (i.e. η∗ = 0), but tend
to be less vulnerable to outlying estimates. Disregarding outliers (i.e. considering the
robust MCD estimator), all estimators have a variability of similar magnitude (except
for Two-stage IV-estimator III and the GMM-estimator, which tend to vary more).
Results in Table 3.4 confirm, in line with the theory, that the Exact IV-estimator,
Two-stage IV-estimators II and III, the Approximate IV-estimator and GMM-estimator
are unbiased in the absence of a causal effect, but that the other estimators can have
substantial bias at the causal null hypothesis. In line with Palmer et al. (2008), we
observe a larger bias of the Approximate IV-estimator as the association between Y
and X becomes more positive, and thus as η∗ increases. We observed no clear benefit
of the Adjusted IV-estimator (and often even a somewhat worse performance). The
Two-stage IV-estimator I was closest to the Adjusted IV-estimator, often yielding cor-
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relations above 0.99, and was generally doing better than the Two-stage IV-estimator
II and III, except at the causal null hypothesis.
Table 3.3: Simulation results when exposure X is dichotomous, ψ∗ = 2 and δxz = 0.25.
Bias SE
E(Y) (η∗, ω∗) Methods Median (Mean) MCD (Sample) MAD (MSE) % conv.
Exact I -0.54 (-0.29) 0.79 (1.76) 0.82 (3.20) 71.0
Approximate 0.21 (0.25) 1.11 (1.25) 0.81 (1.62) 100
Adjusted 0.22 (0.26) 1.11 (1.25) 0.82 (1.63) 100
0.05 (-2, -3.90) Logist. reg. -1.81 (-1.81) 0.29 (0.33) 1.81 (3.40) 100
Two-stage I -0.31 (-0.29) 0.83 (0.93) 0.67 (0.95) 100
Two-stage II -0.32 (-0.30) 0.83 (0.93) 0.68 (0.95) 100
Two-stage III -0.15 (0.37) 1.02 (2.59) 0.83 (6.86) 98.0
GMM -0.65 (-0.44) 1.05 (1.92) 1.07 (3.90) 29.4
Exact I -0.45 (0.02) 1.10 (3.67) 0.92 (13.47) 79.1
Approximate -0.75 (-0.74) 1.00 (1.15) 0.91 (1.87) 100
Adjusted -0.45 (-0.20) 1.06 (2.11) 0.87 (4.50) 100
0.05 (0, -4.55) Logist. reg. 0.04 (0.49) 0.51 (2.54) 0.40 (6.70) 100
Two-stage I -0.54 (-0.40) 0.84 (1.31) 0.75 (1.88) 100
Two-stage II -0.97 (-0.94) 0.83 (1.00) 1.03 (1.89) 100
Two-stage III -1.03 (-0.91) 0.83 (1.14) 1.10 (2.13) 99.4
GMM -1.20 (-1.01) 0.98 (1.26) 1.34 (2.63) 61.9
Exact I -0.03 (0.11) 0.54 (0.79) 0.43 (0.63) 95.1
Approximate 0.35 (0.39) 0.61 (0.67) 0.50 (0.60) 100
Adjusted 0.35 (0.39) 0.61 (0.67) 0.50 (0.60) 100
0.25 (-2, -2.13) Logist. reg. -1.82 (-1.82) 0.15 (0.16) 1.82 (3.34) 100
Two-stage I 0.28 (0.32) 0.59 (0.65) 0.45 (0.52) 100
Two-stage II 0.27 (0.32) 0.59 (0.65) 0.45 (0.52) 100
Two-stage III 0.87 (1.57) 0.98 (3.57) 0.94 (15.22) 97.6
GMM 0.62 (0.81) 0.97 (1.65) 0.80 (3.38) 28.3
Exact I -0.05 (0.02) 0.68 (0.91) 0.51 (0.83) 96.5
Approximate -0.52 (-0.54) 0.51 (0.57) 0.57 (0.62) 100
Adjusted -0.53 (-0.54) 0.57 (0.63) 0.60 (0.70) 100
0.25 (0 , -2.65) Logist. reg. 0.01 (0.02) 0.21 (0.24) 0.16 (0.06) 100
Two-stage I -0.20 (-0.19) 0.56 (0.62) 0.43 (0.42) 100
Two-stage II -0.39 (-0.41) 0.56 (0.62) 0.52 (0.56) 100
Two-stage III -0.44(-0.37) 0.61 (0.85) 0.63 (0.86) 100
GMM -0.29 (-0.08) 0.80 (1.11) 0.71 (1.24) 84.4
Exact I -0.01 (0.03) 0.37 (0.47) 0.27 (0.22) 100
Approximate 0.45 (0.50) 0.53 (0.61) 0.50 (0.62) 100
Adjusted 0.45 (0.51) 0.54 (0.61) 0.51 (0.63) 100
0.50 (-2, -1.15) Logist. reg. -1.82 (-1.82) 0.13 (0.13) 1.82 (3.31) 100
Two-stage I 0.53 (0.58) 0.55 (0.63) 0.56 (0.73) 100
Two-stage II 0.53 (0.58) 0.55 (0.63) 0.56 (0.73) 100
Two-stage III 1.42 (2.34) 1.05 (4.77) 1.42 (28.27) 94.8
GMM 0.86 (1.07) 0.78 (1.27) 0.87 (2.77) 80.5
Exact I 0.04 (0.02) 0.52 (0.60) 0.39 (0.36) 100
Approximate -0.15 (-0.18) 0.41 (0.47) 0.32 (0.25) 100
Adjusted -0.45 (-0.48) 0.50 (0.56) 0.50 (0.54) 100
0.50 (0, -1.40) Logist. reg. -0.005 (0.005) 0.15 (0.16) 0.11 (0.03) 100
Two-stage I 0.06 (0.03) 0.50 (0.56) 0.37 (0.31) 100
Two-stage II 0.18 (0.14) 0.49 (0.55) 0.40 (0.32) 100
Two-stage III 0.23 (0.30) 0.69 (0.88) 0.52 (0.86) 99.9
GMM 0.05 (0.10) 0.59 (0.75) 0.45 (0.57) 99.2
4.2 Normally distributed exposure
We conducted a second simulation experiment whereby the exposureXi was drawn
from a normal distribution with mean α∗0 + α
∗
1Zi and constant variance 1. We made
the same choices of the outcome mean E(Yi), selected ψ
∗ equal to 0 or 1 and η∗
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Table 3.4: Simulation results when exposure X is dichotomous, ψ∗ = 0 and δxz = 0.25.
Bias SE
E(Y) (η∗, ω∗) Methods Median (Mean) MCD (Sample) MAD (MSE) % conv.
Exact I -0.23 (-0.28) 0.88 (1.36) 0.71 (1.94) 83.7
Approximate -0.03 (0.06) 1.05 (1.20) 0.77 (1.44) 100
Adjusted 0.63 (0.54) 1.09 (1.26) 0.91 (1.99) 100
0.05 (-2, -2.90) Logist. reg. -1.84 (-1.85) 0.30 (0.33) 1.84 (3.55) 100
Two-stage I 0.22 (0.30) 0.90 (1.00) 0.68 (1.10) 100
Two-stage II -0.02 (0.05) 0.87 (0.99) 0.63 (0.99) 100
Two-stage III -0.02 (0.06) 0.80 (1.06) 0.59 (1.12) 100
GMM -0.15 (-0.01) 0.90 (1.42) 0.67 (2.01) 89.5
Exact I -0.02 (-0.17) 1.00 (1.40) 0.73 (1.99) 95.0
Approximate 0.02 (0.005) 1.03 (1.14) 0.76 (1.30) 100
Adjusted 0.02 (0.01) 1.03 (1.14) 0.76 (1.30) 100
0.05 (0, -2.90) Logist. reg. 0.02 (0.02) 0.29 (0.32) 0.22 (0.10) 100
Two-stage I 0.02 (0.02) 0.79 (0.87) 0.58 (0.75) 100
Two-stage II 0.02 (0.004) 0.79 (0.86) 0.58 (0.75) 100
Two-stage III 0.02 (0.003) 0.79 (0.97) 0.59 (0.94) 100
GMM -0.06 (0.007) 0.96 (1.26) 0.71 (1.60) 92.4
Exact I -0.02 (0.001) 0.40 (0.48) 0.30 (0.23) 100
Approximate -0.03 (0.01) 0.54 (0.60) 0.40 (0.36) 100
Adjusted 0.87 (0.93) 0.65 (0.74) 0.87 (1.40) 100
0.25 (-2, -1.10) Logist. reg. -1.80 (-1.80) 0.14 (0.16) 1.80 (3.26) 100
Two-stage I 0.38 (0.42) 0.60 (0.69) 0.52 (0.65) 100
Two-stage II -0.03 (0.01) 0.59 (0.66) 0.44 (0.44) 100
Two-stage III -0.03 (0.01) 0.53 (0.61) 0.39 (0.37) 100
GMM -0.03 (0.06) 0.52 (0.69) 0.40 (0.49) 97.7
Exact I 0.006 (-0.02) 0.52 (0.59) 0.40 (0.35) 100
Approximate 0.006 (-0.01) 0.54 (0.60) 0.40 (0.36) 100
Adjusted 0.01 (-0.01) 0.53 (0.60) 0.40 (0.36) 100
0.25 (0, -1.10) Logist. reg. 0.002 (0.0003) 0.14 (0.16) 0.11 (0.02) 100
Two-stage I 0.007 (-0.01) 0.52 (0.58) 0.38 (0.34) 100
Two-stage II 0.006 (-0.01) 0.52 (0.58) 0.38 (0.34) 100
Two-stage III 0.006 (-0.01) 0.52 (0.61) 0.39 (0.37) 100
GMM 0.006 (0.03) 0.56 (0.65) 0.40 (0.42) 100
Exact I -0.03 (-0.03) 0.36 (0.40) 0.26 (0.16) 100
Approximate -0.04 (0.01) 0.44 (0.51) 0.33 (0.26) 100
Adjusted 0.62 (0.67) 0.54 (0.62) 0.63 (0.83) 100
0.50 (-2, 0) Logist. reg. -1.82 (-1.81) 0.14 (0.16) 1.82 (3.32) 100
Two-stage I 0.10 (0.14) 0.53 (0.61) 0.40 (0.39) 100
Two-stage II -0.04 (0.01) 0.52 (0.60) 0.39 (0.36) 100
Two-stage III -0.04 (0.01) 0.46 (0.55) 0.35 (0.30) 100
GMM -0.04 (0.01) 0.44 (0.53) 0.33 (0.28) 100
Exact I -0.03 (-0.03) 0.48 (0.50) 0.36 (0.25) 100
Approximate -0.03 (-0.03) 0.49 (0.52) 0.36 (0.27) 100
Adjusted -0.01 (-0.03) 0.49 (0.52) 0.37 (0.27) 100
0.50 (0, 0) Logist. reg. -0.004 (-0.004) 0.12 (0.14) 0.09 (0.02) 100
Two-stage I -0.03 (-0.03) 0.50 (0.54) 0.37 (0.29) 100
Two-stage II -0.03 (-0.03) 0.50 (0.54) 0.37 (0.29) 100
Two-stage III -0.03 (-0.03) 0.51 (0.56) 0.37 (0.31) 100
GMM -0.03 (-0.03) 0.49 (0.54) 0.36 (0.29) 100
4 Simulation study 105
Table 3.5: Simulation results when exposure X is dichotomous, ψ∗ = 2 and δxz = 0.15.
Bias SE
E(Y) (η∗, ω∗) Methods Median (Mean) MCD (Sample) MAD (MSE) % conv.
Exact I -1.08 (-1.19) 1.15 (1.62) 1.26 (4.03) 62.8
Approximate 0.01 (0.10) 1.87 (2.20) 1.36 (4.85) 100
Adjusted 0.01 (0.11) 1.86 (2.20) 1.36 (4.84) 100
0.05 (-2, -3.75) Logist. reg. -1.95 (-1.94) 0.28 (0.31) 1.95 (3.86) 100
Two-stage I -0.48 (-0.40) 1.40 (1.66) 1.06 (2.91) 100
Two-stage II -0.46 (-0.41) 1.41 (1.66) 1.05 (2.91) 100
Two-stage III -0.54 (0.02) 1.52 (3.20) 1.39 (10.23) 88.6
GMM -1.48 (-1.38) 1.30 (1.83) 1.58 (5.25) 42.1
Exact I -0.93 (-0.81) 1.59 (3.70) 1.37 (14.37) 70.6
Approximate -0.73 (-0.65) 1.71 (2.05) 1.36 (4.64) 100
Adjusted -0.57 (-0.35) 1.75 (2.46) 1.34 (6.19) 100
0.05 (0, -4.50) Logist. reg. 0.02 (0.29) 0.46 (1.89) 0.34 (3.66) 100
Two-stage I -0.56 (-0.45) 1.39 (1.77) 1.10 (3.33) 100
Two-stage II -0.94 (-0.86) 1.42 (1.74) 1.29 (3.77) 100
Two-stage III -1.11 (-0.76) 1.37 (2.45) 1.46 (6.61) 94.3
GMM -1.67 (-1.63) 1.18 (1.63) 1.75 (5.34) 56.3
Exact I -0.31 (-0.15) 0.83 (1.12) 0.70 (1.27) 79.1
Approximate 0.19 (0.26) 0.99 (1.24) 0.71 (1.60) 100
Adjusted 0.19 (0.26) 0.99 (1.24) 0.71 (1.60) 100
0.25 (-2, -2.00) Logist. reg. -1.95 (-1.95) 0.14 (0.15) 1.95 (3.81) 100
Two-stage I 0.13 (0.19) 0.96 (1.20) 0.68 (1.48) 100
Two-stage II 0.13 (0.19) 0.96 (1.20) 0.69 (1.20) 100
Two-stage III 0.40 (1.36) 1.29 (4.91) 1.03 (25.94) 88.0
GMM -0.14 (0.02) 1.12 (1.38) 0.84 (1.90) 49.1
Exact I -0.27 (-0.23) 0.99 (1.54) 0.72 (2.41) 84.5
Approximate -0.52 (-0.49) 0.87 (1.01) 0.73 (1.27) 100
Adjusted -0.61 (-0.60) 0.97 (1.13) 0.85 (1.64) 100
0.25 (0, -2.58) Logist. reg. 0.01 (0.02) 0.20 (0.22) 0.15 (0.05) 100
Two-stage I -0.20 (-0.19) 0.94 (1.10) 0.70 (1.24) 100
Two-stage II -0.37 (-0.34) 0.95 (1.11) 0.74 (1.36) 100
Two-stage III -0.45 (-0.05) 1.02 (2.39) 0.92 (5.74) 97.1
GMM -0.58 (-0.35) 1.01 (1.65) 0.96 (2.84) 75.9
Exact I -0.04 (0.07) 0.64 (0.88) 0.50 (0.79) 96.0
Approximate 0.38 (0.49) 0.87 (1.14) 0.67 (1.54) 100
Adjusted 0.38 (0.49) 0.87 (1.14) 0.66 (1.54) 100
0.50 (-2, -1.03) Logist. reg. -1.93 (-1.94) 0.12 (0.13) 1.93 (3.77) 100
Two-stage I 0.45 (0.57) 0.90 (1.17) 0.70 (1.70) 100
Two-stage II 0.45 (0.57) 0.90 (1.17) 0.70 (1.70) 100
Two-stage III 0.95 (2.14) 1.30 (10.36) 1.16 (111.83) 81.9
GMM 0.46 (0.71) 0.97 (1.85) 0.79 (3.93) 80.2
Exact I -0.0006 (0.02) 0.85 (1.00) 0.60 (1.00) 97.1
Approximate -0.15 (-0.15) 0.70 (0.80) 0.53 (0.66) 100
Adjusted -0.49 (-0.50) 0.87 (0.99) 0.70 (1.23) 100
0.50 (0, -1.27) Logist. reg. -0.006 (0.002) 0.10 (0.15) 0.02 (0.02) 100
Two-stage I 0.06 (0.05) 0.85 (0.98) 0.63 (0.96) 100
Two-stage II 0.23 (0.22) 0.85 (0.95) 0.63 (0.97) 100
Two-stage III 0.26 (0.68) 1.11 (2.00) 0.85 (4.48) 96.8
GMM 0.009 (0.16) 0.90 (1.41) 0.66 (2.02) 96.5
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equal to −1 or 0 (we chose smaller effect sizes because Xi was now more variable
than before). This setting is advantageous to the Two-stage estimators which were
developed, assuming a normally distributed exposure. The results from these simula-
tion studies are summarized in Tables 3.6 and 3.7. They reveal qualitatively similar
conclusions to before, apart from demonstrating a much better performance of the
Adjusted IV-estimator. Results for Exact IV-estimator II are not reported because
they were very comparable with those for Exact IV-estimator I and required long
convergence times for completion.
Table 3.6: Simulation results when exposure X is continuous, ψ∗ = 1 and ρxz = 0.26.
Bias SE
E(Y) (η∗, ω∗) Methods Median (Mean) MCD (Sample) MAD (MSE) % conv.
Exact I -0.04 (0.14) 0.57 (0.82) 0.49 (0.69) 99.4
Approximate -0.02 (0.01) 0.51 (0.58) 0.37 (0.33) 100
Adjusted -0.01 (0.01) 0.51 (0.58) 0.37 (0.33) 100
0.05 (-1, -3.28) Logist. reg. -0.93 (-0.93) 0.12 (0.13) 0.93 (0.88) 100
Two-stage I -0.25 (-0.23) 0.39 (0.43) 0.33 (0.24) 100
Two-stage II -0.25 (-0.23) 0.39 (0.43) 0.34 (0.24) 100
Two-stage III -0.17 (0.07) 0.48 (1.28) 0.45 (1.64) 97.9
GMM 0.03 (0.81) 0.58 (15.54) 0.44 (242.12) 95.9
Exact I -0.05 (0.17) 0.52 (0.94) 0.44 (0.92) 95.4
Approximate -0.08 (-0.05) 0.48 (0.54) 0.36(0.29) 100
Adjusted -0.02 (0.01) 0.50 (0.56) 0.38 (0.32) 100
0.05 (0, -4.15) Logist. reg. 0.008 (0.01) 0.14 (0.15) 0.11 (0.02) 100
Two-stage I -0.22 (-0.21) 0.40 (0.44) 0.34 (0.24) 100
Two-stage II -0.22 (-0.20) 0.40 (0.45) 0.34 (0.24) 100
Two-stage III -0.24 (-0.08) 0.42 (0.82) 0.43 (0.68) 98.2
GMM -0.05 (0.24) 0.53 (3.37) 0.43 (11.42) 97.9
Exact I -0.004 (0.04) 0.29 (0.35) 0.21 (0.12) 100
Approximate 0.008 (0.02) 0.26 (0.30) 0.20 (0.09) 100
Adjusted 0.009 (0.02) 0.27 (0.30) 0.20 (0.09) 100
0.25 (-1, -1.58) Logist. reg. -0.93 (-0.93) 0.06 (0.06) 0.93 (0.86) 100
Two-stage I -0.02 (-0.007) 0.26 (0.29) 0.19 (0.08) 100
Two-stage II -0.02 (-0.007) 0.26 (0.29) 0.19 (0.08) 100
Two-stage III 0.21 (0.47) 0.40 (1.30) 0.31 (1.90) 98.5
GMM 0.26 (0.90) 0.43 (7.94) 0.36 (63.90) 97.4
Exact I 0.009 (0.05) 0.31 (0.39) 0.23 (0.16) 100
Approximate -0.15 (-0.14) 0.25 (0.26) 0.21 (0.09) 100
Adjusted -0.001 (0.008) 0.29 (0.31) 0.21 (0.09) 100
0.25 (0, -2.09) Logist. reg. -0.002 (0.003) 0.08 (0.90) 0.06 (0.008) 100
Two-stage I -0.05 (-0.04) 0.28 (0.29) 0.21 (0.09) 100
Two-stage II -0.04 (-0.04) 0.28 (0.29) 0.21 (0.09) 100
Two-stage III -0.04 (0.04) 0.34 (0.53) 0.29 (0.28) 99.8
GMM -0.006 (0.11) 0.37 (0.71) 0.29 (0.51) 99.8
Exact I 0.01 (0.02) 0.24 (0.28) 0.18 (0.08) 100
Approximate 0.01 (0.01) 0.23 (0.26) 0.17 (0.07) 100
Adjusted 0.01 (0.01) 0.23 (0.26) 0.17 (0.07) 100
0.50 (-1, -0.64) Logist. reg. -0.93 (-0.93) 0.06 (0.06) 0.93 (0.87) 100
Two-stage I 0.04 (0.04) 0.24 (0.27) 0.18 (0.07) 100
Two-stage II 0.04 (0.04) 0.24 (0.27) 0.18 (0.07) 100
Two-stage III 0.32 (0.55) 0.44 (1.22) 0.38 (1.79) 97.9
GMM 0.36 (0.87) 0.47 (2.00) 0.41 (4.41) 97.2
Exact I 0.009 (0.02) 0.24 (0.27) 0.18 (0.07) 100
Approximate -0.16 (-0.16) 0.20 (0.22) 0.19 (0.07) 100
Adjusted 0.01 (0.01) 0.24 (0.26) 0.18 (0.07) 100
0.50 (0, -0.77) Logist. reg. -0.0004 (0.005) 0.08 (0.08) 0.05 (0.007) 100
Two-stage I 0.004 (0.004) 0.24 (0.26) 0.18 (0.07) 100
Two-stage II 0.005 (0.005) 0.24 (0.26) 0.17 (0.07) 100
Two-stage III 0.01 (0.08) 0.30 (0.54) 0.24 (0.30) 100
GMM 0.01 (0.09) 0.31 (0.55) 0.25 (0.31) 99.9
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Table 3.7: Simulation results when exposure X is continuous, ψ∗ = 0 and ρxz = 0.26.
Bias SE
E(Y) (η∗, ω∗) Methods Median (Mean) MCD (Sample) MAD (MSE) % conv.
Exact I 0.02 (0.01) 0.51 (0.65) 0.37 (0.42) 96.6
Approximate -0.01 (-0.01) 0.47 (0.54) 0.35 (0.30) 100
Adjusted -0.02 (-0.01) 0.51 (0.57) 0.38 (0.33) 100
0.05 (-1, -2.9) Logist. reg. -0.93 (-0.93) 0.14 (0.15) 0.93 (0.90) 100
Two-stage I -0.009 (-0.01) 0.40 (0.45) 0.30 (0.21) 100
Two-stage II -0.01 (-0.01) 0.41 (0.46) 0.30 (0.21) 100
Two-stage III -0.009 (-0.01) 0.37 (0.50) 0.27 (0.25) 100
GMM -0.01 (-0.01) 0.47 (0.59) 0.36 (0.35) 100
Exact I 0.008 (0.04) 0.45 (0.62) 0.33 (0.39) 98.1
Approximate 0.004 (-0.01) 0.45 (0.52) 0.32 (0.27) 100
Adjusted 0.004 (-0.01) 0.45 (0.52) 0.32 (0.27) 100
0.05 (0, -2.9) Logist. reg. 0.003 (0.003) 0.13 (0.14) 0.09 (0.02) 100
Two-stage I 0.005 (-0.009) 0.34 (0.39) 0.25 (0.16) 100
Two-stage II 0.003 (-0.009) 0.34 (0.39) 0.24 (0.16) 100
Two-stage III 0.003 (-0.005) 0.33 (0.48) 0.25 (0.23) 100
GMM 0.002 (-0.01) 0.45 (0.59) 0.32 (0.35) 99.8
Exact I 0.01 (0.02) 0.29 (0.33) 0.21 (0.11) 100
Approximate 0.01 (0.01) 0.24 (0.27) 0.18 (0.07) 100
Adjusted 0.01 (0.02) 0.28 (0.32) 0.21 (0.10) 100
0.25 (-1, -1.09) Logist. reg. -0.92 (-0.92) 0.08 (0.09) 0.92 (0.86) 100
Two-stage I 0.01 (0.02) 0.27 (0.30) 0.20 (0.09) 100
Two-stage II 0.01 (0.02) 0.27 (0.31) 0.20 (0.09) 100
Two-stage III 0.01 (0.02) 0.24 (0.28) 0.18 (0.08) 100
GMM 0.01 (0.02) 0.24 (0.29) 0.18 (0.08) 100
Exact I 0.007 (0.004) 0.26 (0.28) 0.18 (0.08) 100
Approximate 0.006 (0.001) 0.25 (0.28) 0.18 (0.08) 100
Adjusted 0.006 (0.001) 0.25 (0.28) 0.18 (0.08) 100
0.25 (0, -1.09) Logist. reg. 0.002 (0.003) 0.06 (0.07) 0.05 (0.005) 100
Two-stage I 0.007 (0.001) 0.25 (0.27) 0.17 (0.07) 100
Two-stage II 0.006 (0.001) 0.25 (0.27) 0.17 (0.07) 100
Two-stage III 0.006 (0.001) 0.25 (0.28) 0.17 (0.08) 100
GMM 0.006 (0.001) 0.25 (0.29) 0.18 (0.08) 100
Exact I 0.01 (0.01) 0.27 (0.30) 0.19 (0.09) 100
Approximate 0.008 (0.01) 0.22 (0.24) 0.16 (0.06) 100
Adjusted 0.005 (0.01) 0.27 (0.29) 0.19 (0.08) 100
0.50 (-1, 0) Logist. reg. -0.92 (-0.92) 0.07 (0.08) 0.92 (0.85) 100
Two-stage I 0.009 (0.01) 0.27 (0.29) 0.19 (0.08) 100
Two-stage II 0.01 (0.01) 0.27 (0.29) 0.19 (0.08) 100
Two-stage III 0.009 (0.01) 0.23 (0.26) 0.16 (0.07) 100
GMM 0.008 (0.01) 0.23 (0.25) 0.16 (0.06) 100
Exact I 0.004 (0.001) 0.23 (0.25) 0.16 (0.06) 100
Approximate 0.004 (0.002) 0.23 (0.25) 0.16 (0.06) 100
Adjusted 0.004 (0.002) 0.23 (0.25) 0.16 (0.06) 100
0.50 (0 , 0) Logist. reg. 0.003 (0.002) 0.06 (0.06) 0.04 (0.004) 100
Two-stage I 0.004 (0.002) 0.23 (0.26) 0.17 (0.07) 100
Two-stage II 0.004 (0.002) 0.23 (0.26) 0.17 (0.07) 100
Two-stage III 0.004 (0.002) 0.23 (0.27) 0.17 (0.07) 100
GMM 0.004 (0.002) 0.23 (0.26) 0.16 (0.07) 100
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5 Discussion
In this article, we have given an expository review of IV-estimators for the causal
odds ratio. We have focused on exact estimators as well as a number of popular ap-
proximate ones, without being exhaustive; in particular, we have omitted estimators
based on principal stratification (e.g. Abadie, 2003; Ten Have et al., 2003) as this
approach does not allow a flexible treatment of continuous exposures and is rather
artificial in the context of Mendelian randomization studies (Didelez, Meng and Shee-
han, 2008). Our results show that the concerns of Robins and Rotnitzky (2004) about
incongeniality of the model of Vansteelandt and Goetghebeur (2003) can be overruled
by leaving the main effect of the IV in their association model unrestricted. This is
useful because the approach of Vansteelandt and Goetghebeur (2003) yields compu-
tationally simpler estimators through the following three steps: (a) fit a standard
association model for the outcome in function of exposure and IV; (b) combine this
with the causal model to obtain predicted values of the exposure-free outcome; and
(c) choose the causal odds ratio such that these predictions become independent of the
IV. For general IVs, leaving its main effect unrestricted requires the use of generalized
additive association models. The performance of the resulting estimator remains to
be studied. Our simulation studies complement recent studies by Didelez, Meng and
Sheehan (2008), Palmer et al. (2008) and Rassen et al. (2009), but include results
on the bias and efficiency of exact IV-estimators. They reveal that these ‘exact’ es-
timators tend to outperform ‘approximate’ estimators of the causal odds ratio that
are commonly used in the literature on Mendelian randomization. Of all considered
estimators, the Exact IV-estimators are the only ones which are asymptotically unbi-
ased, although they may have an important finite-sample bias when there is limited
information (e.g. due to low prevalence, weak IV, small sample size, ...). The Approx-
imate IV-estimator tended to outperform standard logistic regression when there was
confounding of a sufficient magnitude, and was doing especially well at the causal null
hypothesis. This estimator has a number of attractions over the Exact IV-estimators
in that it can be used for the analysis of case-control data (Smith et al., 2005) and
lends itself particularly well to meta-analyses based on summary measures (Minelli et
al., 2004). In addition, it can be extended to the analysis of time-varying exposures.
Indeed, consider the following logistic structural nested mean model
logitE(Yt(xs0)|Xs = xs, Z)
−logitE(Yt(xs−10)|Xs = xs, Z) = ψ∗I(s = t)xt + γ∗I(s < t)xs
where Yt(xs0) denotes the counterfactual outcome that would be observed at time t if,
possibly contrary to fact, the exposure history Xt = (X1, ...,Xt) equalled (xs, 0, ..., 0).
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This model allows for the short term effect ψ∗ to differ from the long term effect γ∗.
Using similar approximations as in Section 2.4, it can be shown that this model implies
logitE(Yt|Z) = ω∗t + ψ∗E(Xt|Z) + γ∗
t−1∑
s=1
E(Xs|Z)
where Yt is the observed outcome at time t > 0. Having obtained estimates of E(Xs|Z)
for s > 0, this model can be fitted - and thus estimates of ψ∗ and γ∗ can be obtained
- using standard software for marginal models. The resulting estimators continue to
share the local robustness property of being consistent at the causal null hypothesis.
It remains to be evaluated to what extent the approximation errors propagate with
time and thus how prone to bias these estimators are away from the causal null
hypothesis. It additionally remains to be studied whether similar adjustments as for
the Adjusted IV-Estimator (possibly including the previously suggested corrections
for measurement error) can remedy some of the bias of the resulting estimator.
With the exception of GMM-estimators, our focus in this article has been on
estimation of the exposure effect conditional on the observed exposure, as defined
in (3.1). In linear structural mean models (Robins, 1994), the assumption that the
treatment effect is not modified by the instrument, i.e. that
E(Y − Y0|X,Z) = ψ∗X
does not depend on Z, implies that marginal and conditional effects are the same.
This is seen because the above model implies the same observed data restriction,
namely E(Y − ψ∗X|Z) = E(Y − ψ∗X), as model E(Y − Y1|X,Z) = φ∗(X − 1), thus
indicating that
E(Y1 − Y0|X = 1, Z) ≡ ψ∗ = φ∗ ≡ E(Y1 − Y0|X = 0, Z)
and, consequently, that ψ∗ = E(Y1 − Y0). The same is no longer true in logistic
structural mean models, where additional assumptions are required to infer marginal
causal effects.
Adjustment for baseline covariates (more generally, covariates which are not causally
affected by exposure, outcome or IV) was not discussed in this article because it is
not commonly considered in biostatistical and epidemiological applications. This is
justified by the fact that covariate adjustment is only needed when there are mea-
sured confounders of the association between IV and outcome, when there is a specific
interest in assessing effect modification or when an boost in efficiency is anticipated.
Covariate adjustment is easily realized for all considered IV-estimators by addition-
ally including these in all considered regression models. For the Exact IV-estimators,
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this requires testing whether the predicted counterfactual outcome Y0 is independent
of the IV, conditional on baseline covariates. When there is a continuous baseline
covariate or multiple discrete covariates, then the model of Vansteelandt and Goet-
ghebeur (2003) is no longer guaranteed to yield a congenial parameterization, unlike
the model of Robins and Rotnitzky (2004). The similarity of the estimating functions
indicates that, nevertheless, similar estimates would typically be obtained with both
approaches.
Appendix 3.A: Local
robustness and Incongenial
models
Local robustness
When ψ∗ = 0, then equation (3.7) becomes
∑n
i=1
(
Zi −
∑n
j=1 Zj
n
)
expit{m(Xi, Zi; βˆ)}.
Suppose now that the association model includes an intercept and main effect in Zi,
and that βˆ is the standard maximum likelihood estimator of β∗. We then show that
equation (3.7) equals
∑n
i=1
(
Zi −
∑n
j=1 Zj
n
)
Yi, which has mean zero at ψ
∗ = 0, even
under model misspecification. That this equality is true follows because βˆ satisfies
the following score equations:
0 =
n∑
i=1
(
1
Zi
)[
Yi − expit{m(Xi, Zi; βˆ)}
]
from which
∑n
i=1 ZiYi =
∑n
i=1 Ziexpit{m(Xi, Zi; βˆ)} and
∑n
i=1
∑n
j=1 Zj
n Yi =
∑n
i=1
∑n
j=1 Zj
n
×expit{m(Xi, Zi; βˆ)}.
Incongenial models
It follows from the parameterization of Robins and Rotnitzky (2004) that the
logistic structural mean model (3.2) is congenial with an association model of the
form
P (Yi = 1|Xi, Zi) = expit{ψ∗Xi + q(Xi, Zi) + v(Zi)}
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where q(Xi, Zi) is an arbitrary function of (Xi, Zi) satisfying q(0, Zi) = 0 for all Zi
and where v(Zi) solves
ω =
∫
expit{q(Xi = x,Zi) + v(Zi)}P (Xi = x|Zi)dx
for some value ω. Consider now an association model of the form
P (Yi = 1|Xi, Zi;β∗) = expit{β∗1Xi + q∗(Xi, Zi;β∗2) + v∗(Zi;β∗3)}
with v∗(Zi;β3) and q∗(Xi, Zi;β2) arbitrary functions of (Zi, β3) and of (Xi, Zi), sat-
isfying q∗(0, Zi;β2) = 0 for all Zi and β2, respectively. It then follows from the stated
results of Robins and Rotnitzky (2004) that this association model is congenial with
the logistic structural mean model (3.2) for every choice of model q∗(Xi, Zi;β2) when
no restrictions are imposed on the function v∗(Zi;β3), e.g. when Zi is dichotomous
and v∗(Zi;β3) is chosen to be of the form β30+β31Zi for unknown parameters β30, β31.
Two-stage estimator
In this section, we explain how to derive E(Yi0|Zi) under models (3.12) and (3.13).
Note that
E(Yi0|Zi,Xi) = P (Ui ≤ θ∗0 + θ∗1Xi + θ∗2Zi − φ∗Xi)
where Ui is a standard normally distributed variate, independent of (Zi,Xi). Aver-
aging over the exposure, conditional on Zi, then yields
E(Yi0|Zi) =
∫∞
−∞ P (Ui + (φ
∗ − θ∗1)Xi ≤ θ∗0 + θ∗2Zi)dF (Xi|Zi)
where F (Xi|Zi) refers to the conditional distribution of Xi, given Zi. Define U∗i =
Ui+(φ
∗−θ∗1)Xi. Then, assuming that Xi is normally distributed with mean α∗0+α∗1Zi
and constant variance σ2∗, conditional on Zi, U∗i has a normal distribution with mean
µu∗ = (φ
∗ − θ∗1)(α0 + α1Zi) and variance σ2u∗ = 1 + (φ∗ − θ∗1)2σ2. Then
E(Yi0|Zi) =
∫ ∞
−∞
∫ θ∗0+θ∗2Zi
−∞
dF (U∗i ,Xi|Zi) = Φ{(θ∗0 + θ∗2Zi − µu∗)/σu∗}.
The conditional mean E(Yi|Zi) can be derived using similar arguments.
Chapter 4
Correcting Instrumental
Variables Estimators for
Systematic Measurement
Error
Summary
Instrumental variables (IV) estimators are well established to correct for measure-
ment error on exposure in a broad range of fields. In a distinct prominent stream
of research IV’s are becoming increasingly popular for estimating causal effects of
exposure on outcome since they allow for unmeasured confounders which are hard
to avoid. Because many causal questions emerge from data which suffer severe mea-
surement error problems, we combine both IV approaches in this article to correct
IV-based causal effect estimators in linear (structural mean) models for possibly sys-
tematic measurement error on the exposure. The estimators rely on the presence of a
baseline measurement which is associated with the observed exposure and known not
to modify the target effect. Simulation studies and the analysis of a small blood pres-
sure reduction trial (n = 105) with treatment noncompliance confirm the adequate
performance of our estimators in finite samples. Our results also demonstrate that
incorporating limited prior knowledge about a weakly identified parameter (such as
the error mean) in a frequentist analysis can yield substantial improvements.
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1 Introduction
Instrumental variables (IV) methods have a long tradition in economics and econo-
metrics, where they are used in connection with structural equation models. They
have more recently entered the medical, epidemiological and biostatistical literature
(for reviews, see e.g. Greenland, 2000; Martens et al., 2006). To estimate the aver-
age causal effect of an exposure on an outcome in the presence of unmeasured con-
founders, these methods rely on so-called instrumental variables. These are variables
which (i) are associated with the exposure; (ii) have no direct effect on the outcome;
and (iii) do not share common causes with the outcome (Herna´n and Robins, 2006).
Instrumental variables arise naturally in double-blind randomized trials with treat-
ment noncompliance because randomization (i.e. the instrument) is associated with
received treatment (i.e. exposure), often does not affect outcome other than through
received treatment and shares no common causes with outcome by virtue of random-
ization. They are hence frequently used to adjust for treatment noncompliance in
randomized experiments (see e.g. Goetghebeur and Vansteelandt, 2005, for a review)
and for the analysis of randomized encouragement designs (Ten Have et al., 2004).
At the same time, they are becoming increasingly popular in observational settings
where the conditions for an instrumental variable are harder to justify. In genetics,
for instance, the random assortment of genes transferred from parents to offspring
- called ‘Mendelian randomization’ - resembles the use of randomization in exper-
iments and is therefore a natural instrumental variable for estimating the effect of
genetically affected exposures on a given trait (Didelez and Sheehan, 2007). Casas et
al. (2005) use this idea to assess the influence of plasma homocysteine level on the
risk of stroke with homozygosity at a specific allele as an instrumental variable. In
most observational studies no real or natural randomization is present, in which case
the availability of an instrumental variable must be assessed on theoretical grounds.
For instance, Leigh and Schembri (2004) use the cigarette price per region as an in-
strumental variable to estimate the effect of smoking on health, assuming that the
price of cigarettes may only impact health by mediating exposure to cigarette smoke.
With the increasing popularity of IV methods in causal inference comes the grow-
ing concern for their performance under common complications, such as misclassifi-
cation or measurement error on exposure. Indeed, in the context of noncompliance
adjustment in clinical trials (Dunn, 1999; Goetghebeur and Vansteelandt, 2005) for
instance, simple measures of compliance with drug therapy, such as pill counts, are
notorious for overestimating the amount of drug actually taken (Urquhart and De
Klerk, 1998). HIV prevention studies tend to rely on self reported measures of sexual
activity and accompanying preventive action, including use of condoms or microbi-
cide gels, which are subject to ‘pleasing bias’ (Van Damme et al., 2005). Many other
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exposure measures are popular even though they are bias prone.
Random measurement error on exposure is not alarming for IV estimators in linear
(structural mean) models (Goetghebeur and Vansteelandt, 2005). These estimators
continue to be asymptotically unbiased when random measurement error is ignored,
with at most a slight loss of efficiency. When measurement error is systematic, tests
of the causal null hypothesis of no effect remain valid, but effect estimates may be-
come biased. Because systematic error is a real concern in many practical settings
(e.g. overreporting of drug compliance, underreporting of alcohol use, ...), our goal in
this article is to investigate how IV estimators for the parameters in linear (structural
mean) models may be adjusted for systematic measurement error. Goetghebeur and
Vansteelandt (2005) show how this can be done when the average size of the error is
known. This allows for sensitivity analyses, but leaves open the question of how to
estimate the average size of the measurement error and subsequently correct for it.
Because of identifiability problems, the latter can only be realized when extraneous
information is available. One common source of information is an IV for the mea-
surement error (Buzas and Stefanski, 1996; Carroll et al., 2004, 2006). In contrast
to the original IV used for confounder adjustment, this is a (pre-exposure) surrogate
for the observed exposure (in the sense that it is correlated with exposure), which is
assumed not to modify the exposure effect of interest. Our interest in such variables
stems from the fact that we can identify settings where such variables exist and that
other sources of information on the measurement error, such as repeated measure-
ments or validation samples, are typically not available in large classes of problems
(e.g. noncompliance adjustment).
In the next section, we build on ideas from linear regression models with error in
the covariates (Carroll et al., 2006) to show how an IV for the measurement error can
help correct IV-based causal effect estimators for systematic error under linear struc-
tural mean models (Goetghebeur and Lapp, 1997; Robins, 1994). In Section 2.3, we
diagnose poor performance of the error-adjusted estimator in small to moderate sam-
ple sizes as compared to the standard estimator which ignores measurement error. We
show in Section 3 that this is due to the average magnitude of the error being weakly
identified at effects close to zero. In Section 3, we accommodate this by imposing lib-
eral bounds on the magnitude of the average error. This leads to reliable estimators
for the causal effect of observed exposure with good performance in finite samples.
The latter is confirmed through the analysis of a placebo-controlled hypertension trial
in Section 4 and through simulation studies in Section 3.2. Our results reveal how
the incorporation of prior information (in the form of bounds on weakly identified
nuisance parameters) in a frequentist analysis, can recover considerable precision for
the target parameter.
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2 Adjusting for measurement error
2.1 Assumptions
We consider data on a scalar exposure Zi, a scalar outcome Yi and possibly a
vector of baseline (i.e. pre-exposure) covariates Xi drawn from independent subjects
i = 1, ..., n, to study the average effect of exposure Zi on outcome Yi. We define this
effect as an expected contrast
E(Yi − Yi0|Zi,Xi), (4.1)
between observed outcomes Yi and potential exposure-free outcomes Yi0 (Rubin,
1978). The latter indicates a reference response which would have been measured
for subject i if all conditions had been the same as in the current study, but no ex-
posure had been received; that is, if the assigned experimental treatment contained
no active dose. Because true exposure Zi is imprecisely measured, the observed ex-
posure level Wi for subject i may differ from the actual exposure level Zi, which is
unobserved.
Since Yi0 and Zi are not generally observed, identification of the causal effect (4.1)
requires assumptions.
Assumption A1 (Causal IV assumption): Ri is a causal instrumental variable (IV-
C) for inferring the causal effect of Zi on Yi; that is, Ri is conditionally dependent
on Zi, given Xi, and satisfies the following assumptions:
1. exclusion restriction (Angrist, Imbens and Rubin, 1996): Ri has no direct effect
on the outcome (only an indirect effect via the exposure is possible). That is,
with Yi0r the potential outcome that we would have observed for subject i if
(Ri, Zi) were set to (r, 0), we assume that Yi0r = Yi0 for all values of r in the
support of Ri.
2. randomization assumption: within strata of baseline covariates Xi,
E(Yi0|Xi, Ri) = E(Yi0|Xi).
In double-blind randomized trials of an asymptomatic disease, one expects these as-
sumptions to hold for randomization Ri since patients and physicians are unaware of
the assigned treatment (Robins, 1994).
Assumption A2 (Consistency assumption): to link exposure-free outcomes to ob-
served outcomes, we assume that Yi = Yi0 for subjects with Zi = 0.
Assumption A3 (Model assumption): the expected causal effect (4.1) follows the
linear structural mean model (Robins, 1994; Goetghebeur and Lapp, 1997)
E(Yi − Yi0|Zi,Xi, Ri) = γ(Xi;ψ∗)Zi (4.2)
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where γ(Xi;ψ) is a known function smooth in ψ, satisfying γ(Xi;0) = 0, and where
ψ∗ is an unknown finite-dimensional parameter. For instance, in placebo-controlled
randomized experiments with Ri = 1 for subjects randomized to the experimental arm
and Ri = 0 for placebo control and with Zi denoting exposure to the experimental
treatment, we may choose
E(Yi − Yi0|Zi,Xi, Ri) = ψ∗Zi. (4.3)
Here, ψ∗ expresses the expected change in outcome when those exposed to Zi = 1
would have their exposure set to zero. When treatment effects are potentially modified
by pre-treatment covariates, one may add covariate-exposure interactions, as in
E(Yi − Yi0|Zi,Xi, Ri) = (ψ∗1 + ψ∗
′
2 Xi)Zi.
Here, ψ∗2 defines the change in the average effect of unit exposure per unit increase
in Xi.
Note that we restrict our development to models (4.2) which postulate the causal
effect to be linear in the exposure. This is a standard restriction in the literature
on IV-estimation and on two-stage-least-squares estimation of causal effects (Herna´n
and Robins, 2006) because linear structural mean models with nonlinear exposure
effects suffer from identification problems, even in the absence of measurement error
(Vansteelandt and Goetghebeur, 2005). For similar reasons, no effect modification
by the IV-C is allowed. Note, however, that model (4.2) will often give a reasonable
approximation, even for nonlinear causal effects.
Assumption A4 (Measurement error IV assumption): Given the difficulty in ob-
taining information about measurement error characteristics, we introduce an instru-
mental variable for the measurement error (IV-M). In contrast to an IV-C which
satisfies Assumption A1, we define this as a surrogate Ti ⊆ Xi for the observed expo-
sure (in the sense that is it is conditionally associated with Wi, given (Si, Ri), where
Si is such that Xi ≡ (Si,Ti)), which is measured prior to exposure and is such that
it does not modify the causal effect of received exposure on the outcome, i.e. such
that
E(Yi − Yi0|Zi,Xi, Ri) = E(Yi − Yi0|Zi,Si, Ri). (4.4)
We thus assume that γ(Xi;ψ) in (4.2) does not involve Ti. With a slight abuse of
notation, we will denote it γ(Si;ψ). Importantly, note that the IV-M Ti differs from
and satisfies different assumptions than the IV-C Ri, which satisfies Assumption A1.
The former instrumental variable will be used to correct for systematic measurement
error, the latter to infer a causal effect of Z on Y .
The use of no-interaction assumptions such as (4.4) is increasingly common in
causal inference, in particular in the context of IV-estimation. For instance, Ten
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Have et al. (2007), Joffe, Small and Hsu (2007) and Albert (2008) use similar no-
interaction assumptions to infer direct causal effects. Vansteelandt and Goetghebeur
(2004) and Fischer and Goetghebeur (2006) rely on no-interaction assumptions for
assessing effect modification by treatment-free responses. In this study, the interest
in Assumption A4 is motivated by the fact that other sources of information on
the measurement error, such as repeated measurements or validation samples, are
typically not available in large classes of problems (e.g. noncompliance adjustment),
and by the fact that we can identify settings where the assumption is reasonable. For
instance, in randomized clinical trials, one source of an IV for the measurement error
on treatment noncompliance would be a measurement of placebo compliance during
a run-in period of the study. Indeed, run-in placebo compliance is associated with
treatment compliance and likely not further related to the treatment effect, given
the actual compliance during the active study period. More generally, one can use a
second causal IV as an IV for the measurement error. Indeed, an IV-C is associated
with the considered exposure by Assumption A1 and does not modify the target
causal effect by Assumption A3. It thus satisfies the conditions for an IV-M. The
use of multiple IV-C’s turns out feasible in practice as it is commonly considered
in econometrics and more recently also in Mendelian randomization studies (Didelez
and Sheehan, 2007). For instance, to assess the effect of C-reactive protein on insulin
resistance, one may use the CRP-gene as an IV-C and the interleukin-6 gene - which
is known to be associated with C-reactive protein through other pathways than the
CRP-gene and which thus applies as a second IV-C - as an IV-M. Note, however
that the restrictions for an IV-M are much weaker than those for an IV-C as an
IV-M need not satisfy the exclusion restriction, nor the randomization assumption
(see Assumption A1). Note also that assumption (4.4) is weaker than the typical
IV-assumption encountered in measurement error models (Carroll et al., 2006) as it
does allow for the IV to be associated with the outcome, conditional on the exposure.
Assumption A5 (Constant average measurement error): For simplicity and be-
cause information about the average error is weak, we develop our approach below for
constant (but unknown) average error E(Wi − Zi|Xi, Ri) = δ∗. This assumption is
standard in the measurement error literature, but is straightforwardly relaxed (e.g.,
by postulating E(Wi − Zi|Xi, Ri) = δ∗0 + δ∗
′
1 Xi).
2.2 Inference
Our goal is to estimate the parameter ψ∗ indexing (4.2) under model A, which is
the model for the observed data (Yi,Wi, Ri,Xi) defined by assumptions A1-A5 with
the conditional density
f(Ri|Xi) known. (4.5)
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The latter assumption holds in a randomized trial when Ri indicates randomized
assignment, because treatment allocation is then under the control of the investigator.
If assumption (4.5) fails, then all further results continue to hold upon replacing
f(Ri|Xi) with a consistent estimator.
It follows from Proposition 1 below that the average measurement error δ∗ is all
that must be known for identifying ψ∗ under model A.
Proposition 1. Model A is the same model for the observed data as the conditional
mean independence model B for the observed data model, which is defined by a known
function f(Ri|Xi) (as in (4.5)) and
E [Yi − γ(Si;ψ∗) (Wi − δ∗) |Xi, Ri] = E [Yi − γ(Si;ψ∗) (Wi − δ∗) |Xi] . (4.6)
Note the essential difference between models A and B. Model A is expressed in terms
of counterfactuals and therefore has parameters with a causal interpretation. Model B
imposes the same restrictions on the observed data as model A, but is not expressed in
terms of counterfactuals. This makes the parameters in this model harder to interpret,
but simplifies inference as the model is expressed in terms of observed data only. Note
also that model A imposes only weak restrictions on the error distribution. First, it
allows the error to be associated with both the true exposure Zi and observed exposure
Wi. It thus encompasses both the classical and Berkson error model (Carroll et al.,
2006). In addition, by avoiding assumptions about the conditional association between
Wi and Yi, given Zi, it allows for so called differential error, which is associated with
outcome conditional on exposure (see the proof of Proposition 1 for a more explicit
argument). This can be important. For instance, in a clinical trial, patients may be
more reluctant to ‘confess’ to noncompliance when their outcome stayed below target.
Finally, model A makes no assumptions on the measurement error distribution other
than Assumption 5. This is useful because the error distribution can be quite complex.
For instance, with low level exposures negative errors become constrained by the fact
that negative exposures are never reported.
By Proposition 1 and the fact that ψ∗ is the same functional of the observed data
under models A and B, inference for ψ∗ is the same under both models. It follows
that the set of all consistent and asymptotically normal (CAN) estimators for ψ∗ is
the same under models A and B, where the latter can be obtained as in Robins (1994)
by solving the mean independence estimating equations
n∑
i=1
d(Ri,Xi) [Yi − γ(Si;ψ)(Wi − δ)− q(Xi)] = 0 (4.7)
jointly for θ = (ψ′, δ)′, with d(Ri,Xi) = g(Ri,Xi) − E {g(Ri,Xi)|Xi} and with
g(Ri,Xi) and q(Xi) arbitrary (non-trivial) index functions of the dimension of θ.
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Note that estimating equation (4.7) is designed to make the predicted exposure-free
outcomes Yi − γ(Si;ψ)(Wi − δ) mean independent of Ri, conditional on Xi, in order
to satisfy Assumption A1. The index functions g(Ri,Xi) and q(Xi) can be arbitrarily
chosen without affecting the consistency of the resulting estimators of ψ∗. In particu-
lar, they can be chosen in view of efficiency. Under the homoscedasticity assumption
that the conditional variance of Yi − γ(Xi;ψ)(Wi − δ), given (Ri,Xi), is constant,
semi-parametric efficiency (Robins, 1994) is for instance obtained by setting q(Xi)
equal to
qopt(Xi) = E {Yi − γ(Si;ψ)(Wi − δ)|Xi, Ri}
and d(Ri,Xi) equal to dopt(Ri,Xi) = gopt(Ri,Xi)− E {gopt(Ri,Xi)|Xi} with
gopt(Ri,Xi) = E
{
∂γ(Si;ψ)(Wi − δ)
∂θ
|Xi, Ri
}
.
These choices will be used later in the data analysis and simulation study.
Theorem 1.
1. Under weak regularity conditions, the solution ψˆ(d, q) to (4.7) satisfies√
n
(
ψˆ(d, q)−ψ∗
)
→N (0,Γ(d, q)) in distribution, where
Γ(d, q) = E−1
{
∂Ui(d, q;ψ
∗)
∂ψ
}
V ar{Ui(d, q;ψ∗)}E−1′
{
∂Ui(d, q;ψ
∗)
∂ψ
}
(4.8)
with d(Ri,Xi) = (dψ(Ri,Xi), dδ(Ri,Xi)) and
Ui(d, q;ψ) =
[
dψ(Ri,Xi)− E {dψ(Ri,Xi)γ(Si;ψ)}
E {dδ(Ri,Xi)γ(Si;ψ)} dδ(Ri,Xi)
]
× [Yi − γ(Si;ψ)(Wi − δ)− q(Xi)]
2. The average error δ∗ is not root-n estimable at ψ∗ = 0.
3. For arbitrary (d, q), Γ(dopt, qopt) ≤ Γ(d, q) where A ≤ B is defined as A − B
being semi-positive definite.
Part 1 of Theorem 1 confirms that the solution ψˆ(d, q) to (4.7) is a root-n CAN
estimator of ψ∗. This is even so at ψ∗ = 0 where δ∗ is not root-n estimable. Theorem
1 also shows how to calculate the efficient score Ui(dopt, qopt;ψ) for ψ
∗ in model
A. For example, in Section 4, we will consider the analysis of a placebo-controlled
randomized trial with Zi denoting compliance to the experimental treatment. Because
the placebo arm (Ri = 0) is unexposed, Zi = ZiRi and there is no measurement error
in that arm so that we modify Assumption A5 to E(Wi − Zi|Xi, Ri) = δ∗Ri. With
Xi = Ti, γ(Si;ψ) = ψ and assuming homoscedasticity and constant randomization
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probabilities π = P (Ri = 1) = P (Ri = 1|Xi), the semi-parametric efficient score for
ψ∗ is
(Ri−π) [E(Wi|Ri = 1,Xi)− E {E(Wi|Ri = 1,Xi)}] {Yi − ψ(Wi − δ)Ri − qopt(Xi)} .
This score differs from the efficient score in the absence of biased measurement error
(i.e. assuming that δ∗ = 0) in that it carries the additional termE {E(Wi|Ri = 1,Xi)},
which corrects for estimation of the error mean. This term reduces the variance of
the estimating functions and, as such, encodes efficiency loss. Specifically, note that
the efficient score becomes 0 when the IV-M, T , is uncorrelated with the observed
exposure, and hence that ψ∗ is not root-n estimable in that case. By the same token,
instruments for the measurement error which are weakly correlated with observed
exposure, may yield unstable effect estimates.
2.3 Bias-variance Trade-off
The anticipated loss of efficiency of the error-adjusted estimator raises the ques-
tion whether the bias correction developed so far is useful. To this end, we investigate
the bias-variance trade-off for the error-adjusted and the standard unadjusted es-
timator for the causal effect ψ∗, in a specific case. Tractable expressions for the
mean-squared error of both estimators, are obtained when Z ∼ N(µz, σ2z), T |Z ∼
N(ν0 + ν1Z, σ
2
t|z), Y0|Z, T ∼ N(α0 + α1Z + α2T, σ20) and Y = Y0 + (ψ + ǫ)RZ with
ǫ|Y0, Z, T ∼ N(0, σ2). Under the working assumption of no systematic measurement
error (i.e. fixing δ∗ = 0 in equation (4.7) and not estimating it), the efficient score for
ψ∗ is Uu(ψ) = (0.5−R)E(W |T,R = 1){Y −ψRW −E(Y |R = 0, T )} in model A with
Xi = Ti under the above data-generating mechanism. It follows after some algebra
that the solution ψˆu to
∑n
i=1 Uui(ψ) = 0 has bias which can be approximated by
E−1
(
∂Uu(ψ)
∂ψ
)
E{Uu(ψ)} = ψδ(µz + δ)
σ2z − σ2z|t + (µz + δ)2
where σ2z|t = σ
2
zσ
2
t|z/(ν
2
1σ
2
z+σ
2
t|z) is the conditional variance of Z given T , and asymp-
totic variance given by
1
n

4σ20 + 4α21σ2z|t + 2ψ2σ2u + ψ2δ2
σ2z − σ2z|t + (µz + δ)2
+
ψ2δ2(σ2z − σ2z|t){
σ2z − σ2z|t + (µz + δ)2
}2

 .
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Allowing for systematic measurement error, the efficient estimator ψˆc for ψ
∗ under
model A has no asymptotic bias and asymptotic variance which equals
1
n
σ20 + α
2
1σ
2
z|t + 0.5ψ
2σ2u
0.52(σ2z − σ2z|t)
.
Note that the bias of the unadjusted estimator and the asymptotic variance of both
estimators is inversely proportional to the multiple correlation coefficient for the re-
gression of Z on T . The variance of the error-adjusted estimator becomes infinite
when Z and T are uncorrelated.
Figure 1 shows the range of values δ for the average error under which the standard
estimator, which ignores measurement error, has smaller mean squared error than
the error-adjusted estimator. This is displayed in function of the sample size and
the correlation between Z and T . Specifically, the values of δ comprised between the
solid lines indicate data-generating mechanisms under which the standard estimator
outperforms the error-adjusted estimator in terms of mean squared error. The figure
was constructed using parameter values which are reflective of the hypertension study
that we will analyze in Section 4. It shows that at small sample sizes (n = 105),
correction for systematic measurement error leads to smaller mean squared error, but
only when the systematic error component is substantial (i.e. of about the size of the
average exposure µz) and, at the same time, the IV-M, T , is strongly correlated with
Z. Figure 1 reveals further that bias correction using the error-adjusted estimator is
only helpful at moderate degrees of error and moderate correlations between T and
Z when sample sizes are very large.
3 Incorporating prior information
The previous results demonstrate the poor performance of the error-adjusted es-
timator, even in settings where the sample size is moderate and good (pre-exposure)
predictors of exposure are available. In particular, tests of the causal null hypothesis
can loose substantial power by using this approach rather than the standard test of
the causal null (i.e. that R and Y are conditionally independent, given Xi), which
is immune to measurement error on the exposure (Goetghebeur and Vansteelandt,
2005). This is surprising, considering that the score test of ψ∗ = 0 under model
A does not involve δ∗ and, hence, does not need to correct for measurement error
when testing the causal null hypothesis. Curiously, it follows that one can validly and
efficiently test the causal null hypothesis without correction for measurement error,
but that a score test of ψ∗ = ψ0 with ψ0 arbitrarily close to (but different from) 0,
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Figure 1: Curves indicating the tuples (R, δ) where the standard SMM estimator
and the error-adjusted instrumental variable estimator have the same mean squared
error, for R equalling the correlation between Z and T , for different sample sizes
n = 105, 1000 and 5000 and with µz = 0.85, σ
2
z = 0.11, ν0 = 0.75, ν1 = 0.12, σ
2
t|z =
0.012, α0 = −4.4, α1 = 6.8, α2 = −13.7, σ20 = 53.2, σ2u = 0, ψ = −7.5 and σ2 = 0.
Left: for R from 0 to 1; Right: for R from 0.5 to 1.
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would require correcting for measurement error and hence could imply a serious and
sudden loss of power.
The root cause of this apparent discontinuity is the fact that, as shown in Part 2
of Theorem 1, δ∗ is not root-n estimable at ψ∗ = 0 so that estimation of δ∗ affects
the distribution of the score test statistic, even though it gets multiplied by ψ∗ = 0
in the test statistic (i.e. even at the causal null hypothesis). In particular, it follows
from the proof of Theorem 1 that
√
n
{
δˆ(d, q)− δ∗
}
ψ∗, with δˆ(d, q) the solution for
δ to (4.7), is bounded in probability with strictly positive variance for each value of
ψ∗, suggesting that δˆψ∗ fluctuates around 0, even when ψ∗ = 0. This happens with
decreasing variance as the sample size increases.
Similar problems of inestimability at a local point in the parameter space have been
noted in other measurement error problems (Gustafson, 2005). More general problems
of inferring a parameter ψ∗ when a nuisance parameter δ∗ disappears under the null
(ψ∗ = 0) have been discussed mainly in the econometrics literature (Davies, 1977,
1987; Hansen, 1992; Andrews and Ploberger, 1994). To the best of our knowledge,
attention has only been given to testing problems in which the test statistic involves
a nuisance parameter which is unidentified at the null. Some of these approaches
assume that the nuisance parameter lies within a known open set and base inference
on the supremum of a score or likelihood ratio test statistic, taken over all values
of the nuisance parameters in the chosen set (Davies, 1977, 1987). Andrews and
Ploberger (1994) postulate a prior distribution for the nuisance parameter and base
inference on the average of a score or likelihood ratio test statistic over the chosen prior
distribution. Our problem is different in that our main focus is on estimation rather
than testing, and that a score test for the causal null hypothesis does not involve
the nuisance parameter. Nonetheless, inspired by the work of Davies (1977, 1987)
and by sensitivity analyses for IV-estimators with measurement error (Goetghebeur
and Vansteelandt, 2005), we proceed by considering estimation under the assumption
that the average error δ∗ lies within a known open set ∆. This strategy is further
motivated by the fact that (a) subject-matter experts often have a good sense of the
extent of expected mismeasurement (Gustafson, 2005); (b) it forces the estimate for
δ∗ to have bounded variation around the truth, contrary to what happens under the
approach of Section 2.2.
3.1 Improved Error Adjustment
Our first approach under the assumption that δ∗ ∈ ∆ =]∆l,∆u[ solves equations
(4.7) with δ replaced by {I(λ < 0)∆l+ I(λ > 0)∆u}λ/(1+ |λ|) and λ unknown. This
guarantees estimates δ∗(λˆ) within the set ∆ and thus greatly improves the stability
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of estimators for the causal effect ψ∗. A drawback which will become apparent in
the simulation study of Section 3.2, is that tests of the causal null hypothesis may
still loose substantial power under this approach due to the fact that also λ is not
root-n estimable at ψ∗ = 0. To accommodate this, we will develop a second, recom-
mended approach which trades bias for precision by solving a weighted average of the
estimating functions for the standard SMM estimator and for the error-adjusted es-
timator of Section 2.3. Estimating functions for the standard estimator are weighted
proportionally to the estimated probability that δ∗ falls outside the chosen set ∆.
The philosophy behind this choice is that estimates for δ∗ will not likely fall within
the set ∆ in situations where little information on the error mean is available. Hence
more weight will be given to the standard unadjusted estimator in those cases. For
pedagogic purposes, we will explain our proposal for the case γ(Xi;ψ) = ψ and with
Assumption A5 modified to E(Wi − Zi|Xi, Ri) = δ∗Ri. We further delete reference
to the index functions (d, q) in the estimators. For each value ψ in a chosen grid, we
calculate an estimator δˆ(ψ) for δ∗ which solves (4.7) for the given ψ with dδ(Ri,Xi)
in place of d(Ri,Xi). Next, we consider a weighted average of the estimating function
Uψi(ψ, δ) for ψ
∗ (as defined in (4.7) with dψ(Ri,Xi) in place of d(Ri,Xi)), evaluated
at the profile estimator δ = δˆ(ψ) and at δ = 0, respectively:
1√
n
n∑
i=1
U˜i(ψ) ≡ 1√
n
n∑
i=1
Pˆ{δˆ(ψ) ∈ ∆}Uψi{ψ, δˆ(ψ)}+ Pˆ{δˆ(ψ) /∈ ∆}Uψi(ψ, 0) (4.9)
In this expression, the weights involve the estimated probability Pˆ{δˆ(ψ) /∈ ∆} that
δˆ(ψ) falls outside the chosen interval ∆ =]∆l,∆u[. Using a similar development as in
the proof of Theorem 1, this probability can be approximated by
P{δˆ(ψ) /∈ ∆} = 1 + Φ
(
∆l − δ
σ(ψ)/(
√
n|ψ|)
)
− Φ
(
∆u − δ
σ(ψ)/(
√
n|ψ|)
)
(4.10)
with Φ(.) the cumulative standard normal distribution function, and where δ may be
replaced by a consistent estimator (for instance, min[∆u,max{∆l, δˆ(ψ)}]) and σ(ψ)
by a consistent estimator σˆ(ψ) for the standard deviation of the scaled estimating
function E−1 [dδ(R, T,X)R]Uiδ(ψ, δ) for δ∗. We define the improved error-adjusted
estimator ψ˜ for ψ∗ as the value of ψ at which the score test (4.9) becomes zero.
Curiously, this estimator assigns much weight to the standard estimating equations
(which do not adjust for measurement error) when the error mean is estimated to
be large. This is (a) because the philosophy behind the estimator is that such large
values for the error mean are indicative of imprecision; and (b) because the estimating
functions are designed to equal the unadjusted estimating functions at the causal null
hypothesis (see further).
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Theorem 2. Suppose that γ(Xi;ψ) = ψ,Zi = ZiRi and E(Wi − Zi|Xi, Ri) =
δ∗Ri. Then, under regularity conditions stated in the Appendix and for any fixed ψ,
1√
n
∑n
i=1 U˜i(ψ)→N (0,Σ(ψ)) in distribution, where Σ(ψ) is the variance of
P{δˆ(ψ) ∈ ∆}Uiψ(ψ, δ) + P{δˆ(ψ) /∈ ∆}Uiψ(ψ, 0)−
[
P{δˆ(ψ) ∈ ∆}
+
{
ϕ
(
∆l − δ
σ(ψ)/(
√
n|ψ|)
)
− ϕ
(
∆u − δ
σ(ψ)/(
√
n|ψ|)
)} √
n|ψ|δ
σ(ψ)
]
×E {dψ(R,X)R}
E {dδ(R,X)R}Uiδ(ψ, δ)
with ϕ(.) the standard normal density function.
Theorem 2 can be used to construct (1 − α)100% confidence intervals for ψ∗ as
the range of values ψ0 for ψ such that the two-sided score test based on (4.9) does not
reject the null hypothesis H0 : ψ
∗ = ψ0 at the α100% significance level. To evaluate
this score test, one may replace the variance of the score test statistic by the sample
variance with P{δˆ(ψ) ∈ ∆} replaced by Pˆ{δˆ(ψ) ∈ ∆}, δ by δˆ(ψ) and σ(ψ) by σˆ(ψ).
The resulting confidence intervals have the desirable feature that, asymptotically,
they exclude 0 if and only if the standard test of the causal null hypothesis (i.e., that
Y ⊥⊥ R|X) rejects. Indeed, at the null hypothesis Pˆ{δˆ(0) /∈ ∆} p→ 1 and hence the
score test statistic becomes
1√
n
n∑
i=1
Uψi(ψ, 0) =
1√
n
n∑
i=1
dψ(Ri,Xi){Yi − q(Xi)}+ op(1)
for an arbitrary function dψ(Ri,Xi) with conditional mean zero, givenXi. When δˆ(ψ)
in Uψi(ψ, δˆ(ψ)) is restricted to ∆ as described in the first paragraph of this Section,
this statistic is asymptotically equivalent to a score test statistic of the causal null
hypothesis under the observed data model defined by restriction (4.5).
Unfortunately, the suggested confidence intervals are no uniform asymptotic con-
fidence intervals. The reason is that, at each sample size, there exists a ψ∗ depending
on n which is sufficiently close to zero that the score test statistic (4.9) is significantly
biased as a result of bias in the estimating functions of the standard unadjusted SMM
estimator. Specifically, it follows from the proof of Theorem 2 that the improved error-
adjusted estimator ψ˜ is asymptotically biased within root-n shrinking neighbourhoods
of zero (i.e. when ψ∗ = k/
√
n for some constant k) and may not converge to a normal
distribution along such sequences. Curiously, ψ˜ is asymptotically unbiased and nor-
mally distributed along faster converging sequences (i.e. when ψ∗ = kn−a for some
constant k and a > 1/2) and in particular at ψ∗ = 0. The reason is that, although
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the probability that δˆ(ψ) ∈ ∆ now converges to 0 and hence ψ˜ is asymptotically
equivalent to the standard unadjusted SMM estimator, ψ∗ is sufficiently close to zero
to make any bias in the estimator negligible. Likewise, ψ˜ is asymptotically unbiased
and normally distributed along slower converging sequences (i.e. when ψ∗ = kn−a
for some constant k and 0 ≤ a < 1/2). The reason is that the estimated probabil-
ity of δˆ(ψ) ∈ ∆ now converges to 1 so that the improved error-adjusted estimator
is asymptotically equivalent to the error-adjusted estimator of Section 2.2, which is
asymptotically unbiased.
The practical implication of the foregoing discussion is that the improved error-
adjusted estimator ψ˜ and confidence intervals have no guaranteed performance in
finite samples in the sense that, for each sample size, one can find a causal effect ψ∗
which is close, but not too close to zero so that ψ˜ is significantly biased and that
confidence intervals for ψ∗ do not cover ψ∗ at the nominal level. This local bias is
the price we pay for estimators with smaller variability and limited loss of power
for testing the causal null hypothesis. Because this problem only appears within 1
over root-n distances from zero and not within larger or shorter distances, we expect
adequate performance in many practical situations. However, to be conservative we
develop uniform asymptotic confidence intervals in the next section.
3.2 Uniform Asymptotic Confidence Intervals
Uniform asymptotic (1−α)100% confidence intervals are expected to have better
finite-sample properties than the intervals of the previous section because they guar-
antee the existence of a minimal sample size such that, at larger sample sizes, they
cover ψ∗ with at least (1 − α)100% chance regardless of the value of ψ∗. Following
ideas in Robins (2005), we construct such intervals by first constructing, for each ψ,
an asymptotic uniform (1− ǫ)100% confidence interval C(ψ) for δ∗, where the choice
of ǫ < α will be discussed later. Because we assume the parameter space for δ∗ to be
∆, a conservative asymptotic interval C(ψ) may be obtained as{
δˆ(ψ)± zǫ/2
σˆ(ψ)
|ψ|√n
}
∩∆.
Using Theorem 5.1 in Robins (2005), an asymptotic uniform (1− α)100% confidence
interval for ψ∗ may be obtained as the set of ψ-values for which
inf
δ∈C(ψ)
|V ar−1/2{Uψi(ψ, δ)} 1√
n
n∑
i=1
Uψi(ψ, δ)| < z(α−ǫ)/2
The optimal choice of ǫ that leads to confidence intervals of minimum length is difficult
to determine (Robins, 2005). In this article, we propose to choose ǫ in function of
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ψ as 0.5α|ψ|/(1 + |ψ|). This choice guarantees that C(ψ) will equal ∆ for ψ∗ = 0
and equal a (1− α/2)100% confidence interval for δ∗ at causal effects ψ∗ far from 0.
The philosophy behind this choice is that estimates for δ∗ will be highly imprecise
at causal effects close to zero and hence, given that the parameter space for δ∗ is
bounded, we expect no difference between 100% confidence intervals and (1−α)100%
confidence intervals for δ∗ at ψ∗ = 0. As such, we need not offer the significance
level for ψ∗ at small causal effects and will thus get narrower intervals in return.
Specifically, the proposed confidence intervals have the feature that they involve no
correction for measurement error at ψ∗ = 0, which is desirable because there is no
bias due to measurement error at ψ∗ = 0.
4 Data analysis
We analyze data from a placebo-controlled randomized hypertension trial which
enrolled some 300 hypertensive patients (Goetghebeur and Lapp, 1997). After a run-
in period of 4 weeks where all patients received placebo tablets, they were randomized
to 4 weeks of one of two active treatments (A or B) or placebo. All treatments were
prescribed at one tablet per day. Here, we analyze the subset of 105 patients random-
ized to A or placebo, for whom treatment compliance was electronically measured,
ignoring 5 patients with missing diastolic blood pressure or compliance.
An intent-to-treat analysis reveals an average difference in blood pressure reduc-
tion over the active 4-week study period of 7.5 mmHg (95% CI 4.0; 11.0) without
adjustment. This reveals the effect of assignment to treatment A (instead of placebo)
on expected diastolic blood pressure reduction from baseline (i.e. the time of random-
ization). Primary interest lies however in the effect of received treatment on average
blood pressure reduction. We will therefore fit model (4.3) with Yi the blood pressure
reduction over the active study period, Ri the randomization indicator as the IV-C
(which is 1 if assigned to experimental treatment and 0 if assigned placebo), Zi the
average number of prescribed pills taken, and Xi the age of patient i. Assuming that
compliance measurements are free of systematic error, we estimate that the average
blood pressure reduction would have been 9.6 mmHg (95% CI 3.5; 11.8) smaller over
the study period among those who choose to take on average one pill per day, had they
not taken the exposure. Note that this estimand averages the effect over patients with
different compliance patterns, but with the same average pill intake. Distinguishing
between these patients would require more detailed compliance measures, but would
suffer from identifiability problems (Vansteelandt and Goetghebeur, 2005).
In reality, there are concerns that also electronic compliance measurements carry
systematic errors and thus that the above estimate may be biased. Because this study
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was not designed to correct for measurement error, no natural instrumental variables
for the measurement error have been recorded. Our analysis is hence for illustrative
purposes only and will use age as an IV-M (i.e., Ti = Xi equals age). Age was chosen
because effect modification through age is not anticipated (nor observed) in this study
population, which consists of middle aged hypertensive patients (5th, 95th percentiles:
41 and 69 years), and thus Assumption A4 is anticipated to be approximately true. A
more adequate analysis would use placebo compliance during the run-in period (where
no electronic adherence measures were taken) as an IV-M. Using the error-adjusted
estimator of Section 2.2, we estimate a larger treatment effect of 27.0 mmHg (95%
CI -91.2; 145.2). To improve this imprecise result, we impose the weak assumption
that the average error is smaller than 0.25. We believe this assumption to be rea-
sonable, given that the observed percentage of assigned dose taken (i.e. the observed
exposure) is 0.85 (i.e., 85%) on average. Choosing ∆ = [−0.25, 0.25] thus allows for
30% of the observed average exposure to be due to systematic error. Using the im-
proved error-adjusted estimator for inference, we estimate a slightly smaller effect of
9.0 mmHg (95% CI 4.4; 17.4) as compared to the standard analysis. As predicted
by the theory, the estimate is less precise than the unadjusted estimator, but still
significantly different from 0 at the 5% significance level. The uniform asymptotic
95% confidence interval (2.7; 16.8) has a more guaranteed performance in finite sam-
ples. To investigate the sensitivity of our result to the choice of ∆, Figure 2 shows
the improved error-adjusted estimate, along with uniform 95% confidence intervals in
function of the assumed maximum error mean ∆u, with ∆ = [−∆u,∆u]. It reveals
reasonable stability. Comparison with the sensitivity analysis results of Goetghebeur
and Vansteelandt (2005) shows that the error-adjustment described in this article
reduces uncertainty.
5 Simulation study
To investigate the behaviour of the error-adjusted estimators in finite samples
with ψ∗ possibly close to zero, we conducted simulation experiments. Each experi-
ment was based on 5000 replications of random samples of size 105 (i.e. the sample
size of the blood pressure study) or 1000, generated as follows. In each experiment,
the instrument T for the measurement error was normal with mean 0.83 and stan-
dard deviation 0.14 and R was independently generated from a Bernoulli distribution
with success probability 0.5. The true exposure Z and exposure-free response were
generated as Z = T + 0.32ǫZ and Y0 = −4.4 + 6.8Z − 7.3T + 7.3ǫ0 for independent
standard normal variates ǫZ , ǫ0. Finally, we generated Y as Y0 + ψRZ and the ob-
served exposure W as W = Z + U where U ∼ N(δ, 0.01). Table 4.1 summarizes the
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Figure 2: Improved error-adjusted estimate, along with uniform 95% confidence in-
tervals in function of the maximum error mean ∆u, with ∆ = [−∆u,∆u].
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results for estimation of ψ using i) the standard IV estimator which ignores system-
atic measurement error (STD); (ii) the error-adjusted estimator of Section 3.1 (IV1);
iii) the error-adjusted estimator of Section 3.3 which guarantees estimates for δ to
stay within ∆ = [∆l,∆u] with ∆u = −∆l equal to 0.5, 0.25 or 0.05, by defining
δ = {I(λ < 0)∆l + I(λ > 0)∆u}λ/(1 + |λ|) for unknown λ (IV2); the improved error-
adjusted estimator of Section 3.3 with the same choices for ∆ (IV3). In addition,
the table shows uniform asymptotic 95% confidence intervals (UI) corresponding to
these choices. The results for the different estimators are as predicted by the theory.
The error-adjusted estimator (IV1) is extremely variable at small sample sizes, but
performs adequately at larger sample sizes, even at ψ = 0. Estimator (IV2) is less
variable, although still substantially less precise than the standard unadjusted esti-
mator. Figures 3 and 4 show that estimator (IV1) is normally distributed in moderate
sample sizes, even at ψ = 0, but not in small samples. It also shows that the improved
error-adjusted estimator (IV3) is much less variable than the error-adjusted estimator
(IV1). While the former follows a normal distribution in small samples, deviations
from normality appear in larger sample sizes as a result of convergence to a normal
distribution not being uniform in ψ. By the same token, the improved error-adjusted
estimator is more biased than the error-adjusted estimator in larger samples, and even
than the standard IV estimator in some scenarios. Informally, this happens because
data sets which carry evidence for causal effects close to zero, yield estimated prob-
abilities of δˆ(ψ) ∈ ∆ close to zero. The bias then arises because the small estimated
causal effects in such data sets will be more attracted towards the estimates obtained
from a standard structural mean analysis (which ignores measurement error) than
large estimated causal effects. Additional simulations (not displayed) have shown
that, as predicted by the theory, this bias and deviation from normality disappears
again in larger sample sizes. Furthermore, note that the confidence intervals for the
improved error-adjusted estimator retain their coverage despite these deviations, al-
though there is a tendency for the approach to be conservative. Finally, as predicted
by the theory, the uniform confidence intervals are conservative and also wider on
average than those obtained via the improved error-adjusted estimator. The impact
of narrower intervals ∆ = [−0.25, 0.25] was large at small sample sizes, but moderate
at large sample sizes. For instance, confidence intervals based on the improved error-
adjusted estimator had an average length of 8.42 (instead of 13.3) and coverage of
97.0% (instead of 97.7%) in the small samples and 4.35 (instead of 4.83) and 98.0% (in-
stead of 97.8%), respectively, in the large samples. The impact of ∆ = [−0.05, 0.05]
not including the error mean was to induce bias of the order of magnitude of the
standard unadjusted estimator. The 95% confidence intervals based on the improved
error-adjusted estimator and uniform 95% confidence intervals then no longer cover
at the nominal rate. Coverage of those intervals was still better than the coverage
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Table 4.1: Bias of the different effect estimators and coverage and average length of corresponding 95%
confidence intervals.
∆ n ψ δ Bias Coverage Average length CI
STD IV1 IV2 IV3 STD IV1 IV2 IV3 UI STD IV1 IV2 IV3 UI
0.5 105 -7.5 0.15 1.11 -3.77 -2.65 0.68 86.8 96.5 99.8 97.7 99.8 5.87 3039 56.2 13.3 18.8
0.5 105 -7.5 0 -0.020 -3.77 -2.31 -0.046 93.7 96.5 99.9 98.7 100 6.96 3039 55.7 10.8 29.2
0.5 105 0 0 -0.015 -3.63 -0.019 -0.0096 93.5 96.5 100 94.1 96.2 6.94 3027 63.8 8.88 21.1
0.5 1000 -7.5 0.15 1.13 -0.15 -0.28 0.81 36.4 95.1 99.9 97.8 100 1.90 14.0 14.0 4.83 11.4
0.5 1000 -7.5 0 -0.0048 -0.15 -0.52 -0.62 95.0 95.1 98.1 95.1 100 2.25 14.0 14.0 12.4 16.7
0.5 1000 0 0 -0.0042 -0.14 0.0032 -0.0036 94.9 95.2 100 95.0 96.2 2.24 14.0 13.9 2.78 5.86
0.25 105 -7.5 0.15 1.11 -3.77 0.59 1.06 86.8 96.5 100 97.0 99.5 5.87 3039 56.4 8.42 10.9
0.25 105 -7.5 0 -0.020 -3.77 -0.63 -0.062 93.7 96.5 100 98.8 99.9 6.96 3039 56.8 10.7 14.2
0.25 105 0 0 -0.015 -3.63 -0.013 -0.010 93.5 96.5 100 94.2 94.9 6.94 3027 67.8 8.88 11.6
0.25 1000 -7.5 0.15 1.13 -0.15 0.42 0.78 36.4 95.1 100 98.0 99.9 1.90 14.0 13.9 4.35 5.69
0.25 1000 -7.5 0 -0.0048 -0.15 -0.37 -0.19 95.0 95.1 100 95.8 99.6 2.25 14.0 14.0 5.83 7.61
0.25 1000 0 0 -0.0042 -0.14 -0.0012 -0.0036 94.9 95.2 100 95.0 95.5 2.24 14.0 13.9 2.78 3.43
0.05 105 -7.5 0.15 1.11 -3.77 1.07 1.11 86.8 96.5 100 91.3 94.8 5.87 3039 63.9 6.54 7.47
0.05 105 -7.5 0 -0.020 -3.77 -0.052 -0.015 93.7 96.5 100 96.3 98.2 6.96 3039 64.4 7.87 9.07
0.05 105 0 0 -0.015 -3.63 -0.014 -0.016 93.5 96.5 100 94.1 94.3 6.94 3027 67.9 7.53 8.51
0.05 1000 -7.5 0.15 1.13 -0.15 1.02 1.11 36.4 95.1 100 54.2 74.9 1.90 14.0 13.9 2.32 2.78
0.05 1000 -7.5 0 -0.0048 -0.15 -0.031 -0.0063 95.0 95.1 100 98.3 99.7 2.25 14.0 13.9 2.83 3.43
0.05 1000 0 0 -0.0042 -0.14 -0.0037 -0.0042 94.9 95.2 100 95.0 95.1 2.24 14.0 13.9 2.36 2.55
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Figure 3: QQ-plots for n = 105 and ∆ = [−0.5, 0.5]. Row 1: error-adjusted estimator
IV1; Row 2: improved error-adjusted estimator IV3.
134 Correcting Systematic Measurement Error
−4 −2 0 2 4
−
20
−
10
−
5
0
5
ψ = − 7.5 , δ = 0.15
IV1
Theoretical Quantiles
Sa
m
pl
e 
Qu
an
tile
s
−4 −2 0 2 4
−
20
−
10
−
5
0
5
ψ = − 7.5 , δ = 0
IV1
Theoretical Quantiles
Sa
m
pl
e 
Qu
an
tile
s
−4 −2 0 2 4
−
15
−
5
0
5
10
ψ = 0 , δ = 0
IV1
Theoretical Quantiles
Sa
m
pl
e 
Qu
an
tile
s
−4 −2 0 2 4
−
12
−
10
−
8
−
6
−
4
ψ = − 7.5 , δ = 0.15
IV3
Theoretical Quantiles
Sa
m
pl
e 
Qu
an
tile
s
−4 −2 0 2 4
−
16
−
12
−
8
−
6
−
4
ψ = − 7.5 , δ = 0
IV3
Theoretical Quantiles
Sa
m
pl
e 
Qu
an
tile
s
−4 −2 0 2 4
−
2
−
1
0
1
2
ψ = 0 , δ = 0
IV3
Theoretical Quantiles
Sa
m
pl
e 
Qu
an
tile
s
Figure 4: QQ-plots for n = 1000 and ∆ = [−0.5, 0.5]. Row 1: error-adjusted estimator
IV1; Row 2: improved error-adjusted estimator IV3.
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of 95% confidence intervals based on the standard unadjusted estimator, but at the
expense of being wider.
6 Conclusions
We have proposed a general procedure to correct IV estimators for systematic
error in the exposure when an additional instrumental variable for the measurement
error is available. This procedure complements the sensitivity analysis approach of
Goetghebeur and Vansteelandt (2005) and is especially attractive when the IV-M
assumption (A4) is likely to be met. This is the case in placebo-controlled randomized
trials with noncompliance where measurements Ti on run-in placebo compliance may
very well meet assumption (A4). With concern for compliance mismeasurement,
recording run-in compliance may thus be favourable. More generally, IV-C’s can be
used as IV’s for the measurement error.
On theoretical grounds and on the basis of simulation experiments, we recommend
the improved error-adjusted estimator of Section 3.1. This estimator was designed
so that adjustment for measurement error does not compromise the power of tests
of the causal null. This is attractive, knowing that standard tests of the causal
null hypothesis (i.e., that the causal instrument R is independent of outcome) ignore
exposure measurements and are thus valid in the presence of measurement error.
Because the proposed estimator does not converge uniformly to a normal distribution,
we recommend the uniform confidence intervals of Section 3.2.
For illustrative purposes, we have developed this work under structural mean
models which assume linear exposure effects that are not modified by pre-exposure
covariates. Extensions to linear structural mean models that allow for effect modifica-
tion by baseline covariates are methodologically straightforward, but computationally
more demanding. Finally, we believe our results to be more broadly useful as they
suggest, in line with Gustafson (2005), that incorporating a little prior information on
a weakly identified nuisance parameter may yield substantial efficiency improvements
for the target parameter. Similar ideas may therefore prove useful in related settings
(Vansteelandt and Goetghebeur, 2004; Fischer and Goetghebeur, 2004; Ten Have et
al., 2007) with weak identification. In addition, our results indicate how such prior
information may be adopted in a frequentist analysis.
Appendix 4.A: Proof of
Proposition 1 and Theorems
1, 2
Proof of Proposition 1. Model A implies model B because, with
δ(Xi, Ri) ≡ E(Wi − Zi|Xi, Ri)
,
E (Yi0|Xi, Ri) = E {Yi − γ(Si;ψ∗)Zi|Xi, Ri}
= E [Yi − γ(Si;ψ∗) {Wi − δ(Xi, Ri)} |Xi, Ri]
by (A3) and (A5), and because E (Yi0|Xi, Ri) = E (Yi0|Xi) by (A1). Note that this
does not require assumptions about the conditional association between Yi and Wi,
given Zi, suggesting that this continues to hold when measurement error is differential.
To show that (4.6) is the only restriction (other than (4.5)) imposed on the
observed data law, we proceed as in Robins and Rotnitzky (2004) by exhibiting
for any observed data law satisfying (4.5) and (4.6), a joint law of the full data
(Y, {Yrz,∀r, z}, Z,W,R,X) satisfying the restrictions of model A, where Yrz is the
potential outcome that would have been observed for given subject following ex-
posure to (R,Z) = (r, z), all other experimental conditions being the same as in
the considered study. Given (R = r, Z = z,W = w,X = x, Y = y), we de-
fine Yrz = y to satisfy (A2). We set f(Z|R = r,W = w,X = x, Y = y) equal
to an arbitrary density with conditional mean w − δ to satisfy (A5). We define
f(Yr0|R = r, Z = z,W = w,X = x, Y = y) to be an arbitrary density with condi-
tional mean y−γ(x, r;ψ∗)z. In addition, given (R = r, Z = z,W = w,X = x, Y = y),
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we set Yr0 = Yr′0 ≡ Y0 for each r′ to satisfy (A1). By (4.6), the conditional distribu-
tion of Y0 then also satisfies E(Y0|X = x, R) = E(Y0|X = x) for each x. Remaining
features of the full data density can be chosen arbitrarily.
Proof of Theorem 1. Let for simplicity of exposition, but without loss of
generality, γ(Xi;ψ) = ψ,Zi = ZiRi and E(Wi − Zi|Xi, Ri) = δ∗Ri. Define Uiδ =
dδ(Ri,Xi) [Yi − ψ(Wi − δ)Ri − q(Xi)] and Uiψ = dψ(Ri,Xi) [Yi − ψ(Wi − δ)Ri − q(Xi)]
the estimating functions for δ∗ and ψ∗, respectively. Under weak regularity condi-
tions as stated for general M-estimators in van der Vaart (1998, p.48, 60), Taylor
expansions show that
0 =
1√
n
n∑
i=1
Uiδ + E
(
∂Uδ
∂ψ
)√
n(ψˆ − ψ∗) + E
(
∂Uδ
∂δ
)√
n(δˆ − δ∗)
+
1
2
E
(
∂2Uδ
∂ψ∂δ
)√
n(ψˆ − ψ∗)(δˆ − δ∗) + op(1) (4.11)
from which
√
n(δˆ − δ∗) ψˆ + ψ
∗
2
= op(1)− E−1 {dδ(R,X)R}
×
[
1√
n
n∑
i=1
Uiδ −E {dδ(R,X)(W − δ∗)R}
√
n(ψˆ − ψ∗)
]
Plugging this into a first order Taylor expansion of Uiψ, shows that
√
n(ψˆ − ψ∗) = −
[
E {dψ(R,X)(W − δ∗)R} − E {dψ(R,X)R}
E {dδ(R,X)R}E {dδ(R,X)(W − δ)R}
]−1
×
[
1√
n
n∑
i=1
Uiψ − E {dψ(R,X)R}
E {dδ(R,X)R}Uiδ
]
+ op(1)
Standard application of the Central Limit Theorem and Slutsky’s Theorem now shows
that
√
n(ψˆ − ψ∗) = Op(1) and that Part 1 of Theorem 1 holds.
Note that the last 3 terms in (4.11) can be replaced with
E {dδ(R,X)R}
{
ψ∗ +Op(n−1/2)
}√
n(δˆ − δ),
Appendix 4.A 139
from which
√
n(δˆ − δ)ψ∗ = √n(δˆ − δ)(ψˆ + ψ∗) {1/2 + op(1)} equals
−
[
E {dδ(R,X)R} − E {dδ(R,X)(W − δ
∗)R}
E {dψ(R,X)(W − δ∗)R}E {dψ(R,X)R}
]−1
×
[
1√
n
n∑
i=1
Uiδ − E {dδ(R,X)(W − δ
∗)R}
E {dψ(R,X)(W − δ∗)R}Uiψ
]
+ op(1)
The latter expression is bounded in probability (under standard regularity conditions).
It follows that, as ψ∗ goes to zero with increasing sample size, δˆ does not converge to
δ∗ at root-n rate and hence is not uniformly root-n consistent. In particular, there is
no root-n consistent estimator of δ∗ under model A at ψ∗ = 0, which proves Part 2
of Theorem 1. This is also seen by noting that the expected derivative of the efficient
estimating function for (ψ, δ) w.r.t. δ is zero at ψ = 0.
Part 3 of Theorem 1 is immediate from Robins (1994).
Proof of Theorem 2. Let for simplicity of exposition, but without loss of
generality, γ(Xi;ψ) = ψ,Zi = ZiRi and E(Wi − Zi|Xi, Ri) = δ∗Ri. Then standard
asymptotic theory for M-estimators (van der Vaart, 1998) and Taylor expansions of
the estimating functions (4.9) for ψ∗ w.r.t. δˆ(ψ) shows that (4.9) equals
1√
n
n∑
i=1
P{δˆ(ψ) ∈ ∆}Uiψ(ψ, δ) + P{δˆ(ψ) /∈ ∆}Uiψ(ψ, 0) + op(1)−
[
P{δˆ(ψ) ∈ ∆}
+
{
ϕ
(
∆l − δ
σ(ψ)/(
√
n|ψ|)
)
− ϕ
(
∆u − δ
σ(ψ)/(
√
n|ψ|)
)} √
n|ψ|δ
σ(ψ)
]
E {dψ(R, T )R}
E {dδ(R, T )R}Uiδ(ψ, δ)(4.12)
That the remainder term converges to zero in probability for any fixed ψ can be seen
because, for some δ˜ on the open line segment between δˆ(ψ) and δ∗ (under standard
regularity conditions which include uniform convergence of n−1
∑n
i=1 Uiψ(ψ, δ) w.r.t.
δ), the remainder term equals[
Pδ=δ˜{δˆ(ψ) ∈ ∆}E
{
∂2
∂δ2
Uiψ(ψ, δ˜)
}
+ 2
∂
∂δ
Pδ=δ˜{δˆ(ψ) ∈ ∆}E
{
∂
∂δ
Uiψ(ψ, δ˜)
}
+
∂2
∂δ2
Pδ=δ˜{δˆ(ψ) ∈ ∆}E
{
Ui0(ψ)− Uiψ(ψ, δ˜)
}] √n
2
{δˆ(ψ)− δ∗}2 + op(1)
Here, E
{
∂2Uiψ(ψ, δ˜)/∂δ
2
}
= 0. Because E
{
∂Uiψ(ψ, δ˜)/∂δ
}
= Op(1)ψ under stan-
dard regularity conditions and
√
n{δˆ(ψ) − δ∗}2 = Op(1)n−1/2ψ−2, the second term
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is
Op(1)
{
ϕ
(
∆l − δ˜
σ(ψ)/(
√
n|ψ|)
)
− ϕ
(
∆u − δ˜
σ(ψ)/(
√
n|ψ|)
)}
1
σ(ψ)
= op(1)
for any fixed ψ. Because E
{
Ui0(ψ)− Uiψ(ψ, δ˜)
}
= Op(1)δ˜ψ, the third term is
{
ϕ
(
∆l − δ˜
σ(ψ)/(
√
n|ψ|)
)
− ϕ
(
∆u − δ˜
σ(ψ)/(
√
n|ψ|)
)}
n|ψ|ψδ˜
σ(ψ)3
(∆l −∆u) = op(1)
for any fixed ψ because xaϕ(x)→ 0 as x→∞ for arbitrary a > 0.
Because the estimating functions in (4.12) have mean and variance depending
on the sample size, we use the triangular array Central Limit Theorem (Serfling,
1980, p.31) to derive the asymptotic distribution of (4.9) for fixed ψ. Application
of this Theorem shows that for arbitrary fixed ψ, the estimating functions in (4.9)
are asymptotically normally distributed under the weak regularity condition that the
standard deviation of the estimating functions U˜i(ψ), as defined by (4.12), is bounded
(i.e. O(1)) and that asymptotically E‖U˜i(ψ) − E{U˜i(ψ)}‖k = o(nk/2−1) for each k.
Because for any fixed ψ∗ 6= 0 and δ∗ ∈ ∆ =]∆l,∆u[, P{δˆ(ψ∗) ∈ ∆} converges to 1, it
follows under these conditions that n−1/2
∑n
i=1 U˜i(ψ
∗) will be asymptotically normally
distributed with mean zero and finite variance, which is given by the variance of (4.12).
Within faster than root-n shrinking neighbourhoods of zero (i.e. if ψ∗ = kn−a for
some constant k and a > 1/2), the remainder term in the Taylor series expansion is
still op(1). Further, P{δˆ(ψ∗) ∈ ∆} converges to 0 and U0(ψ∗) has mean converging to
zero at 1 over na-rate. It then again follows that n−1/2
∑n
i=1 U˜i(ψ
∗) is asymptotically
normally distributed with mean zero and finite variance. Finally, within 1 over root-
n shrinking neighbourhoods of zero (i.e. if ψ∗ = kn−1/2 for some constant k), the
remainder term in the Taylor series expansion is bounded in probability, but not
op(1). The significant contribution of the squared term
√
n{δˆ(ψ∗)− δ∗}2 implies that
n−1/2
∑n
i=1 U˜i(ψ
∗) may not converge to a normal distribution, nor to a mean zero
distribution along such sequences. The implications of this will be discussed in the
next paragraph.
To gain insight into the asymptotic distribution of ψ˜ (rather than its estimating
function), we make a further Taylor series expansion of the estimating functions,
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evaluated at ψ˜. This shows that for any fixed ψ
0 =
1√
n
n∑
i=1
P{δˆ(ψ) ∈ ∆}Uiψ(ψ, δ) + P{δˆ(ψ) /∈ ∆}Uiψ(ψ, 0) + op(1)−
[
P{δˆ(ψ) ∈ ∆}
+
{
ϕ
(
∆l − δ
σ(ψ)/(
√
n|ψ|)
)
− ϕ
(
∆u − δ
σ(ψ)/(
√
n|ψ|)
)} √
n|ψ|δ
σ(ψ)
]
E {dψ(R,X)R}
E {dδ(R,X)R}Uiδ(ψ, δ)
+
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P{δˆ(ψ) ∈ ∆}E
{
∂
∂ψ
Uψ(ψ, δ)
}
+ P{δˆ(ψ) /∈ ∆}E
{
∂
∂ψ
Uψ(ψ, 0)
}
+
{
ϕ
(
∆l − δ
σ(ψ)/(
√
n|ψ|)
)
− ϕ
(
∆u − δ
σ(ψ)/(
√
n|ψ|)
)} √
n|ψ|δ(∆l −∆u)
σ(ψ)
E {dψ(R,X)R}
−
[
P{δˆ(ψ) ∈ ∆}+
{
ϕ
(
∆l − δ
σ(ψ)/(
√
n|ψ|)
)
− ϕ
(
∆u − δ
σ(ψ)/(
√
n|ψ|)
)} √
n|ψ|δ
σ(ψ)
]
×E {dψ(R,X)R}
E {dδ(R,X)R}E {dδ(R,X)R(W − δ)}
)√
n(ψ˜ − ψ) (4.13)
That the remainder term converges to zero in probability for any fixed ψ can be seen
using a similar derivation as before. We conclude that, up to an op(1) term and for
fixed ψ,
√
n(ψ˜ − ψ) is a linear transformation of n−1/2∑ni=1 U˜i(ψ) and thus shares
its asymptotic properties. Specifically, within faster and slower than 1 over root-n
shrinking neighbourhoods of zero (and in particular at arbitrary fixed ψ),
√
n(ψ˜−ψ)
is asymptotically normally distributed with mean zero and finite variance under weak
regularity conditions. Within 1 over root-n neighbourhoods of zero,
√
n(ψ˜ − ψ) may
be asymptotically biased and not normally distributed.
Chapter 5
Comparison of Causal Effect
Estimators Under Exposure
Misclassification
Summary
Over the past decades, various principles for causal effect estimation have been
proposed, all differing in terms of how they adjust for measured confounders: either
via traditional regression adjustment, by adjusting for the expected exposure given
those confounders (e.g., the propensity score), or by inversely weighting each subject’s
data by the probability of the observed exposure, given those confounders. When
the exposure is measured with error, this raises the question whether these different
estimation strategies might be differently affected under the assumption of no unmea-
sured confounders. In this article, we investigate this by comparing inverse probability
of treatment weighted (IPTW) estimators and doubly robust estimators for the ex-
posure effect in linear marginal structural mean models (MSM) with G-estimators,
propensity score (PS) adjusted estimators and ordinary least squares (OLS) estima-
tors for the exposure effect in linear regression models. We find analytically that
these estimators are equally affected when exposure misclassification is independent
of the confounders, but not otherwise. Simulation studies reveal similar results for
time-varying exposures and when the model of interest includes a logistic link.
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1 Introduction
Measurement error in exposures is inevitable in many observational studies, in
particular when exposures are difficult to measure (e.g. individual exposure to pol-
lutants) or when risk behaviours such as condom use, diet, smoking, alcohol con-
sumption, etc. are obtained through self-report or questionnaires (Buonaccorsi et al.,
2005; Landin et al., 1995; Spiegelman et al., 2001). It forms a common source of bias
in estimates of exposure effects, in particular when those effects are confounded by
measured covariates (Budtz-Jørgensen et al., 2003). In view of this, a large literature
has come available on how to quantify the effects of exposure mismeasurement on ad-
justed regression coefficients (Buonaccorsi et al., 2005; Budtz-Jørgensen et al., 2003;
Veierod and Laake, 2001), and on how to correct for this when an accurate estimate
of the error variance or misclassification probability is known (Gustafson et al., 2001;
Carroll et al., 2006) or when sources of information on the measurement error (e.g.
from validation studies) are available (Lyles et al., 2007; Thu¨rigen et al., 2000).
Over the past decades, alternatives to ordinary regression adjustment for confounder
control have been proposed, based on adjustment for the propensity score (i.e. the
probability of being exposed, given measured background characteristics) (Rosen-
baum and Rubin, 1983; Rubin, 1997), and on inverse weighting by the probability
of the observed exposure, given measured background characteristics (Robins et al.,
2000). These strategies have mainly been introduced:
• because they work better in settings where there is little overlap in the distri-
bution of confounders between exposed and unexposed subjects (Rubin, 1997;
Lunceford and Davidian, 2004);
• because some allow correction for confounders which are intermediate on the
path from early exposure to outcome (Robins et al., 2000);
• and because they separate the modelling of confounders from the modelling of
treatment effects, thus being less vulnerable to data-driven presentation of the
most favorable treatment effect estimators (Moore and van der Laan, 2007).
To the best of our knowledge, the impact of exposure mismeasurement on such esti-
mators has not previously been investigated. The purpose of this paper is therefore
to explore and illustrate the consequences of exposure mismeasurement on these dif-
ferent methods for confounder control. Our interest in this is partly motivated by
the fact that some of the considered methods not only use the exposure as a covari-
ate in a regression model, but also rely on estimates of the expected exposure, given
background covariates, and may therefore be differently affected by measurement er-
ror. Throughout the paper, our focus will be on misclassification of dichotomous
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exposures because propensity score and IPTW methods were specifically designed
to analyze such exposures. We do not consider instrumental variables estimators on
which we report elsewhere (Vansteelandt and Goetghebeur, 2005; Vansteelandt et al.,
2007).
2 Estimating the causal effect of point-exposures
Consider a study whose goal is to estimate the causal effect of a binary exposure
(or dose) D (D = 1 if exposed, 0 if not) based on a random population sample.
Let Yd represent the potential outcome which a subject would have had if, possibly
contrary to fact, the exposure D were set to d (Rubin, 1974). The expected contrast
β∗ = E(Y1−Y0) then defines the average causal effect of exposure on outcome. Assume
that for each subject we either obtain Y0 = Y (when D = 0) or Y1 = Y (when D = 1).
Suppose furthermore that all confoundersX for the association betweenD and Y have
been accurately measured, so that the no unmeasured confounders assumption
D ⊥⊥ Yd|X (5.1)
for d = 0, 1 holds. Then β∗ may be evaluated under the following semiparametric
model,
E(Yd|X) = β∗d+ g(X) (5.2)
where g(X) is a unknown function of the covariates X. Note that this model has
a parametric component β∗d and a nonparametric component g(X) (Robins et al.,
1992). Alternatively, β∗ can be estimated by fitting the marginal structural mean
model (MSM),
E(Yd) = β
∗d+ α∗ (5.3)
where α∗ = E{g(X)}. Note that model (5.2) is more restrictive than model (5.3)
because it assumes that the exposure effect is not modified by the given covariates X.
Model (5.3) may therefore be of greater interest in settings where there is no specific
interest in effect modification.
Inference for β∗ in models (5.2) and (5.3) has been extensively described (see
e.g. Robins et al., 2000 and 1992) and different estimators for β∗ in these models
have been proposed. Due to curse of dimensionality, these estimators rely on correct
specification of certain working models:
• Some postulate a model for the conditional association g(X) between Y and X,
given D. For example, standard OLS estimators are obtained by assuming a
parametric working model g(X) = α∗+δ∗X (with (α∗, δ∗) unknown) at the risk
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of finding biased causal effect estimators when this model is misspecified and at
the risk of extrapolation when the distribution of X has little overlap between
exposed and unexposed subjects (Rubin, 1997; Lunceford and Davidian, 2004).
• Some rely on a model for the marginal distribution of D, given X (e.g. the
IPTW estimator of Section 2.1). As such, they may avoid explicit regression
extrapolation and be more reliable in settings where the investigator has better
a priori knowledge of the association between exposure and confounders, than
about the association between outcome and confounders.
• Finally, so-called doubly robust estimators of β∗ assume correct specification of
at least one of these 2 working models, but not necessarily both (e.g. the doubly
robust IPTW estimator of Section 2.1 or the G-estimator of Section 2.2). The
latter estimators are therefore more robust to misspecification of the working
models.
In the following sections, we briefly review these different estimators, assuming that we
have available a random sample of measurements (Yi,Di,Xi) for independent subjects
i = 1, ..., n. In Section 3, we then examine the impact of exposure misclassification
on these estimators.
2.1 (Doubly robust) IPTW estimation
Estimates for the parameter β∗ in model (5.3) can be obtained by IPTW estima-
tion; that is, by fitting a linear regression model for Y on D where the contribution of
each subject i is weighted by 1 over the probability of that subject’s observed exposure
given the confounders X. Indeed, the impact of inverse weighting by the probability
P (D|X) is to remove the association between D and X (while leaving the causal ef-
fect unchanged), thus eliminating the need to control for X. IPTW estimation under
model (5.3) thus proceeds by solving the weighted regression equation
n∑
i=1
UiI(α, β) =
n∑
i=1
(
1
Di
)
1
P (Di|Xi) (Yi − α− βDi) = 0 (5.4)
for (α, β), where index I stands for IPTW estimator. In practice, the probabilities
P (Di|Xi) are unknown and must be estimated. Because D is a dichotomous exposure,
this may be done by fitting the logistic regression model
P (Di = 1|Xi; θ) = expit (θ0 + θ1Xi) (5.5)
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for P (Di = 1|Xi), where expit(z) = ez/(1 + ez). Estimation thus proceeds in two
stages: first estimate θ in model (5.5); next, solve (5.4) using the fitted values from
model (5.5) to obtain an estimate for β∗. A drawback of IPTW estimators is that
they can be quite unstable and inefficient when confounding is severe. This is because
the probabilities P (Di|Xi) are then typically small for some individuals, who thus re-
ceive a large weight in the analysis, and may become influential. Doubly robust (DR)
estimators (van der Laan and Robins, 2002; Yu and van der Laan, 2003) alleviate this
problem by allowing misspecification of the inverse weights 1/P (Di|Xi), provided that
a conditional mean model for E(Yi|Di,Xi) holds. As a result, they allow truncation of
extreme weights (Yu and van der Laan, 2003). These estimators have the added ad-
vantage of being efficient under the model defined by (5.3) and (5.5) when in addition
to these models, the conditional mean E(Yi|Di,Xi) is correctly specified.
In practice, doubly robust estimator can be obtained by solving an estimating
equation of the form
n∑
i=0
UiD(α, β) =
n∑
i=1
[(
1
Di
)
Yi − E(Yi|Di,Xi)
P (Di|Xi)
+
1∑
d=0
(
1
d
)
{E(Yi|Di = d,Xi)− α− βd}
]
= 0 (5.6)
where index D stands for doubly robust estimator. Here P (Di|Xi) and E(Yi|Di,Xi)
are unknown, but can be estimated by fitting a model P (Di|Xi; θ) for P (Di|Xi) as
in the previous paragraph and a model E(Yi|Di,Xi; γ) for E(Yi|Di,Xi), for example
E(Yi|Di,Xi; γ) = γ0 + γ1Di + γ2Xi. (5.7)
Estimation then proceeds in three stages: first obtain an estimate θˆ of θ in model
(5.5); then, obtain an estimate γˆ of γ in model (5.7); finally, solve (5.6) using fitted
values from models (5.5) and (5.7) to obtain an estimate
βˆD =
1
n
n∑
i=1
(2Di − 1)Yi − E(Yi|Di,Xi; γˆ)
P (Di|Xi; θˆ)
+ γˆ1 (5.8)
for β∗. The above methods continue to work for logistic MSMs for a binary outcome
P (Yd = 1) = expit (α
∗ + β∗d) (5.9)
upon substituting α∗ + β∗d in the above estimating equations with expit(α∗ + β∗d).
Note that, due to noncollapsibility of the odds ratio, the parameter β∗ in model (5.9)
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differs from the corresponding parameter β∗∗ in model
P (Yd = 1|X) = expit {g(X) + β∗∗d} (5.10)
which can be estimated via traditional logistic regression under a parametric work-
ing model for g(X). Because different studies typically adjust for different sets of
covariates X, it follows that estimates of β∗ are better comparable between studies
(and may thus be of greater interest) than estimates of β∗∗ (Moore and van der Laan,
2007).
2.2 G-estimation and propensity score adjustment
Estimates for the parameters β∗ indexing model (5.2) may be obtained via G-
estimation (Robins et al., 1992; Brumback et al., 2003). The principle is that after
subtracting the causal effect β∗D from the outcome, the resulting ‘treatment-free
outcome’ Y − β∗D should be conditionally mean independent of D, given X, by the
no unmeasured confounders assumption (5.1). One may thus estimate β∗ as the value
for which this conditional independence holds in the observed data set; that is, by
solving
n∑
i=1
UiG(β) =
n∑
i=1
{Di − E(Di|Xi)} [Yi − E(Yi|Xi)− β {Di − E(Di|Xi)}] = 0 (5.11)
where index G stands for G-estimator. This is equivalent to fitting the linear model
E(Yi|Di,Xi; γ, β) = γ0 + γ1Xi + β {Di − E(Di|Xi)} (5.12)
or
E(Yi|Di,Xi; γ, β) = γ0 + γ1Xi + γ2E(Di|Xi) + βDi (5.13)
and is thus equivalent to regression adjustment for the propensity score in linear
models. This is because (5.11) is the projection of the score for β in models (5.12)
and (5.13) onto the orthocomplement for the tangent space of the parameters γ0, γ1
(and γ2) (Bickel et al., 1993). Here, E(Di|Xi) is unknown, but can be estimated by
fitting a model E(Di|Xi; θ) for E(Di|Xi). Estimation thus proceeds in two stages:
first estimate θ in model (5.5); then, fit model (5.12). The resulting estimator has
the attractive property of being doubly robust in the sense that, βˆG is a consistent
estimator of β∗ when either working model E(Di|Xi; θ) or the model for E(Yi|Xi) (i.e.
E(Yi|Xi) = γ∗0 + γ∗1Xi for unknown parameters γ∗0 , γ∗1 in model (5.12)) is correctly
specified (Robins et al., 1992). G-estimation has no immediate extensions to logistic
regression models for a dichotomous outcome (Robins et al., 1992), but traditional
regression adjustment for the propensity score P (Di = 1|Xi) remains valid in such
models.
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3 The impact of point-exposure misclassification
In this section, we study the impact of exposure misclassification on the previous
causal effect estimators. Specifically, suppose that instead of D, we observe an error-
prone version W . Then our goal is to quantify the asymptotic bias due to exposure
misclassification on each of the above effect estimators when the exposure misclas-
sification probabilities are known. Intuitively, one would expect that the different
estimators will be differently affected by measurement error. Indeed, OLS estimators
merely rely on a conditional mean model for the outcome, which involves the error-
prone exposure. In contrast, IPTW estimators may be affected by misclassification
in 2 manners: (a) through estimation of the inverse weights; and (b) by substitut-
ing W for D in model (5.3) or model (5.9). Likewise, G-estimators and propensity
score adjusted estimators may be affected by misclassification through estimation of
the conditional probabilities P (D|X), but could potentially be less affected than the
IPTW estimators by avoiding inverse weighting.
3.1 Asymptotic bias
Throughout, we measure the degree of misclassification in terms of the conditional
probabilities πd|w,X = P (D = d|W = w,X). Here, the probability π1|1,X = P (D =
1|W = 1,X) expresses how likely it is for someone who is classified as exposed with
covariates level X to be truly exposed, and likewise, π0|0,X = P (D = 0|W = 0,X)
expresses how likely it is for someone who is classified as unexposed with covariates
level X to be truly unexposed. In line with Buonaccorsi et al. (2005), we call π0|0,X
and π1|1,X reclassification probabilities. Note that it is more common to measure
misclassification in terms of the probabilities P (W = w|D = d,X) (Buonaccorsi et al.,
2005; Veierod and Laake, 2001; Gustafson et al., 2001). Our reason not to adopt this
more common definition is that IPTW estimators and G-estimators rely on a working
model for P (W |X). Given that W and X are jointly observed on each subject it
is more natural to assume the model for P (W |X) to be correctly specified and, in
addition, to assume knowledge about the probabilities P (D|W,X). Throughout this
article, we assume non-differential misclassification of the exposure in the sense that
among subjects with the same level of the measured confounder X, misclassification
happens independently of the (potential) outcome; i.e. Yd ⊥⊥W |D,X for d = 0, 1.
In the Appendix, we derive the bias of the (DR) IPTW estimator, the G-estimator
and the OLS estimator due to misclassification under the linear models (5.2) and (5.3).
This is done by calculating the limiting values α and β that solve the expected (i.e.
limiting) estimating equation corresponding to these estimators. For instance, for the
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IPTW estimator, we solve
E{UiI(α, β)} =
1∑
wi=0
1∑
di=0
(
1
wi
)
E[πdi|wi,Xi{E(Yidi |Xi)− α− βwi}] = 0.
Comparing the solution α and β with the true values α∗ and β∗ in model (5.3) reveals
that
β = β∗ + E(π1|1,X + π0|0,X − 2)β∗, (5.14)
α = α∗ + E(1− π0|0,X)β∗. (5.15)
The asymptotic bias of the naive IPTW estimator of β∗ thus equals
E(π1|1,X + π0|0,X − 2)β∗ (5.16)
or, when the reclassification probabilities do not depend on X, equals (π1|1 + π0|0 −
2)β∗. These expressions hold regardless of the choice of index functions (1 Wi) in (5.4)
with Di replaced by Wi. As shown in the Appendix, the DR IPTW estimator has the
same asymptotic bias. In contrast, the asymptotic bias of the G-estimator and the
OLS estimator additionally depends on the correlation between the exposure variance
σ2W |X ≡ var(W |X) and the reclassification probabilities π1|1,X , π0|0,X . Specifically,
the asymptotic bias of the G-estimator of β∗ is{
cov(σ2W |X , π1|1,X + π0|0,X)
E(σ2W |X)
+ E(π1|1,X + π0|0,X − 2)
}
β∗ (5.17)
and the asymptotic bias of the OLS estimator is
cov
[
σ2W |X + {P (W = 1|X)− E∗(W |X)}2 , π1|1,X + π0|0,X
]
E
[
σ2W |X + {P (W = 1|X)− E∗(W |X)}
2
] (5.18)
+E(π1|1,X + π0|0,X − 2)
)
β∗
(see the Appendix), where E∗(W |X) is the fitted value from a linear regression of W
on X. We conclude that the four considered estimators of the exposure effect of β∗
are biased when the exposure D is subject to misclassification and the exposure effect
differs from 0. Remarkably, they are equally affected by misclassification under linear
models if misclassification does not depend on the confoundersX used for adjustment.
In Section 3.2, we interpret the above bias expressions in more detail and investigate
to what extent the bias may differ between the estimators when misclassification
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depends on X. Finally, note that, for each of the estimators, tests of no exposure
effect are valid in the presence of misclassification error (in the sense of preserving
the nominal Type I error rate) because the bias expressions (5.16), (5.17) and (5.18)
are zero under null hypothesis that β∗ = 0, but that they may be less powerful than
in the absence of error.
3.2 Simulation study
To investigate the bias of the 4 considered estimators in finite samples, we con-
ducted a simulation experiment. Data were simulated to mimick the birth weight
study reported in Hosmer and Lemeshow (2000) with Y representing birth weight, D
maternal smoking status during pregnancy and X a confounder score based on ma-
ternal age, weight at last menstrual period, race and history of hypertension. Each
experiment was based on 1000 replications of random samples of size 189. In each ex-
periment, the covariate X was normally distributed with mean µX=3.09 and standard
deviation σX=0.32. The observed exposure W and true exposure D were generated
to be dichotomous with P (W = 1|X) = expit(θ0+ θ1X) where θ1 = 0.84 is estimated
from the birth weight data and P (D = 1|W,X) = Wπ1|1,X + (1 −W )(1 − π0|0,X)
with π1|1,X = π0|0,X = expit(η0 + η1X). The outcome was chosen to be normally
distributed with mean β∗D +X, β∗ = −0.36 and constant standard deviation 0.65,
as estimated from the birth weight data.
Table 5.1 summarizes the results for different choices of the confounder-exposure asso-
ciation, ORW |X = exp(θ1), the exposure mean E(W ), the dependence η1 of misclassi-
fication on X, the average reclassification probability E(π1|1,X), the correlation ρ1 be-
tween σ2W |X and π1|1,X and the correlation ρ2 between σ
2
W |X+{E(W |X)−E∗(W |X)}2
and π1|1,X (see expressions (5.17) and (5.18), respectively). Specifically, we consid-
ered the following cases: θ1 equal to 0.84, 1.68 and −0.84, E(W ) equal to 0.40 and
0.6, η1 = 1/σX = 3.15 for the case where π1|1,X increases with X, η1 = 0 when
misclassification does not depend on covariates X, and η1 = −1/σX = −3.15 for the
case where π1|1,X decreases with X, and finally E(π1|1,X) equal to 0.80 and 0.90.
As predicted by the theory, all 4 estimators have the same bias when misclassification
does not depend on covariates (see the case where η1 = 0 in Table 5.1). By noting
that π1|1,X = π0|0,X under our simulations, it follows from expressions (5.14) and
(5.17) that the ratio of the bias of the G-estimator versus the (DR) IPTW estimator
is
BiasG
Bias(DR)IPTW
=
cov(σ2W |X , π1|1,X)
E(σ2W |X)E(π1|1,X − 1)
+ 1.
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Therefore, the G-estimator is asymptotically less biased than the (DR) IPTW esti-
mator when cov(σ2W |X , π1|1,X) ≥ 0 (and thus the negative numerator in the above
expression is larger than the negative denominator). This is the case if σ2W |X and
π1|1,X are both increasing or both decreasing functions of X. It follows from the
derivative of σ2W |X with respect to X,
∂σ2W |X
∂X
=
∂
∂X
P (W = 1|X){1− P (W = 1|X)}
= θ1µW |X(1− µW |X)(1− 2µW |X),
that σ2W |X increases with X when the average exposure, µW |X ≡ P (W = 1|X), is less
than 50% and the confounder and exposure have a positive association (i.e. θ1 > 0).
Likewise, π1|1,X = expit(η0 + η1X) is increasing in X when η1 > 0. It follows that
the G-estimator is less biased than the (DR) IPTW estimator when the confounder-
exposure association is positive (negative), the average exposure is less (more) than
50%, and the reclassification probabilities increase (decrease) with X. They are more
biased otherwise. Note that these theoretical findings are also reflected in the sim-
ulation results. The earlier expressions for the asymptotic bias become intractable
when logistic regression models for a dichotomous outcome are considered. We will
therefore additionally evaluate the impact of exposure misclassification under logistic
regression models by simulation. Each experiment was based on 1000 replications
of a random sample in which the observed exposure W and true exposure D were
generated as above. The covariate X was standard normally distributed. The out-
come Y was generated to be binary with P (Y = 1|D,X) = expit(α + 2D + X).
In each simulation experiment, α was chosen such that the outcome mean is 50%,
in order to ensure the precision of the estimators to be comparable over the differ-
ent experiments. The different simulation experiments are characterized by different
choices of the confounder-exposure association, ORW |X = exp(θ1), of the exposure
mean E(W ) and of the average reclassification probability E(π1|1,X) = E(π0|0,X),
with varying dependence η1 of misclassification on covariates X. Figure 1 shows the
relative asymptotic bias of the ordinary maximum likelihood estimator under model
(5.10) with g(X) = α∗ + δ∗X, the propensity score adjusted estimator (Lunceford
and Davidian, 2004), the IPTW estimator and the DR IPTW estimators. Remember
that the propensity score adjusted estimator and the IPTW estimator converge to
different limiting values because the interpretation of logistic regression parameters
changes depending on the covariates included in the model. Specifically, the true
causal effect in the marginal structural model (i.e. the causal odds ratio) is equal to
β∗MSM = log odds(Y1 = 1) − log odds(Y0 = 1) with P (Yd = d) =
∫
P (Yd = 1|X =
x)fX(x)dx with d = 0, 1 and fX(x) the density of X, evaluated at x. Because the
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Table 5.1: Coverage of 95% confidence intervals for β∗ and relative bias
E{(βˆ − β∗)/β∗} for 4 considered estimators in function of the confounder-exposure
association ORW |X , the mean E(W ) of the observed exposure, the dependence η1 of
misclassification on X, the average reclassification probability E(π1|1,X), the corre-
lation ρ1 between σ
2
W |X and π1|1,X (see expression (5.17)) and the correlation ρ2
between σ2W |X + (P (W = 1|X)− E∗(W |X))2 and π1|1,X (see expression (5.18)).
Coverage Relative Bias×103
ORW |X E(W ) η1 E(pi1|1,X ) ρ1 ρ2 OLS G IPTW DR OLS G IPTW DR
3.15 0.80 0.99 0.99 10.7 10.7 12.5 8.3 -376 -376 -393 -393
0.90 0.98 0.98 67.5 67.1 72.2 63.3 -183 -183 -194 -194
0.40 0 0.80 0.00 0.00 7.4 7.3 10.2 7.6 -407 -407 -407 -407
0.90 0.00 0.00 57.7 57.3 65.8 57.6 -210 -210 -210 -210
-3.15 0.80 -0.77 -0.78 7.9 7.7 15.0 10.5 -412 -412 -399 -399
0.90 -0.68 -0.67 59.9 60.1 69.5 62.5 -207 -207 -200 -200
2.31
3.15 0.80 -0.77 -0.77 8.4 8.4 15.7 10.0 -398 -398 -386 -386
0.90 -0.68 -0.68 61.6 61.9 72.1 64.5 -199 -199 -192 -192
0.60 0 0.80 0.00 0.00 8.9 8.7 14.5 9.1 -391 -391 -391 -391
0.90 0.00 0.00 61.3 61.1 69.6 61.3 -196 -196 -196 -196
-31.5 0.80 0.99 0.99 12.0 12.1 13.7 9.7 -375 -375 -392 -391
0.90 0.98 0.98 66.4 66.1 70.7 62.2 -186 -187 -197 -197
3.15 0.80 0.93 0.93 15.2 14.6 13.5 10.1 -361 -363 -395 -395
0.90 0.93 0.93 69.6 68.7 71.5 64.4 -176 -177 -199 -198
0.40 0 0.80 0.00 0.00 8.4 8.7 15.0 9.7 -395 -395 -395 -395
0.90 0.00 0.00 62.3 62.4 72.2 63.0 -197 -197 -197 -197
-3.15 0.80 -0.52 -0.52 8.4 8.4 16.3 10.8 -413 -412 -393 -393
0.90 -0.41 -0.41 58.1 57.9 72.8 61.6 -210 -210 -202 -202
5.34
3.15 0.80 -0.53 -0.53 8.0 8.2 16.4 11.6 -409 -408 -390 -389
0.90 -0.42 -0.42 58.7 58.7 70.3 60.8 -210 -209 -201 -201
0.60 0 0.80 0.00 0.00 7.8 7.4 14.1 7.8 -404 -404 -404 -404
0.90 0.00 0.00 63.0 62.6 72.4 63.6 -197 -197 -197 -197
-3.15 0.80 0.93 0.93 16.8 16.2 16.4 11.1 -357 -359 -392 -391
0.90 0.95 0.94 70.6 69.6 71.5 64.4 -173 -175 -196 -196
3.15 0.80 -0.77 -0.77 7.2 7.1 12.9 8.7 -412 -411 -399 -399
0.90 0.68 0.68 59.1 59.0 70.4 62.4 -205 -205 -197 -197
0.40 0 0.80 0.00 0.00 8.4 8.3 12.5 9.0 -396 -396 -396 -396
0.90 0.00 0.00 60.6 60.7 67.2 60.8 -201 -201 -201 -201
-3.15 0.80 0.99 0.99 11.3 11.3 12.8 7.8 -377 -377 -394 -394
0.90 0.98 0.98 63.5 63.2 69.1 60.3 -189 -189 -200 -200
0.43
3.15 0.80 0.99 0.99 10.0 9.9 12.2 7.8 -383 -384 -400 -400
0.90 0.99 0.98 64.6 64.1 69.4 61.9 -186 -186 -196 -196
0.60 0 0.80 0.00 0.00 7.6 7.6 11.0 7.6 -403 -403 -403 -403
0.90 0.00 0.00 64.3 64.3 72.6 64.4 -191 -191 -191 -191
-3.15 0.80 -0.75 -0.75 8.4 8.3 14.3 10.8 -400 -400 -388 -388
0.90 -0.66 -0.66 62.5 62.1 72.2 63.9 -196 -196 -190 -190
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Figure 1: Relative bias E{(βˆ − β∗)/β∗} as a function of the average reclassification
probability E(π1|1,X) = E(π0|0,X): Solid line is for the OLS estimator, segmented line
is for the IPTW estimator, dotted line is for the DR IPTW estimator and dashed line
is for the propensity score adjusted estimator. The confounder-exposure association
equals ORWX = 4.48 in column 1, 2.72 in column 2 and 0.22 in column 3. The
dependence η1 of misclassification on X equals 1 in row 1, 0 in row 2 and −1 in row
3. The correlation Cor(π1|1,X ,X) varies from 0.98 to 0 as E(π1|1,X) changes from
0.65 to 1.00 in row 1, equals zero in row 2, and varies from −0.98 to 0 as E(π1|1,X)
changes from 0.65 to 1.00 in row 3. For all scenarios E(W ) = 0.80 and E(Y ) = 0.50.
4 Estimating the causal effect of time-varying exposures 155
true causal effect estimands differ between the different estimation methods, we will
also present the relative bias of the estimators, defined as the ratio of their asymptotic
bias to the true causal effect. Figure 1 shows results for 3 cases where π1|1,X increases
with X (row 1), where misclassification does not depend on covariates (row 2) and
where it decreases with X (row 3). It shows the relative bias of the 4 estimators
versus the average reclassification probabilities for 9 considered scenarios. Note, in
line with the results for linear models, that the propensity score adjusted estimator is
more (less) biased than the (DR) IPTW estimator when π1|1,X increases (decreases)
with X, E(W ) > 0.5 and the confounder-exposure association is positive (and vice
versa when the confounder-exposure association is negative).
4 Estimating the causal effect of time-varying ex-
posures
Consider now a longitudinal study whose goal is to estimate the causal effect of a
time-varying all-or-nothing exposure Dit on outcome Yit at study cycles t = 0, . . . , T
for each of i = 1, . . . , n independent subjects. For any fixed, non-random treatment
history dt = (d1, . . . , dt), let Ytdt be the potential outcome which a subject would have
had at time t if, possibly contrary to fact, the exposure history Dt = (D1, ...,Dt) were
set to dt through time t. For each possible history dt at time t, we assume a subject’s
response Ytdt is well defined and would be observed when dt = Dt. Suppose again that
at each time t, the entire confounder history Xt = (X1, . . . ,Xt) for the association
between Yt and Dt has been measured, in the sense that for each s and t with s ≤ t,
Ytdt
∐
Ds|Ds−1 = ds−1,Xs (5.19)
for all histories dt (i.e. the no unmeasured confounders assumption). Then we may
obtain an estimate for the causal effect of Dt on Yt at time t by fitting the structural
mean model
E{Ytdt − Yt(dt−1,0)|Dt = dt,Xt} = β∗dt (5.20)
for all t. This model is similar to the structural nested models of Robins (Robins,
1999), but is less restrictive because it merely specifies the effect of the last exposures
and not the effect of earlier exposures. It is therefore mainly of interest in settings
where no long-term exposure effects are anticipated. For instance, Dt could indicate
condom use at time t and Yt the resulting HIV status at that time. Additionally, our
interest in such models is motivated by the fact that they can be fitted via standard
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software. Alternatively, one may develop insight into the causal effect of exposure on
outcome by fitting a marginal structural model (Robins, 1999 and 1986); e.g.
E(Ytdt) = α
∗
t + β
∗dt. (5.21)
Note that model (5.21) postulates only the last exposure dt to have an effect on
the outcome at time t. In that sense, this model is more restrictive than model
(5.20), which makes no assumptions about the effect of early exposures. It is thus not
surprising that model (5.20) with the additional restriction that there is not effect of
early exposures; that is
E{Ytds − Yt(ds−1,0)|Ds = ds,Xs} = 0
for all s < t, implies model (5.21). In contrast, when early exposures themselves affect
the outcome, on must extend model (5.21) by explicitly parameterizing these effects;
for instance, by fitting model
E(Ytdt) = α
∗
t + β
∗
1dt + β
∗
2
t−1∑
s=1
ds. (5.22)
Standard regression approaches for longitudinal data are unable to adjust for time-
varying confounders, and thus unable to fit models (5.21) and (5.22), even when all
the relevant time-varying confounders have been measured (Robins, 1999 and 1986;
Herna´n et al., 2002). This is because standard regression approaches ignore that
the exposure and time-varying confounders may mutually influence each other over
time. Specifically, exposure and outcome in longitudinal studies may be influenced by
previous exposures and outcomes and possibly also by other time-varying confounders
which may be intermediate on the causal path from the exposure to the outcome
(Robins, 1999 and 1986). In this section, we briefly review IPTW estimation of
the causal parameters indexing the marginal structural model (5.21) and likewise
model model (5.22). In addition, we introduce G-estimators for the causal parameters
indexing the structural mean model (5.20), which can be obtained with standard
software. In Section 5, we then examine the impact of exposure misclassification on
these estimators.
4.1 IPTW estimator
Estimates for β∗ in model (5.21) may be obtained by extending the IPTW ap-
proach of Section 2.1 to time-varying exposures, as discussed in (Robins et al., 2000;
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Robins, 1999). Specifically, they may be obtained by fitting the sequential conditional
mean model
E(Yt|Dt) = α∗t + β∗Dt
for t = 1, . . . , T using generalized estimating equations (GEE) with independence
working correlation (see Vansteelandt, 2007, for more efficient estimation approaches),
where the contribution of each subject i’s data at time t is weighted by
SWit =
t∏
s=1
P (Dis|Di,s−1)
P (Dis|Di,s−1,Xis)
. (5.23)
Assuming that α∗t = α
(0)∗ + α(1)∗t for illustration, IPTW estimation thus proceeds
by solving the following estimating equation for β
n∑
i=1
UIit(α
(0), α(1), β) =
n∑
i=1
T∑
t=1

 1t
Dit

SWit (Yit − α(0) − α(1)t− βDit) = 0.
(5.24)
In (5.23), the denominator represents the probability that subject i follows his/her
own exposure history, given the history of time-varying confounders. As the denomi-
nator probabilities are unknown, they may be estimated by fitting logistic regression
models for the observed exposure Dt at each time t, given Dt−1 and Xt. When the
exposure regime is monotone (i.e., when Dt = 0 implies Ds = 0 for all s > t), this
may happen by fitting a logistic regression model of the form
P (Dit = 1|Dit−1 = 1,Xit; θ) = expit (θ0 + θ1t+ θ2Xit) (5.25)
for t = 1, ..., T . Likewise, the numerator represents the unconditional probability that
subject i follows his/her own exposure history and (for monotone regimes) may be
estimated by fitting a logistic regression model of the form
P (Dit = 1|Dit−1 = 1;φ) = expit (φ0 + φ1t) (5.26)
for t = 1, ..., T . The denominator weights ensure that after inverse weighting, there
is no association between Ds and Xs for s = 1, ..., t at each time t, so that there are
no further time-varying confounders. Correct specification of the regression models
corresponding to these weights is henceforth important. The numerator weights are
used to improve the finite-sample performance of the IPTW estimator, which may be
poor when the denominator probabilities are small for some subjects. Misspecification
of these numerator weights does not affect the validity of the approach.
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4.2 G-estimator
Estimates for the causal parameters β∗ in model (5.20) may be obtained by re-
peating the two-step G-estimation procedure of Section 2.2 at each time point in the
study. Specifically, model (5.20) implies
E{Yt − β∗Dt|Dt,Xt} = E{Yt(Dt−1,0)|Dt,Xt} = E{Yt(Dt−1,0)|Dt−1,Xt} (5.27)
where the last equality follows from the no unmeasured confounders assumption
(5.19). It then follows from (5.27) that
E
[{Dt − E(Dt|Dt−1,Xt)} {Yt − β∗(Dt − E(Dt|Dt−1,Xt))− gt(Dt−1,Xt)}] = 0
for each function gt(Dt−1,Xt) of the past exposure history Dt−1 and covariate history
Xt. Summing this over all time points yields an unbiased estimating equation for β
∗:
0 =
n∑
i=1
UGi(β) =
n∑
i=1
T∑
t=1
{
Dit − E(Dit|Di,t−1,Xit)
}
×[Yit − β(Dit − E(Dit|Di,t−1,Xit))− (5.28)
gt(Di,t−1,Xit)]
where D0 = 0. Choosing
gt(Di,t−1,Xit) = E(Yit|Di,t−1,Xit)
yields an estimating equation which is unbiased when at each time t, either the
working model for E(Dit|Di,t−1,Xit) is correctly specified, or the working model
for E(Yit|Di,t−1,Xit). Estimators which are consistent and asymptotically normally
distributed when at each time t = 1, ..., T one of these 2 working models is cor-
rectly specified, are referred to as 2T multiply-robust estimators (Vansteelandt et al.,
2007). Solving (5.29) with gt(Di,t−1,Xit) = γ∗0+γ
∗
1 t+γ
∗
2Xit for unknown parameters
γ∗0 , γ
∗
1 , γ
∗
2 is equivalent to fitting the sequential conditional mean model
E{Yit|Dit,Xit; γ0, γ1, γ2, β} = γ0+ γ1t+ γ2Xit+β{Dit−E(Dit|Dit−1,Xit)}. (5.29)
The parameters in this model can be estimated using standard software by solving
independence generalized estimating equations (GEE) (see Vansteelandt, 2007, for
more efficient estimation approaches).
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5 The impact of time-varying exposure misclassifi-
cation
In longitudinal repeated measures data, reclassification probabilities of time-varying
exposures at each time t should be formulated in function of the true and observed
exposure history and in function of the history of time-varying confounders. That is,
at each time t, we must postulate the reclassification probabilities as
P (Dt = dt|Wt = wt,Dt−1,W t−1,Xt).
In practice, because little information is typically available about these probabili-
ties, we will assume for simplicity that time-varying reclassification probabilities are
independent of covariates. In addition, as is common in analyses of time-varying
exposures (Dawson and Lavori, 2002), we will consider monotone exposure regimes.
Further assuming that misclassification does not depend on the history of true or
observed exposure, we thus find that the reclassification probabilities at each time t
equal
P (Dt = dt|Wt = wt,Dt−1,W t−1,Xt) =
{
πdt|wt if Dt−1 = 1
I(dt = 0) if Dt−1 = 0
(5.30)
where I(dt = 0) is 1 if dt = 0 and 0 otherwise. Specifically, reclassification probabil-
ities can be expressed P (Dt = 1|Dt−1 = 1,W t = 1,Xt) = π1|1 and P (Dt = 0|Wt =
0,Dt−1 = 1,W t−1,Xt) = π0|0. It also follows that P (Dt = 0|W t,Dt−1 = 0,Xt) = 1.
As in the previous section, we will assume that misclassification is non-differential
in the sense that Ytdt
∐
Wt|Dt,W t−1,Xt for each t = 1, . . . , T and for all possible
exposure histories dt. This assumption states that the degree of misclassification is
independent of the outcome at each time t.
To obtain the asymptotic bias of the IPTW estimator of Section 4.1 and the G-
estimator of Section 4.2 with Dt replaced by Wt, we calculated the limiting value of β
that solves the corresponding expected estimating equation. The latter involves the
conditional distribution of Xt given Dt−1,Xt−1 and Xt given Xt−1 in a complex way,
which is difficult to estimate well in practice because of its possible high dimension-
ality. We will therefore report simulation studies to investigate the asymptotic bias
of both estimators.
In each of 1000 simulation runs, time-varying covariates Xt were generated as
Xt = ρXt−1I(t > 1) +Dt−1I(t > 1) +N(0, σ2)I(t = 1) where the autocorrelation ρ
was chosen to equal (σ2−1)/σ2, such that the variance of Xt is constant at each time
t. The time-varying observed exposures Wt and true exposures Dt were generated to
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be binary with P (Wt = 1|Xt,W t−1,Dt−1) = expit(θ0 + 0.03t + θ2Xt) and P (Dt =
1|Xt,W t,Dt−1) =Wtπ11+(1−Wt)(1−π00). Time-varying outcomes were generated
as Yt = −1.5 + 1.5t + γXt + β∗Dt + N(0, 1) with β∗ = 2. Note that both the no
unmeasured confounders asumption (5.19) and the non-differential misclassification
assumption hold under our simulations.
In all simulations, we fitted the following model
E(Ytdt) = α0 + α1t+
t−1∑
k=1
αk+1dk + βdt (5.31)
for the IPTW estimator by using the corresponding linear regression model with
stabilized weights. It can be shown that this model is correctly specified under the
data-generating mechanism of our simulation experiment, with β = 2. When fitting
this model, we used a stepwise model building approach to select appropriate past
exposure histories to be included in the model at each time t. Further, the following
correctly-specified model
E(Yt|Dt,Xt) = α0 + α1t+ γXt + β(Dt − E(Dt|Dt−1,Xt)) (5.32)
was fitted using ordinary generalized estimating equations (GEE) (Liang and Zeger,
1986) with independence working correlation to obtain the G-estimator. We have
carried out different simulations by various choices of (θ2, γ, ρ). Here, θ2 measures
the strength of the association between confounders and exposures, with ORWt|Xt =
exp(θ2). Further, γ measures the strength of the association between confounders
and outcome, and ρ is the autocorrelation of Xt at each time t = 1, ..., 10. Simulation
studies are repeated for 6 choices of the parameter values, listed in Table 5.2. In each
scenario, θ0 was selected to keep the mean value of Wt approximately fixed over the
different time points t = 1, ..., 10 (see Table 5.2). Figure 2 shows the relative bias
E{(βˆt − β∗)/β∗} of the IPTW estimator and the G-estimator versus the end-of-study
time t when the association between outcomes and covariates is γ = 1. The figure
considers 3 cases with reclassification probabilities π0|0 = π1|1 equal to 1, 0.9 and 0.8,
as well as various cases of confounder-exposure association and correlation between
Xt and Xt+1 at each time t. Note that we also show results for the unadjusted esti-
mator (i.e. the IPTW estimator with weights set to 1) so as to illustrate the degree
of confounding bias in each simulation. Figure 2 shows that the IPTW estimator and
the G-estimator are equally affected by misclassification error when the confounder-
exposure association θ2 is equal to 0.5 and 1 (left 4 panels). When this association
becomes severe (θ2 = 2), the G-estimator becomes significantly less biased than the
IPTW estimator. This is because the weights in the IPTW estimator are then more
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variable so that the IPTW estimator has greater finite sample bias, even in the ab-
sence of measurement error. This increased variability of the weights is displayed in
Table 5.2, where we show the empirical ratio P0.975/P0.025 of the 97.5th and 2.5th
percentile of the distribution of the stabilized weights SW (t) over all time points
t = 1, ..., 10. We also found the discrepancies between the IPTW-estimator and the
G-estimator to be slightly increased with higher autocorrelation. This is because this
higher autocorrelation leads to less information and thus an IPTW estimator which
is slightly more biased in finite samples. Finally, Figure 3 shows the relative standard
deviation SD(βˆt)/β
∗ of the different estimators and suggests the increased efficiency
of the G-estimator over the IPTW estimator at each time.
Table 5.2: Simulation set-up: parameters, ratio of the 97.5th and 2.5th percentile of
the stabilized weight distribution and mean value of Wt at time t = 1 and t = 10.
(θ2, γ, ρ) (
P1,0.975
P1,0.025
,
P10,0.975
P10,0.025
) (E(W1),E(W10))
(0.5,1.0,0.3) (3.05,6.35) (0.17,0.79)
(1.0,1.0,0.3) (7.08,34.28) (0.14,0.75)
(2.0,1.0,0.3) (13.39,76.77) (0.10,0.67)
(0.5,1.0,0.6) (2.80,5.78) (0.15,0.76)
(1.0,1.0,0.6) (8.44,35.06) (0.16,0.70)
(2.0,1.0,0.6) (12.33,144.22) (0.13,0.62)
6 Discussion
In this paper, we have investigated the impact of exposure misclassification on the
asymptotic bias of different effect estimators when exposure effects are confounded
by measured covariates. Our interest in this stems from the fact that we anticipated
the different estimators to be differently affected by misclassification error because
some of them not only use the exposure as a covariate in a regression model, but also
rely on estimates of the expected exposure, given background covariates. However,
in contrast to our anticipation, we found OLS estimators, (DR) IPTW estimators
and G-estimators to be equally affected by misclassification error under linear mod-
els (and approximately under logistic models) when misclassification is unrelated to
the considered confounders. Differences in asymptotic bias between the different es-
timators arise when misclassification is related to the confounders. Indeed, now the
bias of the OLS estimator and G-estimator becomes dependent upon the degree of
162 Causal Effect Estimators Under Exposure Misclassification
2 4 6 8 10
−
0.
5
0.
0
0.
5
time
R
el
at
iv
e 
Bi
as
1 3 5 7 9 2 4 6 8 10
−
0.
5
0.
0
0.
5
time
R
el
at
iv
e 
Bi
as
1 3 5 7 9 2 4 6 8 10
−
0.
5
0.
0
0.
5
time
R
el
at
iv
e 
Bi
as
1 3 5 7 9
2 4 6 8 10
−
0.
5
0.
0
0.
5
time
R
el
at
iv
e 
Bi
as
1 3 5 7 9 2 4 6 8 10
−
0.
5
0.
0
0.
5
time
R
el
at
iv
e 
Bi
as
1 3 5 7 9 2 4 6 8 10
−
0.
5
0.
0
0.
5
time
R
el
at
iv
e 
Bi
as
1 3 5 7 9
Figure 2: Relative bias E{(βˆt − β∗)/β∗} as a function of end-of-study time t, for the
unadjusted estimator (solid line), the IPTW estimator with stabilized weights (seg-
mented line) and the G-estimator (dotted line), when the reclassification probabilities
are π0|0,X = π1|1,X = 0.8, 0.9, 1 and γ takes the value 1. For the IPTW estima-
tor and the G-estimator from top to bottom of each plot, the lines correspond to
π0|0,X = π1|1,X = 1, 0.9 and 0.8. In rows 1 and 2 from left to right, θ2 takes the
values 0.5, 1 and 2 respectively. The autocorrelation ρ equals 0.3 in row 1 and 0.6 in
row 2.
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Figure 3: Relative standard deviation SD(βˆt)/β
∗ as a function of end-of-study time t,
for the unadjusted estimator (solid line), the IPTW estimator with stabilized weights
(segmented line) and the G-estimator (dotted line), when reclassification probabilities
are π0|0,X = π1|1,X = 0.8, 0.9, 1 and γ takes the value 1. In rows 1 and 2 from left to
right θ2 takes the values 0.5, 1 and 2 respectively. The autocorrelation ρ equals 0.3 in
row 1 and 0.6 in row 2.
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confounders-exposure association, unlike the bias of the (DR) IPTW estimator. The
latter may be due to the inherent impact of inverse weighting, which is to eliminate
the association between exposure and confounder.
Appendix 5.A: Derivation of
asymptotic bias expressions
for the considered causal
effect estimators
In this Appendix, we calculate the asymptotic bias of the four considered estima-
tors by solving the expected estimating function of these estimators with D replaced
by W . For IPTW estimators, we first take the expectation of the estimating function
(with general index function h(w) = (h1(w) h2(w)) over the conditional distribution
of D, given (Yd,W,X) and the conditional distribution of W , given (Yd,X). Upon
noting that Yd ⊥⊥ W |D,X for d = 0, 1 together with the assumption of no unmea-
sured confounders (5.1) implies that Yd ⊥⊥W |X for d = 0, 1, this yields,
0 = E(UI(β
∗)) = E
[
1∑
d=0
h(W )
P (D = d|W,Yd,X)
P (W |X) (Yd − α− βW )
]
= E
[
1∑
w=0
1∑
d=0
h(w)P (D = d|W = w,X)(Yd − α− βw)
]
= E
[
1∑
w=0
1∑
d=0
h(w)πd|w,X {g(X) + β∗d− α− βw}
]
=
1∑
w=0
1∑
d=0
h(w)E{πd|w,X
(
g(X)− α)}+ E(πd|w,X)(β∗d− βw
)
.
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Solving the resulting set of equations
(hj(0) + hj(1))(α
∗ − α) + [hj(0)(1− E(π0|0,X)) + hj(1)E(π1|1,X)]β∗ − hj(1)β = 0
for j = 1, 2 yields (5.14) and (5.15), regardless of the choice of index functions.
The estimating function for the doubly robust (DR) IPTW estimator is
UD(α, β) =
h(W )(Y − α− βW )
P (W |X) − E
{
h(W )(Y − α− βW )
P (W |X) |W,X
}
+E
{
h(W )(Y − α− βW )
P (W |X) |X
}
where the last 2 terms have mean zero when, as we assume, the model for P (W |X)
is correctly specified. It follows that E{UD(α, β)} = E{UI(α, β)} and thus that DR
IPTW and IPTW estimators have the same bias.
To find the asymptotic bias of G-estimator, we take the expectation of the esti-
mating function (5.11) (with D replaced by W ) over the conditional distribution Y ,
given (D,W,X) and then over the conditional distribution D, given (W,X):
0 = E{UG(β)} = E [{W − E(W |X)}{E(Y |D,W,X)− βW − E(Y − βW |X)}]
= E [{W − E(W |X)}{β∗(D − E(D|X))− β(W − E(W |X))}]
= E
[{W − E(W |X)}2{β∗(π1|1,X − π1|0,X)− β}]
= E
[
β∗σ2W |X(π1|1,X − π1|0,X)− βσ2W |X
]
.
Solving this equation yields
β =
β∗
E{σ2W |X}
E{σ2W |X(π1|1,X + π0|0,X − 1)}
= β∗
[
Cov(σ2W |X , π1|1,X + π0|0,X − 1)
E(σ2W |X)
+ E(π1|1,X + π0|0,X − 1)
]
.
From Robins et al.(1992, page 486) the OLS estimator can be obtained by replacing,
E(W |X) with E∗(W |X), the fitted value from a linear regression of W on X in the
estimating equation (5.11). It then follows that σ2W |X in the above expression should
be replaced with
E{(W − E∗(W |X))2|X} = E{(W − E(W |X) + E(W |X)− E∗(W |X))2|X}
= σ2W |X + {E(W |X)− E∗(W |X)}2.
Appendix 5.B: T ime-varying
exposures
Here, we show that when there is no interaction effect between Dt and Xt at
each time t, model (5.20) with the additional restriction that there is no effect of
early exposures, that is, E{Yt(dt−1,0) − Yt0|Dt−1,Xt−1} = 0, implies model (5.21). It
follows from model (5.20) that,
E{YtDt |Dt,Xt} = E{Yt(Dt−1,0)|Dt−1,Xt}+ β∗Dt
by no unmeasured confounders assumption, we will have
E{YtdtDt−1 |Dt−1,Xt} = E{Yt(dt−1Dt−2,0)|Dt−2,Xt)}+ β∗dt.
By taking expectation on the latter expression with respect to Xt,
E{Ytdtdt−1Dt−2 |Dt−2,Xt−1} = E{Yt(dt−1dt−2Dt−3,0)|Dt−3,Xt−1)}+ β∗dt
by repeating this process we will obtain E{Ytdt} = E{Yt(dt−1,0)}+β∗dt. Therefore by
supposing that E{Yt(dt−1,0)} = αt implies model (5.21).
Now we show that the expected estimating equations of both estimators involve the
conditional distribution Xt given Dt−1,Xt−1 and Xt given Xt−1. For illustration
t = 2, model (5.21) can be written E{Y2d2} = α∗2 + β∗d2. The estimating equation of
(5.24) when Wt is observed instead of Dt with non stabilized weights can be obtained
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UI2(β) =

 11
W1

 1
P (W1|X1 (Y1d1 − α1 − βW1)
+

 12
W2

 1
P (W1|X1)P (W2|W1,X2)
(Y2d2 − α2 − βW2).
By non-misclassification assumption, the expected estimating equation of UI2(β) fol-
lows that,
0 = E(UI2(β)) = E{
1∑
d=0

 11
W1

 P (D1 = d1|W1,X1)
P (W1|X1 (Y1d1 − α
(1) − βW1)
+
1∑
d1=0
1∑
d2=0

 12
W2

 I(D1 = d1)P (D2 = d2|W 2,D1 = d1,X2)
P (W1|X1)p(W2|W1,X2)
(Y2d2 − α(2) − βW2)}
and the limiting values (α1, α2, β) that solve the resulting expected estimating equa-
tion should be obtained by solving equation below which is involved the conditional
distribution of X2 given D1, W1,X1 and X2 given X1,
0 = E(UI2(β)) = E{
1∑
d=0
1∑
w1=0

 11
w1

πd1|w1(Y1d1 − α0 − α1 − βw1)
+
1∑
d1=0
1∑
w1=0
1∑
w21=0
1∑
d2=0

 12
w2

πd1|w1πd2|w2 P (X2|D1 = d1,W1 = w1,X1)P (X2|X1)
×(Y2d2 − α0 − 2α1 − βw2)}.
The limiting value β that solves the resulting expected limiting estimating equation
(5.29) of G-estimation is also involved the conditional distribution X2 given D1, W1
and X1 and X2 given X1.
Chapter 6
Discussion
Summary
This chapter gives a final discussion and plans for future work. We review the
results which were presented in the previous chapters. We will explain how the meth-
ods discussed in this thesis can be extended and what obstacles that one might be
confronted with. Moreover, we will discuss plans for future work.
Introduction
This thesis has addressed two problems: the problem of measurement error in
exposures and of measured or unmeasured confounding of the effect of exposure on
outcome. As stated, a common strategy for dealing with two these problems is to use
instrumental variable estimation methods.
In this thesis, we have first given an expository review of IV-estimators for the causal
odds ratio. Specifically, we have focused on exact estimators as well as a number
of popular approximate ones, without being exhaustive; in particular, we have omit-
ted estimators based on principal stratification (e.g. Abadie, 2003; Ten Have et al.,
2003) as this approach does not allow a flexible treatment of continuous exposures
and is rather artificial in the context of Mendelian randomization studies (Didelez,
Meng and Sheehan, 2008). Our results have shown that the concerns of Robins and
Rotnitzky (2004) about incongeniality of the model of Vansteelandt and Goetghebeur
(2003) can be overruled by leaving the main effect of the IV in their association model
unrestricted. For general IVs, leaving its main effect unrestricted requires the use of
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generalized additive association models. The performance of the resulting estima-
tor remains to be studied. Our simulation studies complemented recent studies by
Didelez, Meng and Sheehan (2008), Palmer et al. (2008) and Rassen et al. (2008),
but include results on the bias and efficiency of exact IV-estimators. They have re-
vealed that these ‘exact’ estimators tend to outperform ‘approximate’ estimators of
the causal odds ratio that are commonly used in the literature on Mendelian random-
ization. Of all considered estimators, the Exact IV-estimators are the only ones which
are asymptotically unbiased, although they may have an important finite-sample bias
when there is limited information (e.g. due to low prevalence, weak IV, small sam-
ple size, ...). The Approximate IV-estimator tended to outperform standard logistic
regression when there was confounding of a sufficient magnitude, and was doing espe-
cially well at the causal null hypothesis. This estimator has a number of attractions
over the Exact IV-estimators in that it can be used for the analysis of case-control
data (Smith et al., 2005) and lends itself particularly well to meta-analyses based
on summary measures (Minelli et al., 2004). In addition, it can be extended to the
analysis of time-varying exposures. Indeed, consider the following logistic structural
nested mean model
logitE(Yt(xs0)|Xs = xs, R)−logitE(Yt(xs−10)|Xs = xs, R) = ψ∗I(s = t)xt+γ∗I(s < t)xs
where Yt(xs0) denotes the counterfactual outcome that would be observed at time t if,
possibly contrary to fact, the exposure history Xt = (X1, ...,Xt) equaled (xs, 0, ..., 0),
and R is instrumental variable (IV) the effect of Xt on Yt at time t, which by defini-
tion, satisfies the following properties (a) R is associated with Xt; (b) R affects the
outcome Yt only through Xt (i.e. often referred to as the exclusion restriction); (c)
the association between R and Yt is unconfounded. This model allows for the short
term effect ψ∗ to differ from the long term effect γ∗. Using similar approximations in
one time point, it can be shown that this model implies
logitE(Yt|R) = ω∗t + ψ∗E(Xt|R) + γ∗
t−1∑
s=1
E(Xs|R)
where Yt is the observed outcome at time t > 0. Having obtained estimates of
E(Xs|R) for s > 0, this model can be fitted, and thus estimates of ψ∗ and γ∗ can
be obtained using standard software for marginal models. The resulting estimators
continue to share the local robustness property of being consistent at the causal null
hypothesis. It remains to be evaluated to what extent the approximation errors prop-
agate with time and thus how prone to bias these estimators are away from the
causal null hypothesis. It additionally remains to be studied whether similar adjust-
ments as for the Adjusted IV-Estimator (possibly including the previously suggested
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corrections for measurement error) can remedy some of the bias of the resulting es-
timator. When the exposure and error are additive, then the Adjusted IV-estimator
is still prone to some bias because the model for E(X|R) may be misspecified and
because, even when it is correctly specified, E(X|R) is not known in practice so that
X − Eˆ(X|R) is an imprecise estimate of the unmeasured confounder U . It remains to
be explored whether methods for measurement error correction, such as Simulation-
Extrapolation (Carroll et al., 2006), can help attenuate this bias.
In linear structural mean models (Robins, 1994), the assumption that the treatment
effect is not modified by the instrument, i.e. that
E(Y − Y0|X,R) = ψ∗X
does not depend on R, implies that marginal and conditional effects are the same.
This is seen because the above model implies the same observed data restriction,
namely E(Y − ψ∗X|R) = E(Y − ψ∗X), as model E(Y − Y1|X,R) = φ∗(X − 1), thus
indicating that
E(Y1 − Y0|X = 1, R) ≡ ψ∗ = φ∗ ≡ E(Y1 − Y0|X = 0, R)
and, consequently, that ψ∗ = E(Y1 − Y0). The same is no longer true in logistic
structural mean models, where additional assumptions are required to infer marginal
causal effects. Adjustment for baseline covariates (more generally, covariates which
are not causally affected by exposure, outcome or IV) can be discussed in future work.
Covariate adjustment is easily realized for all considered IV-estimators by addition-
ally including these in all considered regression models. For the exact IV-estimators,
this requires testing whether the predicted counterfactual outcome Y0 is independent
of the IV, conditional on baseline covariates. When there is a continuous baseline
covariate or multiple discrete covariates, then the model of Vansteelandt and Goet-
ghebeur (2003) is no longer guaranteed to yield a congenial parameterization, unlike
the model of Robins and Rotnitzky (2004). The similarity of the estimating functions
indicates that, nevertheless, similar estimates would typically be obtained with both
approaches.
Because of the close link between IV-estimators for inferring causal effects and IV-
estimators for correcting for measurement error (Dunn, 2005; Greenland, 2000, 2005),
it will be of interest to examine in future work whether the considered exact IV-
estimators of the causal odds ratio may shed new light on measurement error correc-
tion in logistic regression models in the presence of an IV. In Chapter 3, we have taken
this link one step further in the context of linear structural mean models, and used
one IV for inferring a causal effect and another IV for correcting for measurement
error in the exposure. Specifically, we have proposed a general procedure to correct
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IV estimators for systematic error in the exposure when an additional instrumental
variable for the measurement error was available. Note from the Chapter 3 that the
2 considered IV’s satisfy different restrictions. The IV for inferring a causal effect
satisfies the assumptions that it is: associated with the exposure, has not direct effect
on outcome except through the exposure, and that its association with outcome is
unconfounded; and in contrast the IV for measurement error correction satisfies the
assumption that it is a (pre-exposure) surrogate for the observed exposure (in the
sense that it is correlated with exposure), which was thus assumed not to modify the
exposure effect of interest. In our example, the Causal-IV R was randomization and
the Measurement error-IV T was age which is assumed not to modify the treatment
effect. In placebo-controlled randomized trials with noncompliance, measurements T
on run-in placebo compliance may very well meet the assumption of a measurement
error IV. With concern for compliance mismeasurement, recording run-in compliance
may thus be favorable. More generally, we have shown that IV-Causal’s can be used
as IV’s for the measurement error. On theoretical grounds and on the basis of simula-
tion experiments, we recommend the ‘improved error-adjusted estimator’ of Chapter
3 for data analysis. This estimator was designed so that adjustment for measurement
error does not compromise the power of tests of the causal null. This is attractive,
knowing that standard tests of the causal null hypothesis (i.e., that the causal in-
strument R is independent of outcome) ignore exposure measurements and are thus
valid in the presence of measurement error. Because the proposed estimator does not
converge uniformly to a normal distribution, we recommend the proposed uniform
confidence intervals. For illustrative purposes, we have developed this work under
structural mean models which assume linear exposure effects that are not modified
by pre-exposure covariates. Extensions to linear structural mean models that allow
for effect modification by baseline covariates are methodologically straightforward,
but computationally more demanding. Finally, we believe the results of Chapter 3
to be more broadly useful as they suggest, in line with Gustafson (2005), that in-
corporating a little prior information on a weakly identified nuisance parameter may
yield substantial efficiency improvements for the target parameter. Similar ideas may
therefore prove useful in related settings (Vansteelandt and Goetghebeur, 2004; Fis-
cher and Goetghebeur, 2004; Ten Have et al., 2007) with weak identification. In
addition, our results indicate how such prior information may be adopted in a fre-
quentist analysis.
In this thesis, we have finally investigated the impact of exposure reclassification
on the asymptotic bias of different effect estimators when exposure effects are con-
founded by measured covariates. We have done this by comparing inverse probability
of treatment weighted (IPTW) estimators and doubly robust estimators for the ex-
posure effect in linear marginal structural mean models (MSM) with G-estimators,
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and propensity score (PS) adjusted estimators. Our interest in this stems from the
fact that we anticipated the different estimators to be differently affected by reclas-
sification error because some of them not only use the exposure as a covariate in a
regression model, but also rely on estimates of the expected exposure, given back-
ground covariates. To allow for measurement error correction, it would be of interest
to adapt the misclassification SIMEX (MC-SIMEX) approach to settings where the
reclassification probabilities are supposed to be known or can be obtained from other
studies.
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